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The European-Japanese Cerebrovascular Congress origi-
nally started as a Swiss-Japanese joint conference on cere-
bral aneurysm. The Congress was held in Zürich, Switzerland, 
from 5–7 May 2001 with Prof. Y. Yonekawa of Zürich and 
Prof. Y. Sakurai of Sendai as the presidents.
At that time, Japanese National Hospitals received Health 
Sciences Research Grants for Medical Frontier Strategy 
Research from the Japanese Ministry of Health, Labour and 
Welfare regarding multi-center studies on the treatment of 
unruptured cerebral aneurysms. Since an international coop-
erative study was organized between Prof. Yonekawa of the 
Department of Neurosurgery of Zürich University and 
Japanese National Hospitals, the congress was planned as a 
research meeting for the theme.
The first day offered a unique opportunity to gather 
European and Japanese neurosurgeons to discuss the treat-
ment of unruptured cerebral aneurysms. Presentation of 
these new clinical experiences facilitated intensive discus-
sions in order to clarify updated and appropriate ways to 
focus the treatment. The second day provided updated infor-
mation on neurocritical care as well as endovascular and sur-
gical treatment modalities carried out in daily practice in 
Zürich and Japan. Roundtable discussions encouraged inter-
active communication between the participants and faculties 
(Fig. 1).
Three years later, in July of 2004, the second meeting was 
also held at Zürich, with wide-ranging conference topics on 
cerebral stroke surgery.
The first day was to discuss the treatment of cerebral 
aneurysms and subarachnoid hemorrhage.
The discussion on the second day focused on the treat-
ment of intracranial arteriovenous malformations, and dis-
cussion on the third day was on cerebral revascularization 
(Fig. 2).
Publication of the proceedings books of the conference as 
supplements of ACTA Neurochirurgica is one of the main 
reasons we have been able to continue this conference for 
almost 20 years. We sincerely thank Prof. Steiger for his con-
tinuous and generous cooperation as the series Editor of 
ACTA Neurochirurgica.
The third meeting at Zürich in 2006 was the key congress 
for future development. The conference was expanded to the 
European-Japanese Joint Conference for Stroke Surgery 
(Fig. 3).
As the year of 2006 was the 70th Anniversary of the 
Department of Neurosurgery, University Hospital Zürich, 
Prof. Krayenbühl, Prof. Yasargil, and Prof. Yonekawa intro-
duced the impressive history of the Department of 
Neurosurgery at the conference. We were all impressed by 
the contribution of Zürich University to the development of 
neurosurgery in Europe, Japan, and throughout the world.
Symposiums on the treatment of moya moya disease, 
aneurysms, AVM, and AVF were held at the same time.
The AVM randomized trial (ARUBA) was introduced by 
Prof. J.  P. Mohr of New  York. Professor A.  Valavanis of 
Zürich gave a lecture on the endovascular treatment of 
AVM, and Prof. E. Motti of Milano gave a lecture on AVM 
treatment using Gamma knife. An epidemiological survey 
of dural AV fistula in Japan was described by Prof. 
N. Kuwayama of Toyama.
The natural history and annual rupture rate of unruptured 
intracranial aneurysms were discussed by Prof. M. Yonekura 
of Nagasaki.
At the fourth European-Japanese Joint Conference on 
Stroke Surgery we moved from Zürich to the beautiful 
Nordic city of Helsinki, with Prof. Juha Hernesniemi as the 
conference president. The participants presented papers and 
discussed surgery for cerebral aneurysms and the manage-
ment of subarachnoid hemorrhage and stroke, arterial dissec-
tion, intracranial arteriovenous malformations, and fistulas. 
Microsurgical extra-intracranial bypass surgery and revascu-
larization techniques were also discussed. On the same 
T. Tsukahara (*) 
Department of Neurosurgery, National Hospital Organization, 
Kyoto Medical Center, Kyoto, Japan
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 occasion, we visited Prof. Hernesniemi’s world-famous 
operating room in Helsinki (Fig. 4).
The fifth joint conference was held at Düsseldolf am Rein 
with Prof. Hans-Jakob Steiger as the conference president. 
Management of cerebral and ventricular hemorrhage, sub-
arachnoid hemorrhage, extra-intracranial bypass surgery, 
surgical and endovascular treatment of arterial occlusive dis-
ease, and embolization and microsurgery of AVM and dural 
AV-fistula were the main themes. Special topics of the con-
ference were cerebral and ventricular hemorrhage and cere-
bral vascular reconstruction. In order to strengthen the focus 
on new trends, an open invitation for submission was made. 
A number of emerging concepts were presented and dis-
cussed in the resulting meeting (Fig. 5).
The sixth conference, named “The European-
Japanese Stroke Surgery Conference” (EJSSC), was 
held in Utrecht, The Netherlands. Professor Luca Regli 
and Prof. Gabriel Rinkel were the conference presi-
dents. The main topics of the conference comprised 
surgical and endovascular management of intracranial 
Fig. 1 Conference program (a) and the proceedings book of the first 
meeting: Yonekawa Y, Sakurai E, Keller E, Tsukahara T, eds. New 
Trends in Cerebral Aneurysm Management. ACTA Neurochirurgica 
Supplement 82. Springer-Verlag/Wien; 2002. (b). Prof. Y. Yonekawa of 
Zürich and Prof. Y. Sakurai of Sendai in the Saal of Zurich University at 
the first meeting (c)
Fig. 2 Conference program 
(a) and the proceedings book 
of the second conference: 
Yonekawa Y, Sakurai E, 
Keller E, Tsukahara T, eds. 
New Trends for Stroke and its 
Perioperative Management. 
Acta Neurochirurgica 




aneurysms and arteriovenous malformations; current 
concepts in cerebrovascular reconstruction; and new 
developments in cerebrovascular imaging. A number 
of emerging concepts were also presented and dis-
cussed at this meeting (Fig. 6).
The seventh European-Japanese Stroke Surgery 
Conference (EJSSC) was held in the beautiful city of 
Verona, Italy with Presidents Prof. Alberto Pasqualin and 
Prof. Giampietro Pinna. The main topics of the conference 
were surgical and endovascular management of intracranial 
aneurysms and arteriovenous malformations and cerebro-
vascular reconstruction. We also enjoyed beautiful paint-
ings by Veronese and opera at the ancient Arena de Verona 
(Fig. 7).
The eighth European-Japanese Cerebrovascular 
Congress (EJCVC) came back to Zürich in the year 
2016 with Prof. Luca Regli as the president. The main 
topics of the conference consisted of management of 
Fig. 3 Conference program 
(a) and the proceedings book 
of the third conference: 
Yonekawa Y, Tsukahara T, 
Valavanis A, Khan N, eds. 
Changing Aspects in Stroke 
Surgery: Aneurysms, 
Dissections, Moyamoya 





Fig. 4 Conference program 
(a) and the proceedings book 
of the fourth conference: 
Laakso A, Hernesniemi J, 
Yonekawa Y, Tsukahara T, 
eds. Surgical Management of 
Cerebrovascular Disease. 
Acta Neurochirurgica 
Supplement 107. Springer- 
Verlag/Wien; 2010. (b)
History of the European-Japanese Cerebrovascular Congress
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Fig. 5 Conference program (a) and the proceedings book of the fifth conference: Tsukahara T. Regli L, Hänggi D, Turowski B, Steiger H-J, eds. 
Trends in Neurovascular Surgery. Acta Neurochirurgica Supplement 112. Springer-Verlag/Wien; 2011. S (b)
Fig. 6 Conference program 
(a) and the proceedings book 
of the sixth conference: 
Tsukahara T, Esposito G, 
Steiger H-J, Rinkel GJE, 
Regli L, eds. Trends in 
Neurovascular Interventions. 
Acta Neurochirurgica 




intracranial aneurysms, arteriovenous malformations, 
cavernoma and dural arteriovenous fistulas, and hem-
orrhagic and ischemic stroke, current trends in cere-
brovascular reconstruction and cerebrovascular 
neuroanatomy, and new concepts in cerebrovascular 
imaging.
At the same time, the Cerebral Blood Flow Meeting and 
Microsurgery Course Zürich were organized (Fig. 8).
Fig. 7 Conference program (a) and the proceedings book of the seventh conference: Tsukahara T, Pasqualin A, Esposito G, Regli L, Pinna G, eds. 
Trends in Cerebrovascular Surgery. Acta Neurochirurgica Supplement 123. Springer International Publishing Switzerland; 2016. (b)
Fig. 8 Conference program 
(a) and the proceedings book 
of the eighth conference: 
Esposito G, Regli L, Kaku Y, 
Tsukahara T, eds. Trends in 
the Management of 
Cerebrovascular Diseases. 
Acta Neurochirurgica 
Supplement 129. Springer 
International Publising; 2018. 
(b)
History of the European-Japanese Cerebrovascular Congress
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The ninth European-Japanese Cerebrovascular 
Congress (EJCVC) was held in the historical room of 
Grande Ospedale Metropolitano Niguarda Milan, Italy, on 
7–9 June 2018, with Prof. Marco Cenzato as the president. 
The main theme of the congress was preventive cerebro-
vascular surgery. A number of emerging concepts were 
presented and discussed by European and Japanese partici-
pants. Very fruitful presentations and discussions will be 
published as the proceedings book of ACTA 
Neurochirurgica Supplement, the same as with previous 
meetings (Fig. 9).
The tenth European-Japanese Cerebrovascular Congress 
(EJCVC) will be held in Kyoto, Japan with Prof. Tetsuya 
Tsukahara and Prof. Yasuhiko Kaku as the presidents. Due to 
the pandemic crisis of Covid-19, the 10th EJCVC in Kyoto 
has been postponed to November 2021.
It will be the first meeting in Japan of the European- 
Japanese Cerebrovascular Congress (EJCVC). A number of 
European and Japanese participants will be expected to join 
the congress and have fruitful discussions on New Trends of 
Cerebrovascular treatment.
Conflict of Interest The author declares that I have no conflict of 
interest.
Fig. 9 Program of ninth conference
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When Is Diagnostic Subtraction 
Angiography Indicated Before Clipping 
of Unruptured and Ruptured 
Intracranial Aneurysms? 
An International Survey of Current 
Practice
Martina Sebök, Jean-Philippe Dufour, Marco Cenzato, 
Yasuhiko Kaku, Michihiro Tanaka, Tetsuya Tsukahara, 
Luca Regli, and Giuseppe Esposito
 Introduction
Digital subtraction angiography (DSA) is considered the 
gold standard for understanding the angioanatomy in rup-
tured and unruptured intracranial aneurysms (IAs) [1–5]. 
More recently, computed tomography angiography (CTA) 
has been introduced as an alternative imaging modality for 
ruptured aneurysms [6]. Sensitivities ranging from 77–97% 
and specificities ranging from 87–100% for the identification 
of ruptured aneurysms using CTA have been reported [3, 4, 
7–9]. High-resolution magnetic resonance angiography 
(MRA), on the other hand, is frequently used for unruptured 
aneurysms as an alternative noninvasive modality [10]. In a 
systematic review [11] of studies evaluating the value of 
MRA for the diagnosis of intracranial aneurysms, a pooled 
sensitivity of 95% and pooled specificity of 89% have been 
reported. By comparison, in 2000 the very first meta-analysis 
[12] reported a per-aneurysm pooled sensitivity and specific-
ity of MRA of 87% and 95% for the detection of IAs, respec-
tively. Both CTA and MRA can in many cases provide the 
necessary information for the preoperative planning of intra-
cranial aneurysms, comparable to DSA [10, 11, 13, 14]. In 
cases of mural calcifications, CTA has a sensitivity superior 
to that of MRA [10, 15].
The goal of this survey is to investigate the daily practice 
regarding indications for DSA before clipping of ruptured 
and unruptured IAs in an international panel of neurovascu-
lar specialists.
 Methods
 Survey Development and Distribution
We elaborated an anonymous survey containing 23 multiple- 
choice questions (see Appendix) to investigate when and 
why cerebrovascular specialists consider a DSA to be indi-
cated before the clipping of ruptured and unruptured IAs.
The survey was structured as follows. First, general ques-
tions about the responder’s specialty and institution were 
asked: country, specialty of responder, number of treated 
aneurysms as main surgeon, and number of treated ruptured 
and unruptured aneurysms per year at responders’ institu-
tion. Second, questions regarding the choice of aneurysm 
treatment and the quality of imaging modalities at the 
responders’ institutions were asked. Third, responders were 
asked the situations (unruptured aneurysms/ruptured aneu-
rysms/ruptured aneurysms with life-threatening hematoma) 
and aneurysm locations (MCA or locations other than MCA) 
in which microsurgical treatment is to be performed without 
preoperative DSA. Finally, responders were asked to select 
factors which in their view influence the need for  preoperative 
M. Sebök · J.-P. Dufour · L. Regli · G. Esposito (*) 
Department of Neurosurgery, Clinical Neuroscience Center, 
University Hospital Zurich, University of Zurich, Zurich, 
Switzerland
e-mail: Martina.Seboek@usz.ch; luca.regli@usz.ch;  
giuseppe.esposito@usz.ch 
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DSA, from a list of aneurysm-, patient-, and treatment- 
related factors (Table 5).
A paper version of this survey was distributed to the 
attendees of the ninth European–Japanese Cerebrovascular 
Congress (EJCVC—www.ejcvc2018.com), which took 
place in Milan, Italy at 7–9 June 2018 and was thereafter col-
lected. The EJCVC is a biennial cerebrovascular meeting 
initiated in Zurich in 2001 and represents a unique opportu-
nity to gather the latest updates on neurovascular surgery and 
interventions for cerebrovascular diseases.
 Data Analysis
Data were manually imported into a digital database 
(Statistical Package for the Social Science) (SPSS) version 
24 for Windows (IBM, Armonk, New York, USA). The vari-
ous results were reported as value or proportion (%). 
Descriptive statistics were used to analyze the collected data. 
Categorical data were analyzed using the χ2 test. Statistical 
significance was defined at p < 0.05.
 Results
 Baseline Characteristics of Survey Responders
The total number of participants at the EJCVC was 152. The 
survey was offered to all participants at the entrance to the 
conference auditorium. A total of 93 surveys were distrib-
uted and 67 (72%) completed surveys were returned during 
the three days of the conference. The responders worked in 
13 different countries. The baseline characteristics are shown 
in Table 1.
Eighty-five percent of all responders were neurosurgeons, 
7.5% neurointerventionalists, and 7.5% hybrid neurosur-
geons. A hybrid surgeon is a cerebrovascular specialist able 
to treat aneurysms both by microsurgical and by endovascu-
lar methods.
Seventeen percent of responders had treated more than 
500 aneurysms as main surgeon, 18% between 200 and 500 
aneurysms, 10% between 100 and 200 aneurysms, 23% had 
treated between 20 and 100 aneurysms, and 12% between 1 
and 20 aneurysms. Twenty percent of responders had never 
treated an aneurysm as a main surgeon.
Twenty-eight percent of all responders worked at institu-
tions that treated 50–100 unruptured aneurysms per year, 
while 48% of all responders worked at institutions that 
treated 20–50 unruptured aneurysms per year.
Twenty-seven percent of all responders worked in institu-
tions where the number of ruptured aneurysms treated per 
year is 50–100, while 54% of responders worked at an insti-
tution treating 20–50 ruptured aneurysms per year.
Concerning the final decision for the type of treatment, 
80% of responders assume an interdisciplinary approach (on 
neurovascular boards or by directly discussing the cases 
among neurosurgeons, neuroradiologists, and neurologist).
Ninety-one percent of all responders worked at institu-
tions offering good quality CTA and 97% at an institution 
with a good quality MRA (at least 1.5 T). Good quality neu-
roimaging is defined as imaging capable of displaying every 
vessel of the circle of Willis in high definition. In cases where 
a preoperative DSA is considered indicated, 82% of respond-
ers also request tridimensional rotational sequences.
No statistical differences were seen in the baseline char-
acteristics between survey responders from Europe and 
Japan.
 Impact of Aneurysm Location and Rupture 
Status
For MCA aneurysms, 64% of survey responders would treat 
unruptured aneurysms without preoperative DSA, and 60% 
Table 1 Baseline characteristics of 67 respondents to the survey
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of responders would treat ruptured MCA aneurysms with-
out preoperative DSA. Ninety-seven percent of responders 
would treat ruptured MCA aneurysms with life-threatening 
hematoma without preoperative DSA (Table 2).
Regarding aneurysms in locations other than the MCA, 
68% of survey responders would treat unruptured aneu-
rysms without preoperative DSA, and 73% of responders 
would treat ruptured aneurysms without preoperative 
DSA. Ninety- six percent of all responders would treat rup-
tured aneurysms in other locations than the MCA with 
life-threatening hematoma without preoperative DSA 
(Tables 2 and 3). There were no statistically significant dif-
ferences in decision-making regarding preoperative DSA 
for aneurysm treatments between European and Japanese 
neurosurgeons.
Because 20% of all responders never treated an aneurysm 
as a main surgeon, in Table 3 we adapted a crosstab of surgi-
cal aneurysm treatment without preoperative DSA based on 
aneurysm location and performed a calculation excluding 
survey responders who never treated an aneurysm as main 
surgeon. Results do not show significant changes if one does 
not consider the surgeons who never clipped an aneurysm 
(Tables 2 and 3).
 Impact of Surgeon Experience on Decision 
to Perform a Preoperative DSA
The benchmark for an experienced surgeon was set at 100 
treated aneurysms as main surgeon. Forty-five percent of survey 
responders classify as experienced aneurysm surgeons. Table 4 
represents a crosstab of the impact of a surgeons’ experience on 
the decision to perform a preoperative DSA. Because in cases of 
life-threatening hematoma nearly all survey responders decide 
to waive a preoperative DSA (Tables 2 and 3), the impact of 
experience in these cases was not calculated.
In cases of unruptured aneurysms in locations other than 
the MCA, experienced neurosurgeons treat aneurysms sig-
nificantly more often without a preoperative DSA, compared 
to less experienced colleagues (experienced vs. less- 
experienced: 80% vs. 43%, p = 0.002).
In cases of unruptured MCA aneurysms, a similar trend is 
seen: Experienced neurosurgeons perform surgeries without 
preoperative DSA more often than less experienced col-
leagues (experienced vs. less-experienced: 71% vs. 49%, 
p = 0.08).
For ruptured MCA aneurysms and ruptured aneurysms in 
other locations, the data again show differences in absolute 
numbers, whereby preoperative DSAs are less frequently 
requested by experienced neurosurgeons (but without reach-
ing significant differences between the experienced and less- 
experienced group).
 Factors Influencing the Decision to Perform 
a Preoperative DSA
Table 5 summarizes aneurysm-related factors, patient-
related factors, and treatment-related factors that influence 
the choice of survey responders to perform a preoperative 
DSA.
The most important aneurysm-related factors indicating 
a preoperative DSA examination are: aneurysmal shape 
(fusiform or dissecting aneurysms: >80% of responders 
ask for a preoperative DSA); infectious aneurysm etiology 
(72% of responders); maximum aneurysm diameter 
>25  mm (85% of responders); paraclinoidal or posterior 
circulations aneurysms (>70% of responders); possible 
perforators and vessels arising from aneurysm sac (85% of 
responders for both); intra-aneurysmal thrombus (73% of 
responders); and previous treatment (90% of survey 
responders).
There are no patient-related factors (age, clinical status) 
(Table  5) that influence the decision for a preoperative 
DSA.
Table 2 Crosstab of surgical aneurysm treatment without preoperative 
DSA based on aneurysm location—all survey responders







In case of life 
threatening 
hematoma
MCA 43 (64) 40 (60) 65 (97)
Other 
location
45 (68) 49 (73) 64 (96)
Table 3 Crosstab of surgical aneurysm treatment without preoperative 
DSA based on aneurysm location—excluding survey responders who 
never treated an aneurysm as main surgeon







In case of life- 
threatening 
hematoma
MCA 37 (70) 36 (68) 51 (96)
Other 
location
39 (74) 39 (74) 51 (96)
Table 4 Impact of surgeon’s experience to treat aneurysm without pre-
operative DSA
Experienced surgeon (n (%))
Aneurysm location YES (n = 30) NO (n = 37) p-value
MCA
Unruptured 23 (71) 22 (49) 0.08
Ruptured 24 (80) 25 (68) 0.20
Other location
Unruptured 24 (80) 16 (43) 0.002
Ruptured 22 (73) 19 (51) 0.18
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Regarding treatment-related factors, 78% of responders 
would ask for a DSA preoperatively in cases where a flow- 
replacement bypass is contemplated as a treatment option. 
Similarly, 85% of responders would ask for a preoperative 
DSA to assess the collateral circulation in cases where the 
possibility of bypass is evaluated.
 Discussion
The goal of the survey was to investigate, among an interna-
tional panel of neurovascular specialists participating at the 
ninth EJCVC, the workup and in particular the indication for 
preoperative DSA for patients undergoing microsurgical 
treatment of ruptured or unruptured intracranial aneurysms.
The analysis of the survey showed that in more than 80% 
of responders, the final decision for the type of aneurysm 
treatment at the responder’s institution is taken in an interdis-
ciplinary setting.
Tables 2 and 3 show a crosstab of microsurgical aneurysm 
treatment without preoperative DSA based on aneurysm 
location and rupture status. For MCA aneurysms, approxi-
mately 60% of responders perform microsurgery without 
preoperative DSA, regardless of rupture status. For aneu-
rysms in  locations other than MCA, microsurgery is done 
without preoperative DSA in 68% of unruptured and 73% of 
ruptured cases. In the case of ruptured MCA and non-MCA 
aneurysms with life-threatening hematoma, the vast majority 
of the responders (96% and 97%, respectively) perform sur-
gery without preoperative DSA.
This high percentage of responders who do not perform a 
DSA in cases of life-threatening hematoma is to be expected. 
Table 5 Aneurysm-, patient- and treatment-related factors influencing 
the choice to perform a preoperative DSA




• Middle cerebral artery (MCA) proximal 
(M1-M2 segments)
29 (43)
• Middle cerebral artery (MCA) distal 
(M3-M4 segments)
31 (46)
• Carotid-posterior communicating artery 
(PCom)
35 (52)
• Carotid-anterior choroidal artery (ACho) 41 (61)
• Carotid-T 34 (51)
• Carotid-hypophyseal 41 (61)
• Carotid-paraclinoidal (ophthalmic) 48 (72)
• Anterior cerebral artery (ACA) proximal 
(A1-A2 segments)
31 (46)
• Anterior cerebral artery (ACA) proximal 
(A3-A4 segments)
29 (43)
• Anterior communicating artery (ACom)
         – Anterior projecting 31 (46)
         – Posterior projecting 39 (58)
         – Superior projecting 37 (55)
         – Inferior projecting 33 (49)
• Posterior circulation:
         – posterior inferior cerebellar artery 
(PICA)
47 (70)
         – others (anterior inferior cerebellar 
artery, superior cerebellar artery, basilar 




         – Saccular 25 (37)
         – Fusiform 54 (81)
         – Dissecting 58 (87)
         – Infectious (i.e., mycotic) 48 (72)
• Shape:
         – Irregularity (bleb/lobulation/
daughter aneurysm)
40 (60)
         – Broad neck 41 (61)
• Maximum diameter (single):
         – <5 mm 22 (33)
         – >10 mm 35 (52)
         – >25 mm 57 (85)
• Possible perforators arising from the 
aneurysm
57 (85)
• Efferent vessels arising from aneurysmal 
sac
57 (85)
• Calcification/atherosclerotic plaque of the 
aneurysm wall
26 (39)
• Intra-aneurysmal thrombus 49 (73)
• Recurrence/previous treatment 60 (90)






Number of respondents 
answering YES (%)
         – <40 20 (30)
         – 40–60 18 (27)
         – >60 18 (27)
• Clinical situation:
         – SAH 22 (33)
         – Cranial nerve deficit 23 (34)
         – Clinical mass effect 26 (39)
         – Radiological mass effect 23 (34)
         – Previous SAH 29 (43)
Treatment-related factors
• Bypass contemplated 52 (78)
         – Visualization of possible donor 
artery (e.g. STA)
51 (76)
         – Visualization of possible recipient 
artery
47 (70)
• Collateral circulation 57 (85)
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In these cases there is no time for a DSA examination: the 
hematoma must be evacuated and the brain decompressed.
For MCA aneurysms without life-threating hematoma, 
40% of responders ask for a DSA preoperatively. This is 
quite a high percentage, especially if one considers the pos-
sible complications of a DSA: According to the literature, 
neurological complications after a DSA examination occur 
in 2.63% of cases, where 0.14% of these are strokes with 
permanent disability [16].
Our survey results suggest that a surgeons’ experience 
plays a role in deciding whether a preoperative DSA is indi-
cated. A clear difference between experienced (>100 treated 
aneurysms as main surgeon) and less experienced neurosur-
geons is seen especially in cases of unruptured aneurysms: 
experienced surgeons ask for a preoperative DSA signifi-
cantly less frequently in these patients.
Regarding the difference in requests for a preoperative 
DSA in MCA aneurysms, an almost-significant difference is 
seen in unruptured aneurysms (p = 0.08) and a trend toward 
statistical significance is seen in ruptured aneurysms 
(p  =  0.20) between experienced surgeons and less experi-
enced surgeons.
To simplify our questionnaire and the statistical workup, 
we separated the aneurysm location into MCA and locations 
other than the MCA. As a consequence, the non-MCA group 
includes a heterogeneous group of aneurysms from the ante-
rior and posterior circulation.
According to the consensus among neurovascular special-
ists, a preoperative DSA is performed more often for aneu-
rysms of the posterior circulation. Our survey confirms this 
trend: ≥70% of survey responders perform a preoperative 
DSA in patients with posterior circulation aneurysms. 
Therefore, the higher percentage of survey responders per-
forming surgeries without DSA in  locations other than the 
MCA compared to MCA aneurysms regardless of rupture 
status (unruptured locations other than MCA vs. unruptured 
MCA aneurysms: 68% vs. 64%; ruptured locations other 
than MCA vs. ruptured MCA aneurysms: 73% vs. 60%) is a 
surprising finding.
Factors which in a high percentage of responders (>70%) 
lead to the request for a preoperative DSA are: location of 
the aneurysm in the posterior circulation or paraclinoid 
aneurysms, non-saccular aneurysmal shape (fusiform or dis-
secting), infectious aneurysm etiology, maximum diameter 
of the aneurysm >25  mm, possible perforators or efferent 
vessels arising from the aneurysm sac, intra-aneurysmal 
thrombus, previous treatment of the aneurysm, bypass con-
templated, and to assess the collateral circulation. All these 
factors could be considered as characteristics of complex 
aneurysms. This is an expected finding since a general con-
sensus among the cerebrovascular specialists exists wherein 
any angioanatomical feature indicating the presence of a 
complex aneurysm should lead to a more detailed workup, 
including preoperative DSA. The aneurysmal complexity is 
namely related to at least one of the following features: (1) 
size ≥2.5 cm, (2) anatomic location (vertebral, basilar, para-
clinoid), (3) involvement of critical perforating or branch 
vessels, (4) previous treatment (endovascular or surgical), 
(5) dissecting, fusiform, saccular lesions with very broad 
neck, (6) intraluminal thrombosis, and (7) atherosclerotic 
plaques and calcifications of the aneurysm wall and/or neck 
[17–24]. There are no patient-related factors (except clinical 
status) that influence the decision for a preoperative 
DSA.  This is an expected finding because in cases of bad 
clinical status, often caused by life-threatening hematoma, 
there is no time for a preoperative DSA.
One of the aims of the survey was to assess in which 
direction the use of diagnostic DSA before microsurgical 
management of ruptured and unruptured cerebral aneurysms 
is moving among European and Japanese neurosurgeons. 
Several advantages of both noninvasive CTA and invasive 
DSA are known and should be considered, as well as the pos-
sible complications of DSA.  Previous studies introduced 
CTA as an alternative imaging modality for ruptured IAs and 
reported sensitivities ranging from 77–97%, and specificities 
ranging from 87–100% [3, 4, 7, 8]. The most recent meta- 
analysis by Menke et  al. [8] was published in 2011 and 
encompassed 45 previous studies, for a total of 3643 patients 
with ruptured and unruptured aneurysm. This meta-analysis 
reported an overall CTA sensitivity of 97.2% and a specific-
ity of 97.9%, as well as a per-aneurysm sensitivity of 95% 
and specificity of 96.2%.
In a comparative analysis between CTA and DSA for the 
diagnosis of ruptured intracranial aneurysms, Philipp et al. 
[25] concluded that the accuracy of CTA for the diagnosis of 
ruptured intracranial aneurysm may be lower than previously 
reported: in fact they found a low sensitivity of CTA (57.6%) 
for aneurysms smaller than 5 mm in size, located adjacent to 
bony structures, and for those arising from small caliber par-
ent vessels.
The “Guidelines for the Management of Patients With 
Unruptured Intracranial Aneurysms” from the American 
Heart Association/American Stroke Association [9] recom-
mend that due to its high sensitivity and specificity, even for 
smaller aneurysms, CTA can be considered as an initial diag-
nostic test for aneurysm detection and screening. However, 
the reconstruction methods may not accurately depict the 
true neck/dome/adjacent small vessel anatomy, but CTA is 
very useful in identifying mural calcification and thrombus, 
which can have a significant impact on treatment decisions 
[15, 26].
Several other advantages of CTA and MRA over DSA 
have been recognized, including reduced cost, avoidance of 
arterial injury and stroke, rapid acquisition, and retrospective 
manipulation of data. Furthermore, it is important to mention 
that both the radiation dosage and the volume of contrast 
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media is inferior with CTA than DSA (one-third to one-half 
for a single CTA compared to a four-vessel DSA) [10, 15].
The most appropriate use of the above-mentioned imag-
ing modalities, especially CTA and DSA, in guiding medical 
decision-making for treatment of ruptured and unruptured 
intracranial aneurysms, remains an issue of debate.
 Limitations
Our survey has several limitations, particularly with regard 
to responder bias and generalizability. First, the survey was 
distributed to participants of the EJCVC 2018 and therefore 
the results represent the current European and Japanese prac-
tice but might not be generalizable to other regions. Second, 
responses were voluntary and could lead to a selection bias 
for people with a particular interest and/or knowledge in 
these issues. Finally, 20% of all responders never treated an 
aneurysm as a main surgeon, indicating a possible limited 
experience in preoperative decision-making. Nonetheless, 
this subgroup of responders could have answered by using 
the decision-making algorithm of their working institution, 
which was the reason we included them in our analysis. 
However, we adapted a crosstab of surgical aneurysm treat-
ment without preoperative DSA based on aneurysm location 
and performed a calculation excluding the responders who 
never treated an aneurysm as main surgeon. The results do 
not show significant changes if one does not consider the 
surgeons who never clipped an aneurysm (Tables 2 and 3).
 Conclusion
There is still a high variability in the surgeons’ preoperative 
decision-making regarding the indication for DSA before 
clipping of intracranial aneurysms, except in case of rup-
tured aneurysms with life-threatening hematoma, where 
most of the responders perform surgery without preoperative 
DSA. For MCA aneurysms, approximately 60% of respond-
ers perform microsurgery without preoperative DSA, regard-
less of rupture status. For aneurysms in locations other than 
MCA, microsurgery is done without preoperative DSA in 
68% of unruptured and 73% of ruptured cases.
The factors favoring the execution of a DSA before clip-
ping are related to the complexity of the aneurysm: aneurys-
mal shape (fusiform, dissecting), etiology (infectious), size 
(>25 mm), possible presence of perforators or efferent ves-
sels arising from the aneurysm, intra-aneurysmal thrombus, 
previous treatment, location (posterior circulation or paracli-
noid), and flow-replacement bypass contemplated for final 
aneurysm treatment.
Moreover, a surgeons’ experience plays a role in the 
decision- making regarding preoperative DSA, with experi-
enced surgeons (>100 aneurysms treated as main surgeon) 
requesting preoperative DSAs less frequently. This effect is 
especially pronounced in patients with unruptured 
aneurysms.
 Appendix: Survey Questions
 1. In which country do you work?
…………………………………………………
 2. At which institution do you work? (if you want to 
answer)
…………………………………………………
 3. Which specialist are you?
 (a) neurosurgeon
 (b) neurointerventionist (interventional neuroradiologist)
 (c) hybrid surgeon
 (d) neurologist
 (e) neurointensivist (Neuro Intensive Care)
 (f) other: ………………………….
 4. What is your position?
 (a) chairman
 (b) senior consultant (attending clinician)
 (c) junior consultant (attending clinician)
 (d) fellow
 (e) resident
 (f) other: ………………………………….
 5. How many aneurysms have you treated in your 







 6. How many patients with unruptured intracranial 






 7. How many patients with ruptured intracranial aneu-
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 8. Who takes the final decision for the type of 
treatment?
 (a) interdisciplinary (boards or discussion of the case 
among neurosurgeons, neuroradiologists, 
neurologists)
 (b) neurosurgeon
 (c) neurointerventionalist (interventional neuroradiologist)
 (d) hybrid surgeon
 (e) neurologist
 (f) neurointensivist (Neuro Intensive Care)
 (g) others: ……………………….
 9. Do you (or surgeons at your institution) nowadays 




 (c) I do not know
 10. Have you (or surgeons at your institution) treated 
surgically in the past also intracranial aneurysms in 
other locations (i.e., not MCA aneurysms)?
 (a) yes
 (b) no
 (c) I do not know
 11. Does the neurosurgeon at your institution sometime 
decide by himself to treat a MCA aneurysm surgi-
cally without having involved the neurointervention-
ist in the decision-making?
 (a) yes
 (b) no
 (c) I do not know
 12. Does the neurosurgeon sometime decide by himself 
to treat an aneurysm in other locations (i.e., not MCA 
aneurysms) surgically without having involved the 
neurointerventionist in the decision-making?
 (a) yes
 (b) no
 (c) I do not know
 13. Does the neurointerventionist sometimes decide by 
himself to treat an aneurysm endovascular without 




 (c) I do not know




 15. Have you at your institution good quality Magnetic 




 16. Do you treat surgically unruptured MCA aneurysms 




 (c) I do not clip
 (d) I have not clipped yet
 17. Do you treat surgically unruptured aneurysms in 




 (c) I do not clip
 (d) I have not clipped yet




 (c) I do not clip
 (d) I have not clipped yet
 19. Do you treat surgically ruptured aneurysms in other 




 (c) I do not clip
 (d) I have not clipped yet
 20. Do you operate ruptured MCA aneurysms without 




 (c) I do not clip
 (d) I have not clipped yet
 21. Do you operate ruptured aneurysms in other 
locations (i.e., not MCA-aneurysms) without pre-




 (c) I do not clip
 (d) I have not clipped yet




 (c) I do not clip
 (d) I have not clipped yet
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 23. Which of the following criteria influence your choice 
to perform a preoperative DSA? If you do not know 




Middle cerebral artery (MCA) proximal (M1-M2 segments)                      Ο  yes   Ο  no
Middle cerebral artery (MCA) distal (M3-M4 segments)                           Ο  yes   Ο  no
Carotid-posterior communicating artery (PCom)                          Ο  yes   Ο  no
Carotid-anterior choroidal artery (ACho)                                Ο  yes   Ο  no
Carotid-T                                                                                                   Ο yes   Ο  no
Carotid-hypophyseal                                                              Ο  yes   Ο  no
Carotid-paraclinoidal (ophthalmic)                                                            Ο yes   Ο  no
Anterior cerebral artery (ACA) proximal (A1-A2 segments)                      Ο  yes   Ο  no
Anterior cerebral artery (ACA) proximal (A3-A4 segments)                     Ο   yes   Ο  no
Anterior communicating artery (ACom)
Anterior projecting                                              Ο  yes   Ο  no
Posterior projecting                                                                     Ο  yes   Ο  no
Superior projecting                                                                      Ο  yes   Ο  no
Inferior projecting                                                      Ο  yes   Ο  no
Posterior circulation: posterior inferior cerebellar artery (PICA)    Ο  yes   Ο  no
Posterior circulation: others (anterior inferior cerebellar artery, superior cerebellar 
artery, basilar artery, posterior cerebral artery)                             Ο  yes   Ο  no
Aneurysmal morphology
Etiology:
Saccular                                                                                                    Ο  yes   Ο  no
Fusiform                                                                                                    Ο yes   Ο  no
Dissecting                                                                                                 Ο  yes   Ο  no
Infective (i.e.: mycotic)                                                                              Ο  yes   Ο  no
Shape:
Irregularity  (bleb/ lobulation/daughter aneurysm)                                  Ο  yes   Ο  no
Broad neck                                                                                      Ο  yes   Ο  no
Others                                                                                                     Ο  yes   Ο  no
Maximum diameter (single)
< 5mm                                                                                                     Ο  yes   Ο  no
>10 mm                                                                                                Ο  yes   Ο  no
>25mm          Ο  yes   Ο  no
Possible perforators arising from the aneurysm Ο  yes   Ο  no
Efferent vessels arising from aneurysmal sac Ο  yes   Ο  no
Calcification/atherosclerotic plaque of the aneurysm wall Ο  yes   Ο  no
Intra-aneurysmal thrombus Ο  yes   Ο  no
Recurrence/previous treatment Ο  yes   Ο  no
Computational fluid dynamic analysis based decision Ο  yes   Ο  no
Patient-related factors
Patient age:
<40                                                                                                            Ο  yes   Ο  no
40-60                                                                                                         Ο  yes   Ο  no
>60 Ο  yes   Ο  no
Clinical situation:
SAH                                                                                                          Ο yes   Ο  no
Cranial nerve deficit                Ο  yes   Ο  no
Clinical mass effect                                                                                   Ο yes   Ο  no
Radiological mass effect                                                                           Ο yes   Ο  no
Previous SAH   Ο  yes   Ο  no
Others: …………………………………………………………………           Ο  yes   Ο  no
Treatment-related factor
Bypass contemplated                                                                                            Ο  yes   Ο  no
Visualization of possible donor artery (e.g. STA)                                     Ο  yes   Ο  no
Visualization of possible recipient artery                                                  Ο  yes   Ο  no
Collateral circulation                                                                                              Ο  yes   Ο  no
Others…………………………………………………………………………….          Ο  yes   Ο  no   
References
 1. Brisman JL, Song JK, Newell DW (2006) Cerebral aneurysms. N 
Engl J Med 355:928–939. https://doi.org/10.1056/NEJMra052760
 2. Marshall SA, Kathuria S, Nyquist P, Gandhi D (2010) Noninvasive 
imaging techniques in the diagnosis and management of aneurys-
mal subarachnoid hemorrhage. Neurosurg Clin N Am 21:305–323. 
https://doi.org/10.1016/j.nec.2009.10.005
 3. Dammert S, Krings T, Moller-Hartmann W, Ueffing E, Hans FJ, 
Willmes K, Mull M, Thron A (2004) Detection of intracranial 
aneurysms with multislice CT: comparison with conventional angi-
ography. Neuroradiology 46:427–434. https://doi.org/10.1007/
s00234-003-1155-1
 4. Chappell ET, Moure FC, Good MC (2003) Comparison of com-
puted tomographic angiography with digital subtraction angiog-
raphy in the diagnosis of cerebral aneurysms: a meta-analysis. 
Neurosurgery 52:624–631; discussion 630–1.
 5. Burkhardt JK, Chua MH, Winkler EA, Rutledge WC, Lawton MT 
(2019) Incidence, classification, and treatment of angiographically 
occult intracranial aneurysms found during microsurgical aneu-
rysm clipping of known aneurysms. J Neurosurg 132:434–441. 
https://doi.org/10.3171/2018.11.Jns182416
 6. Dehdashti AR, Binaghi S, Uske A, Regli L (2006) Comparison of 
multislice computerized tomography angiography and digital sub-
traction angiography in the postoperative evaluation of patients 
with clipped aneurysms. J Neurosurg 104:395–403. https://doi.
org/10.3171/jns.2006.104.3.395
 7. Kangasniemi M, Makela T, Koskinen S, Porras M, Poussa K, 
Hernesniemi J (2004) Detection of intracranial aneurysms with 
two-dimensional and three-dimensional multislice helical com-
puted tomographic angiography. Neurosurgery 54:336–340; dis-
cussion 340–1.
 8. Menke J, Larsen J, Kallenberg K (2011) Diagnosing cerebral aneu-
rysms by computed tomographic angiography: meta-analysis. Ann 
Neurol 69:646–654. https://doi.org/10.1002/ana.22270
 9. Thompson BG, Brown RD Jr, Amin-Hanjani S, Broderick JP, 
Cockroft KM, Connolly ES Jr, Duckwiler GR, Harris CC, Howard 
VJ, Johnston SC, Meyers PM, Molyneux A, Ogilvy CS, Ringer 
AJ, Torner J (2015) Guidelines for the management of patients 
with unruptured intracranial aneurysms: a guideline for health-
care professionals from the American Heart Association/American 
Stroke Association. Stroke 46:2368–2400. https://doi.org/10.1161/
str.0000000000000070
 10. Kouskouras C, Charitanti A, Giavroglou C, Foroglou N, Selviaridis 
P, Kontopoulos V, Dimitriadis AS (2004) Intracranial aneurysms: 
evaluation using CTA and MRA.  Correlation with DSA and 
intraoperative findings. Neuroradiology 46:842–850. https://doi.
org/10.1007/s00234-004-1259-2
 11. Sailer AM, Wagemans BA, Nelemans PJ, de Graaf R, van Zwam 
WH (2014) Diagnosing intracranial aneurysms with MR angiog-
raphy: systematic review and meta-analysis. Stroke 45:119–126. 
https://doi.org/10.1161/strokeaha.113.003133
 12. White PM, Wardlaw JM, Easton V (2000) Can noninvasive imag-
ing accurately depict intracranial aneurysms? A systematic review. 
Radiology 217:361–370. https://doi.org/10.1148/radiology.217.2.r
00nv06361
 13. Joo SP, Kim TS (2017) The clinical importance of perforator 
preservation in intracranial aneurysm surgery: an overview with 
a review of the literature. Chonnam Med J 53:47–55. https://doi.
org/10.4068/cmj.2017.53.1.47
M. Sebök et al.
17
 14. Stafa A, Leonardi M (2008) Role of neuroradiology in evaluating 
cerebral aneurysms. Interv Neuroradiol 14(Suppl 1):23–37. https://
doi.org/10.1177/15910199080140s106
 15. Villablanca JP, Martin N, Jahan R, Gobin YP, Frazee J, Duckwiler 
G, Bentson J, Hardart M, Coiteiro D, Sayre J, Vinuela F (2000) 
Volume-rendered helical computerized tomography angiography 
in the detection and characterization of intracranial aneurysms. J 
Neurosurg 93:254–264. https://doi.org/10.3171/jns.2000.93.2.0254
 16. Kaufmann TJ, Huston J III, Mandrekar JN, Schleck CD, Thielen 
KR, Kallmes DF (2007) Complications of diagnostic cerebral 
angiography: evaluation of 19,826 consecutive patients. Radiology 
243:812–819. https://doi.org/10.1148/radiol.2433060536
 17. Esposito G, Fierstra J, Regli L (2016) Distal outflow occlusion with 
bypass revascularization: last resort measure in managing com-
plex MCA and PICA aneurysms. Acta Neurochir 158:1523–1531. 
https://doi.org/10.1007/s00701-016-2868-3
 18. Esposito G, Dias SF, Burkhardt JK, Fierstra J, Serra C, Bozinov O, 
Regli L (2019) Selection strategy for optimal keyhole approaches 
for MCA aneurysms: lateral supraorbital versus minipterional cra-
niotomy. World Neurosurg 122:e349. https://doi.org/10.1016/j.
wneu.2018.09.238
 19. Esposito G, Durand A, Van Doormaal T, Regli L (2012) Selective- 
targeted extra-intracranial bypass surgery in complex middle cere-
bral artery aneurysms: correctly identifying the recipient artery using 
indocyanine green videoangiography. Neurosurgery 71:ons274–
ons284. https://doi.org/10.1227/NEU.0b013e3182684c45; discus-
sion ons284–5.
 20. Jafar JJ, Russell SM, Woo HH (2002) Treatment of giant intracra-
nial aneurysms with saphenous vein extracranial-to-intracranial 
bypass grafting: indications, operative technique, and results in 29 
patients. Neurosurgery 51:138–144; discussion 144–6.
 21. Lawton MT, Hamilton MG, Morcos JJ, Spetzler RF (1996) 
Revascularization and aneurysm surgery: current techniques, indi-
cations, and outcome. Neurosurgery 38:83–92; discussion 92–4.
 22. Esposito G, Regli L (2014) Surgical decision-making for managing 
complex intracranial aneurysms. Acta Neurochir Suppl 119:3–11. 
https://doi.org/10.1007/978-3-319-02411-0_1
 23. Esposito G, Amin-Hanjani S, Regli L (2016) Role of and indications 
for bypass surgery after Carotid Occlusion Surgery Study (COSS)? 
Stroke 47:282–290. https://doi.org/10.1161/strokeaha.115.008220
 24. Esposito G, Fierstra J, Regli L (2016) Partial trapping strategies for 
managing complex intracranial aneurysms. Acta Neurochir Suppl 
123:73–75. https://doi.org/10.1007/978-3-319-29887-0_10
 25. Philipp LR, McCracken DJ, McCracken CE, Halani SH, Lovasik 
BP, Salehani AA, Boulter JH, Cawley CM, Grossberg JA, Barrow 
DL, Pradilla G (2017) Comparison between CTA and digital 
subtraction angiography in the diagnosis of ruptured aneurysms. 
Neurosurgery 80:769–777. https://doi.org/10.1093/neuros/nyw113
 26. Hirai T, Korogi Y, Ono K, Murata Y, Suginohara K, Omori T, 
Uemura S, Takahashi M (2001) Preoperative evaluation of intracra-
nial aneurysms: usefulness of intraarterial 3D CT angiography and 
conventional angiography with a combined unit--initial experience. 
Radiology 220:499–505. https://doi.org/10.1148/radiology.220.2.r
01au20499
Open Access  This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropri-
ate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in 
a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statu-
tory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
When Is Diagnostic Subtraction Angiography Indicated Before Clipping of Unruptured and Ruptured Intracranial Aneurysms…
19© The Author(s) 2021
G. Esposito et al. (eds.), Trends in Cerebrovascular Surgery and Interventions, Acta Neurochirurgica Supplement 132, 
https://doi.org/10.1007/978-3-030-63453-7_3
Current Strategies in the Treatment 




Very large and giant intracranial aneurysms are defined as 
aneurysms with a diameter >20  mm and >25  mm [1] 
respectively. Giant aneurysms constitute approximately 
2–5% of all intracranial aneurysms [2–4]. The natural his-
tory of these lesions is poor, with reported mortalities rang-
ing from 66–80%. The worst outcomes have been observed 
in untreated posterior circulation giant aneurysms [3–5]. 
The majority of patients harboring very large and giant 
intracranial aneurysms (50–80%) present with thromboem-
bolic events or symptoms of mass effect [3, 6], whereas 
subarachnoid hemorrhage (SAH) occurs in approximately 
20–30% [6].
In view of the poor natural course of these lesions, aggres-
sive treatment aiming for both aneurysm occlusion and relief 
of mass effect has been recommended [6, 7]. The benefits of 
active aneurysm therapy must be weighed against the inher-
ent risks of treatment. Whereas surgical management carried 
a significant morbidity and mortality in the past [3], recent 
meta-analyses reported good clinical outcomes in as many as 
80% of the patients when individualized treatment strate-
gies—including both surgical and endovascular tech-
niques—were adopted [2]. The risk-benefit assessment, 
however, will favor active therapy only when treatment is 
performed at high-volume cerebrovascular centers, where 
the capacities of both neurosurgery and neurointervention 
are available and individualized treatment concepts consid-
ering anatomic location (cavernous vs. subarachnoid, ante-
rior circulation vs. posterior circulation), clinical presentation 
(SAH vs. mass effect vs. incidental presentation), patient 
demographics (age), and aneurysm morphology can be 
applied [6, 7].
Both reconstructive (clipping, coiling, stent-assisted coil-
ing, flow diversion [FD]) and deconstructive techniques 
(parent artery occlusion [PAO], PAO in conjunction with 
bypass surgery, and strategies of flow modification) are 
available for the treatment of cerebral aneurysms [8]. The 
aim of this paper is to review the current literature on the 
management of very large and giant aneurysms and to 
describe representative cases—treated by the senior author, 
who has been dually trained and is cross-experienced in both 
microsurgical and endovascular techniques—to illustrate 
possible treatment strategies.
 Reconstructive Techniques
Reconstructive techniques are usually the preferred treat-
ment strategy in the management of intracranial aneurysms, 
since these procedures do not compromise the patency of the 
parent vasculature and in turn do not interfere with cerebral 
blood flow distal to the aneurysm site. In the management of 
very large and giant aneurysms, open surgical strategies of 
direct aneurysm occlusion have proven technically difficult 
but often highly effective, whereas technically less challeng-
ing endovascular procedures, e.g., intrasaccular coil emboli-
zation, have proven ineffective in the long run. The role of 
more advanced endovascular strategies, e.g., FD stents and 
intra-aneurysmal FD, is still in the process of being defined.
 Clipping and Clip Reconstruction
Direct surgical clip ligation of the neck with preservation of 
the parent vasculature remains the ideal reconstructive treat-
ment strategy in the majority of very large and giant saccular 
aneurysms. Procedural outcomes usually depend on aneu-
rysm morphology (calcifications, intrasaccular thrombus, 
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complex anatomy), aneurysm location, parent artery caliber, 
and perforator anatomy [4, 6, 9, 10].
In the management of very large and giant middle cere-
bral artery (MCA) aneurysms, direct surgical clipping is 
considered the most effective and durable treatment, whereas 
coiling was identified as an independent risk factor for 
retreatment in a recent study describing the management of 
106 large and giant MCA aneurysms [11]. Coiling of MCA 
aneurysms carries a higher recurrence risk even in smaller 
lesions. In detail, the recurrence risk following coil emboli-
zation of >7 mm MCA aneurysms was 17.5% [12], and that 
of MCA aneurysms ≥11 mm was 46% in recent publications 
[13]. Long-term instability of MCA aneurysm occlusion was 
reported in 3% of the patients receiving surgical clipping and 
in >45% of the patients receiving intrasaccular coiling [14].
The success of direct clipping of very large and giant 
aneurysms depends on the ability to soften the aneurysmal 
sac intraoperatively, usually achieved by temporary clipping 
of the parent vasculature or measures inducing transient car-
diac standstill (i.e., pharmacologically induced hypodynamic 
standstill using Adenosine or electrically induced hyperdy-
namic standstill using rapid ventricular pacing). In cases of 
extensive intrasaccular thrombosis, aneurysmotomy and 
subsequent thrombectomy under pharmacologic cerebropro-
tection are required for successful clip reconstruction [6]. 
Multiple clips applied in different techniques (tandem clip-
ping, stacked multiple clips, overlapping clips) are usually 
required (Fig. 1a–c) [15, 16].
 Coil Embolization
Coil embolization has proven ineffective in the treatment of 
very large and giant aneurysms. Low initial complete occlu-
sion rates (10–60%) and high recanalization rates (56–90%) 
have been demonstrated in several studies [17, 18]. 
Mechanisms of recanalization include coil compaction, coil 
migration, and aneurysm regrowth [18, 19].
In a previous study assessing the results of coil emboliza-
tion in patients with very large or giant aneurysms, the senior 
author reported a 71% complete or nearly complete angio-
graphic occlusion rate immediately after the intervention. Of 
note, a single embolization served as definitive treatment for 
only 12.5% of the giant and only 31% of the very large aneu-
rysms in the long run [17]. In partially thrombosed aneu-
rysms presenting with mass effect, selective coiling 
reportedly resulted in continuous aneurysm growth in 18% 
of the cases, whereas only 7% of the aneurysms decrease in 
size [20]. Coiling had little if any effect on the relief of symp-
toms of mass effect.
The current body of literature strongly suggests that the 
initial angiographic occlusion rate after coil embolization is 
related to the risk of re-rupture [21]. Ruptured aneurysms 
with angiographic occlusion rates >90% 6 months after coil-
ing had low rates (0.4%) of recurrent SAH within the subse-
quent 8 years [22]. In large and giant aneurysms, the reported 
annual rebleeding rate of 1.9% after coil embolization was 
substantially higher [23]. A retrospective study reporting 
outcomes after surgical or endovascular therapy of 184 very 
large or giant aneurysms identified the following as risk fac-
tors for incomplete angiographic obliteration: (1) fusiform 
aneurysm morphology, (2) aneurysm location in the poste-
rior circulation, and (3) endovascular treatment (coiling or 
stent-assisted coiling) [24].
 Stent-Assisted Coiling
Intrasaccular coil embolisation has significant limitations in 
wide-necked aneurysms due to comparably lower packing 
densities and subsequently higher rates of recanalization. 
Therefore, alternative techniques using so-called neck bridg-
ing devices have been introduced (Fig. 1d–f). The technique 
of stent-assisted coiling uses a stent—which per se is a non- 
occlusive device—to provide a scaffold to hold the coils 
within the aneurysmal sac [25]. Meta-analyses revealed that 
in patients harboring very large and giant aneurysms, occlu-
sion rates were significantly higher following stent-assisted 
coiling [73%] when compared to coiling alone (59%) [26]. 
Of note, significantly higher treatment morbidities have been 
reported following stent-assisted coiling when compared to 
regular intrasaccular coil embolization [27]. Stent-assisted 
coiling has nowadays become a routine procedure that can be 
performed safely and effectively in expert hands. Since the 
implanted device is endoluminal rather than intra- 
aneurysmal, peri-interventional management of coagulation 
is of major importance and procedure-related complications 
of in-stent thrombosis and subsequent distal thromboembo-
lism are still relevant issues. When compared to flow diver-
sion [FD], stent-assisted coiling of giant aneurysms has the 
potential to further increase aneurysmal mass effect. It 
should be pointed out that stent-assisted coiling of a giant 
aneurysm can be a very expensive undertaking.
 Flow Diversion
Flow diverters have become an attractive alternative for the 
endovascular treatment of complex aneurysms in selected 
cases [28–31] because the technique does not suffer from the 
aforementioned shortcomings of intrasaccular coil emboli-
zation [17, 18, 20, 28]. Flow diverters initially received FDA 
approval for the treatment of large and giant aneurysms 
extending from the petrous to the superior hypophyseal seg-
ment of the internal carotid artery [32] (Fig. 1g–i). Currently, 
however, a variety of aneurysms—including those  previously 
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Fig. 1 Reconstructive surgical and endovascular techniques. (a–c) 
Microsurgical clipping. Fifteen years after uneventful clipping of a 
7 mm left MCA bifurcation aneurysm, a 40 mm partially thrombosed 
aneurysm recurrence is detected on MRI (a). Since STA donor braches 
were of insufficient caliber and three M2 branches were incorporated 
into the aneurysm sac, the decision was made to treat the aneurysm by 
direct surgical clipping after temporary trapping, aneurysmotomy, and 
thrombectomy under pharmacologic cerebroprotection (b). 
Intraoperative left ICA angiograms demonstrate sufficient aneurysm 
obliteration (c) (A.G., procedure performed at the Kepler University 
Hospital Linz). (d–f) Stent-protected coil embolization. MRI (d) and 
right ICA angiograms (e) depict a 20 mm ICA aneurysm at the branch-
ing site of the superior hypophyseal artery. Aneurysmal mass effect 
resulted in optic nerve compression and subsequent visual field deficits. 
The patient was treated by stent-protected coil embolization (f) and 
regained vision over the following months, an effect attributable to 
aneurysm shrinkage after embolization (A.G., procedure performed at 
the Medical University Vienna). (g–i) Flow diversion. Right ICA angio-
grams (g) demonstrate a very large intracavernous ICA aneurysm that 
resulted in partial ophthalmoplegia from mass effect and intracavernous 
cranial nerve compression. The patient was treated by FD stenting (h), 
which resulted in complete aneurysm occlusion (i) and delayed resolu-
tion of ophthalmoplegia due to post FD aneurysm shrinkage (A.G., pro-
cedure performed at the Medical University Vienna)
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treated, acutely ruptured, small sized, located within the pos-
terior circulation, as well as non-saccular lesions including 
fusiform, dissecting, and pseudoaneurysms—are treated 
using FD techniques. For the time being, indications for FD 
treatment are unclear, and many procedures, especially those 
expanding FD indications from untreatable giant aneurysms 
to comparably easy surgical cases, must still be considered 
off-label uses of the device.
Similar to stent-assisted coiling, FD stenting relies on an 
endoluminal device creating an interface between the aneu-
rysmal sac and the parent vasculature. Aneurysm occlusion 
thereby occurs in a delayed fashion over weeks to months 
[23] by intra-aneurysmal flow modification, thrombus for-
mation, and subsequent endothelial overgrowth of the aneu-
rysm neck. Peri-interventional management of coagulation, 
i.e., dual antiplatelet medication, is of major concern, and in 
turn FD stents have limited if any value in the management 
of patients with acutely ruptured aneurysms [33]. Since 
intra-aneurysmal thrombosis occurs progressively over time 
and intra-aneurysmal pressures will remain elevated even 
after the initial angiographic occlusion—which is due to 
stagnant aneurysmal inflow rather than to aneurysm oblitera-
tion (“a flow diverter is not a pressure diverter”) [34]—
patients managed using FD stents in the acute phase after 
aneurysmal SAH are still at risk for early rebleeding.
Possible strategies to circumvent the problem of dual 
anti-platelet medication for FD treatment in acutely ruptured 
aneurysms include (1) techniques of intra-aneurysmal FD 
and (2) staged procedures consisting of partial protective 
coiling of the aneurysm dome in the acute phase followed by 
later definitive FD treatment. Such staged procedures were 
both safe and effective in a recent series of 31 patients with 
acutely ruptured intracranial aneurysms [35].
Unexplained cases of early post-interventional hemor-
rhages after FD treatment—occurring also in initially unrup-
tured aneurysms and with often fatal consequences under 
dual anti-platelet medication—may also be explained by 
intrasaccular processes of active thrombus formation and 
degradation affecting the integrity of the aneurysm wall [36–
38]. These mechanisms remain speculative, however, since 
any residual flow within the aneurysm may per se trigger 
further aneurysm growth or rupture [39]. In line with these 
findings, a recent study demonstrated significantly improved 
occlusion rates in absence of post-interventional hemor-
rhages in patients undergoing FD stenting in conjunction 
with concomitant coiling when compared to FD treatment 
alone (88.9% versus 61.5% complete occlusion rate, respec-
tively) [31].
Similar mechanisms may trigger early giant aneurysm 
growth after FD treatment. A recent retrospective study 
found that 6 out of 45 aneurysms managed by FD stenting 
had increased >20% in size during the first 6 months and pro-
duced symptoms of intracranial mass-effect [36]. Since other 
sources indicate that all aneurysms that underwent FD stent-
ing either collapsed completely (in 90% of cases) or 
decreased significantly in size (in 10% of cases) between 6 
and 18  months after the intervention, it is likely that the 
aforementioned mechanisms of post-FD stenting aneurysm 
expansion are transient in nature [38].
A recent study reported a 95.2% complete occlusion rate 
in complex internal carotid artery aneurysms undergoing FD 
stenting in absence of hemorrhagic or ischemic cerebrovas-
cular events [28]. In the same patient cohort, the complete 
aneurysm occlusion rate after 180 days was 73.6% [28, 40]. 
Other reports have demonstrated complete aneurysm occlu-
sions in as many as 76% of the giant aneurysms treated using 
FD stents. This success, however, came at the cost of compa-
rably higher treatment morbidities when compared to those 
of conventional coil embolization. In detail, the reported 
procedure-related mortality was 5% and the overall ischemic 
stroke rate was 6%. Perforator strokes occurred in 3% and 
patients with posterior circulation aneurysms were more 
likely to be affected. In basilar artery aneurysms, perforator 
territory strokes were encountered in 14% [41]. The rates of 
post-procedural SAH or parenchymal hemorrhage were 3% 
each [29]. Aneurysm morphology may further influence the 
success of FD treatment. Recent data indicate that permanent 
complete aneurysm occlusion is less likely in aneurysms 
incorporating arterial side branches, i.e., in lesions where 
major arteries arising from the aneurysm are jailed during 
FD stent placement [42]. It should therefore be pointed out 
that the clinical safety of FD devices is still in a process of 
being defined [23]; e.g., a multicenter randomized care trial 
and registry was recently halted due to safety and efficacy 
concerns [43].
 Deconstructive Techniques
Deconstructive measures are indicated only in those cases 
where reconstructive treatment of cerebral aneurysms is 
impossible or associated with unacceptable treatment mor-
bidities. As previously mentioned, these strategies include 
[10, 44] therapeutic surgical or endovascular parent artery 
occlusion (PAO), PAO in conjunction with flow replacement 
bypass surgery, was well as techniques of flow modification 
(e.g., deliberate basilar trunk occlusion to induce flow rever-
sal for the management of otherwise untreatable very large 
and giant basilar apex aneurysms).
 Parent Artery Occlusion
As demonstrated in Fig.  2a–c, PAO relies on competent 
crossflow via anterior and posterior communicating artery 
collaterals as well as leptomeningeal anastomoses. The 
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Fig. 2 Deconstructive surgical and endovascular techniques. (a–c) 
Parent artery occlusion. Right ICA angiograms (a) demonstrate a giant 
intracavernous ICA aneurysm that exerted local mass effect and resulted 
in complete right-sided ophthalmoplegia. The patient was managed by 
endovascular parent artery occlusion after successful balloon test occlu-
sion. Left ICA angiograms (b) depict sufficient crossflow via the ante-
rior communicating artery to supply the right hemisphere after 
therapeutic parent artery sacrifice (b). The intracavernous giant aneu-
rysm decreased in size significantly as depicted on follow-up MRIs (c) 
and the patient’s ophthalmoplegia gradually resolved over time (A.G., 
procedure performed at the Medical University Vienna). (d–f) Parent 
artery occlusion under low-flow bypass protection. Right ICA angio-
grams demonstrate a giant intracavernous ICA aneurysm (d) that 
became symptomatic by local cranial nerve compression and mani-
fested in partial oculomotor nerve palsy. The patient was managed by 
STA–MCA double-barrel low-flow bypass revascularization (e) 48  h 
before successful awake balloon test occlusion and subsequent endo-
vascular parent artery occlusion. The bypass in conjunction with pre- 
existent anterior communicating artery crossflow (f) was sufficient to 
revascularize the right hemisphere after therapeutic endovascular par-
ent artery sacrifice (A.G., procedure performed at the Medical 
University Vienna). (g–i) Parent artery occlusion under venous high- 
flow bypass protection. Right ICA angiograms depict a partially coiled, 
recurrent very large aneurysm of the right ICA at the branching site of 
the superior hypophyseal artery, exerting progressive optic nerve com-
pression and resulting in right-sided visual loss (g). The patient was 
managed by saphenous vein high-flow bypass revascularization (h, i) 
followed by parent artery occlusion during the same procedure. The 
patient recovered gradually but never regained vision in her right eye 
(A.G., procedure performed at the Kepler University Hospital Linz)
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safety and feasibility of this strategy is assessed during bal-
loon test occlusions [BTO] in the awake patient prior to 
definitive surgical or endovascular vessel sacrifice. Many 
surgeons, however, prefer revascularization in all cases that 
require major vessel sacrifice [44]. PAO is often followed by 
a significant reduction of aneurysm size and alleviation of 
aneurysmal compressive mass effect (Fig. 2a–c).
 Parent Artery Occlusion in Conjunction 
with Bypass Surgery
In the vast majority of the cases, however, spontaneous col-
lateral crossflow is inadequate to provide sufficient hemi-
spheric blood flow distal to the point of PAO. In these cases, 
cerebral revascularization is required prior to PAO. Generally 
speaking, cerebral bypasses can be stratified according to 
their function (flow replacement bypass, flow augmentation 
bypass), their donor grafts (pedicled, interpositional, in situ), 
the sites of anastomosis (extracranial [EC]–intracranial [IC], 
EC–IC) and the flow provided (low-, intermediate-, and high 
flow) [44]. The revascularization technique selected for flow 
replacement bypass surgery in the management of intracere-
bral aneurysms depends on the treatment strategy chosen. In 
cases in which bypass surgery is performed in conjunction 
with surgical PAO during the same procedure (i.e., cases 
where neurologic assessment of the awake patient is not pos-
sible), high-flow bypass surgery is usually performed. It is 
reasonable to “oversize” the bypass rather than to face isch-
emic complications due to insufficient low-flow bypass 
revascularization (Fig. 2g–i). In those cases, however, where 
the therapeutic strategy involves cerebral revascularization 
1–2 days ahead of BTO and endovascular PAO, other bypass 
techniques (i.e., double barrel STA–MCA bypass in cases of 
anterior circulation aneurysms, OA–PCA or OA–PICA 
bypasses in cases of posterior circulation aneurysms) may be 
justified. The senior author has successfully performed this 
technique in over 40 cases (Fig. 2d–f). Anterior and posterior 
communicating artery crossflow as well as leptomeningeal 
collaterals frequently contribute further to post PAO hemi-
spheric revascularization.
The occlusion rates reported with indirect aneurysm treat-
ment are high. A recent series described the management of 
82 patients with complex intracranial aneurysms using both 
EC-IC and IC-IC bypasses and reported aneurysm oblitera-
tion rates of over 97% with low treatment-related morbidi-
ties [9]. Aneurysms managed by PAO in conjunction with 
bypass revascularization usually shrink in size over time. A 
recent multi-center study observed an average delayed vol-
ume reduction of 55.2% in giant aneurysms treated by PAO 
and bypass revascularization [1].
Whereas revascularization of multiple vascular territo-
ries distal to the site of PAO is usually easily obtained using 
the STA–MCA double-barrel technique (e.g., temporal and 
frontoparietal territories in cases of M1/M2 bifurcation 
aneurysms), this may be difficult in cases of—single-bar-
rel—high-flow revascularization. Recent publications have 
reported a multiple reimplantation technique for the recon-
struction of complex and giant MCA bifurcation aneurysms, 
where the efferent M2 branches are serially reimplanted into 
the saphenous vein donor graft [45]. The technical nuances 
of indirect surgical aneurysm occlusion were addressed in a 
recent publication, describing 18 different bypass strategies 
for the treatment of 30 complex MCA aneurysms, all man-
aged with excellent surgical and clinical results [16].
Perforator occlusion in conjunction with PAO-induced 
thrombosis is always a major concern. A recent case series 
describing the management of 141 giant aneurysms reported 
thrombotic occlusion of perforators or branching arteries in 
7% of the aneurysms receiving indirect treatment [10]. In 
those cases, where complete surgical trapping or endovascu-
lar coil embolization of the aneurysm is impossible due to 
delicate perforator anatomy, proximal or distal occlusions 
may be performed. This strategy relies on intra-aneurysmal 
flow modification to reduce the risk of aneurysm rupture, to 
induce slow aneurysm thrombosis, and to preserve flow into 
the perforating branches [10, 46]. In some cases, however, 
postoperative aneurysm ruptures with devastating conse-
quences have been reported with this technique [47].
Periprocedural ischemia due to prolonged temporary clip-
ping times while suturing the anastomosis is another impor-
tant issue. The larger the caliber of the donor graft (i.e., 
during high-flow bypass surgery), the larger—and thus more 
proximal—the recipient artery should be. In turn, the more 
proximal the recipient artery, (1) the larger the vascular terri-
tory rendered ischemic during temporary clipping for sutur-
ing the anastomosis, and (2) the more difficult and usually 
time-consuming the suturing of the anastomosis will be. To 
overcome this problem, the technique of excimer laser- 
assisted non-occlusive anastomosis [ELANA] bypass was 
introduced to provide high-flow revascularization without 
cross-clamping related distal ischemia or stroke. The role of 
this technique, usually reserved for the most challenging 
lesions, is still in a process of being defined [44, 48]. In many 
cases, originally considered suitable for the ELANA proce-
dure, FD stenting and other innovative reconstructive endo-
vascular techniques have proven effective as well.
 Conclusion
Very large and giant intracranial aneurysms are among the 
most challenging pathologies in neurosurgery. Patients 
harboring such lesions should be managed at high-volume 
cerebrovascular centers by multidisciplinary teams trained 
in all techniques of open and endovascular neurosurgery. 
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In view of the poor natural history, active management 
using  multiprofessional individualized approaches [4, 6, 7, 
9–11, 15, 16, 44–46, 48–50] is required to achieve com-
plete aneurysm occlusion, relief of mass effect, and oblit-
eration of the embolic source with acceptable treatment 
morbidities [7]. Microsurgical and endovascular tech-
niques are complementary rather than competitive strate-
gies that can ideally be combined in hybrid procedures. 
Both microsurgery [6, 7, 15, 16] and neurointervention are 
still improving in technique and outcome. With an increas-
ing endovascular caseload, neurosurgeons working in the 
field of cerebrovascular disease may find themselves in a 
“low case scenario” in the near future, where innovative 
strategies of surgical training—including haptic and vir-
tual models of simulation [51]—will be of major impor-
tance to maintain the current levels of technical skill and 
procedural quality.
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Computational fluid dynamics (CFD) is a computational sci-
ence which connects experiment and theory. Therefore, it is 
important to understand the need of validation and verifica-
tion of CFD for cerebral aneurysms when the hemodynamic 
results are applied to surgical decision-making in clinical 
settings.
CFD for a cerebral aneurysm using the patient-specific 
geometry model was first reported by DA Steinman et al. in 
2003 [1], and it has been revealing that hemodynamics con-
tributes to understanding aneurysm pathology including ini-
tiation, growth, and rupture [2–10]. On the other hand, CFD 
has not permeated into a clinical setting of cerebral aneu-
rysms due to several limitations including analysis time and 
complicated process. Therefore, we present our practical 
application of CFD for the treatment planning of cerebral 
aneurysms.
 CFD Process for Cerebral Aneurysms
The CFD process for cerebral aneurysms is the following [2, 
11, 12]: the digital imaging and communication in medicine 
(DICOM) datasets of 3D CT angiography and 3D rotational 
angiography are loaded into Mimics Innovation Suite 
(Materialise Japan, Kanagawa, Japan) to extract aneurysm 
geometry as stereolithography (STL). The STL file is inte-
grated into 3-matic (Materialise Japan, Kanagawa, Japan) and 
geometry in the region of interest is segmented. In addition, 
the geometry is remeshed by a triangle measuring 0.25 mm at 
the maximum length for correction of a distortion comprising 
the STL. The fluid domain is meshed using ANSYS ICEM 
CFD (ANSYS Inc. Canonsburg, Pennsylvania) to create tet-
rahedral elements that are established as 0.6 mm at maximum 
and 0.1 mm at minimum using the Octree’s method. On the 
geometry surface, six prism layers are added with total 
heights of 0.148 mm. The inlet is prolonged vertically at the 
surface to establish fully developed laminar flow according to 
Poiseuille’s law.
Numerical modeling is performed using ANSYS CFX 
(ANSYS Inc. Canonsburg, Pennsylvania). For the fluid 
domain, 3D laminar flow fields are obtained by solving the 
continuity and Navier-Stokes equations, and discretization is 
made by the finite volume method. Blood is assumed to be 
an incompressible Newtonian fluid with a density of 1056 kg/
m3 and a viscosity of 0.0035 Pa s. Typical flow waveform of 
phase-contrast MR imaging is scaled to the inlet and a flow 
rate is proportional to achieve a physiological wall shear 
stress (WSS). Traction-free boundary conditions are applied 
to the outlets. The time steps are 0.0001 s and transient anal-
ysis with an initial value specification is performed.
 Rupture Status
A lot of CFD studies were reported regarding the rupture 
status of cerebral aneurysms. Compared with unruptured 
aneurysms, ruptured aneurysms had significant characteris-
tics such as low WSS [12–15], high oscillatory shear index 
(OSI) [12, 14], low aneurysm formation indicator (AFI) 
[12], prolonged relative residence time (RRT) [16], complex 
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flow pattern, unstable flow pattern [17], and high oscillatory 
velocity index [18]. Among these hemodynamic parameters, 
low magnitude of WSS is the most noticeable hemodynamic 
characteristic associated the rupture status. Since the magni-
tude of WSS was quantified as time-averaged value, spatial 
minimum and maximum values on the dome, normalized 
WSS and low shear area ratio, we should recognize that the 
distribution of low WSS would be an unchanged observa-
tion. However, comparison of the magnitude of WSS in clin-
ical practice should be carried out as an optimal quantification. 
For instance, time-averaged WSS would be allowed to inves-
tigate the rupture status of multiple cerebral aneurysms in a 
patient with subarachnoid hemorrhage. In particular, mirror 
aneurysms are a useful disease model to predict the rupture 
site of an aneurysm. On the other hand, normalized WSS 
would be recommended for measuring WSS of aneurysms at 
different locations.
 Hyperplastic Remodeling of Aneurysm Wall
Ku described OSI that was a hemodynamic parameter to 
evaluate fluctuation of WSS vectors in 1985 [19]. The stud-
ies using the pulsatile flow data in a Plexiglas model and 
intimal plaque thickness in five human carotid bifurcations 
revealed that oscillations in the direction of wall shear may 
enhance atherogenesis. Aside from OSI, RRT and AFI can 
also evaluate oscillation of WSS vectors. These hemody-
namic parameters were examined regarding hyperplastic 
remodeling of aneurysm wall. Since these hemodynamic 
parameters showed similar distribution to high oscillatory 
WSS vector (Fig. 1), we can use any of these variables as the 
preoperative predictor of thick aneurysm wall. In addition, 
we should recognize that a high OSI region corresponds to a 
low WSS region.
The prediction of hyperplastic remodeling lesions using 
CFD [6, 11, 16] would contribute to avoiding intraoperative 
risks such as inadequate temporary clipping and obstruction 
of small branches (Fig. 2).
 Recurrence of Coiled Aneurysms
Coil embolization of cerebral aneurysms is widely used; 
however, recanalization and re-treatment occur more often 
compared with surgical clipping. Several risk factors for 
recanalization and re-treatment have been reported, such as a 
large aneurysm, wide neck width, minor recurrence on cere-
bral angiogram early after coil embolization, and lower 
packing density.
A number of authors reported hemodynamic risk fac-
tors associated with coiled aneurysms. High WSS 
observed near the remnant neck of partially coiled aneu-
rysms are more likely to have recanalization [20]. 
However, since the geometry of neck remnant is obtained 
only after coiling, it is impossible to predict the recur-
rence risk as presurgical decision- making based on this 
method. In a clinical setting, it is desirable that hemody-
namic evaluation using presurgical geometry models can 
predict recanalization of coiled aneurysms. Sugiyama 
et al. demonstrated the correlations between the hemody-
namics before coil embolization and the outcomes after 
treatment for basilar tip aneurysms [21]. In their study, 
aneurysmal inflow rate coefficient (AIRC) was calculated 








where Qa and Qb were the aneurysmal inflow rate and the 
basilar artery flow rate, respectively.
In 57 basilar tip aneurysms, AIRC was significantly 
higher in the recanalized group and correlated to the 
types of basilar bifurcation configuration. Although it 
was sensible to make a decision for coil embolization 
based on these findings, packing density should be con-
sidered simultaneously. Therefore, CFD using porous 
media modeling was developed to predict recurrence of 
coil embolization. Umeda et al. calculated residual flow 
volume (RFV) to quantify the residual aneurysm vol-
ume after simulated coiling, which has a mean fluid 
domain above 1.0 cm/s [22]. In 37 unruptured cerebral 
aneurysms, the recurrence group had significantly larger 
RFV than the stable group. Receiver-operating charac-
teristic (ROC) curve analyses showed that the cut-off 
value of RFV was 20.4 mm3 and that the area under the 
ROC curve was 0.86. Although this study was retrospec-
tive, these findings could be applied to indicate a target 
packing density. In addition, CFD using double porous 
media modeling was developed to simulate stent-
assisted coiling (Fig. 3) [23]. Since these porous media 
modeling have discrepancies between actual distribu-
tion of placed coil and expanded strut in the aneurysm, 
large-scale clinical studies are required to confirm the 
accuracy of the prediction for recurrence of coiled 
aneurysms.
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Fig. 1 Comparison of hemodynamic parameters to evaluate the fluc-
tuation of WSS vector in a patient of ruptured middle cerebral artery 
aneurysm: (a) visualization of OSI, showing high OSI near the neck; 
(b) visualization of RRT; (c) visualization of AFI, in which low AFI has 
similar distribution to prolonged RRT and low WSS; (d) visualization 
of WSS, in which high OSI, prolonged RRT and low AFI regions are 
depicted in the low WSS area
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Fig. 2 Seventy-six-year-old man with unruptured left internal carotid 
artery-anterior choroidal artery bifurcation aneurysm: (a, b) visualiza-
tion of OSI, showing high OSI at the parent artery (white arrow) and the 
backside of the aneurysm neck at which anterior choroidal artery arises 
(black arrow); (c) visualization of time-averaged WSS, showing distri-
bution of low WSS (white arrow) which is similar to that of high OSI; 
(d, e) intraoperative photography, demonstrating atherosclerotic lesions 
of the parent artery (white arrow) and at the backside of the aneurysm 
neck (black arrow), respectively, which correspond with high OSI 
regions; (f) aneurysm clip is applied with an intended space to keep 
blood flow of the anterior choroidal artery




Fig. 3 Seventy-nine-year-old woman with left internal carotid artery- 
posterior communicating artery bifurcation aneurysm: (a) 3D surface 
rendering image of rotational angiography; (b) angiography after stent- 
assisted coiling of the aneurysm with a packing density of 35.9%; (c) 
head CT revealing subarachnoid hemorrhage 19 months after the coil-
ing; (d) left internal carotid artery angiography revealing the recanali-
zation of the coiled aneurysm; (e) retrospective CFD findings using 
double porous media setting, one of which is a porous media setting for 
the coiled aneurysm and another of which is that for an intracranial 
stent (arrow), to evaluate the hemodynamic changes of stent-assisted 
coiled aneurysm. Residual flow volume (pink domain) is 62.3  mm3, 
which is larger than the cut-off value to predict the recurrence of coiled 
aneurysms
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 Conclusions
This review describes the practical application of CFD to 
treatment planning of cerebral aneurysms. Several hemody-
namic parameters have valuable aspects not only in an endo-
vascular treatment but also in a direct clipping. Although 
prospective trials are needed to evaluate the rupture risk of 
unruptured cerebral aneurysms determined using CFD, 
recent knowledge of hemodynamics of cerebral aneurysms 
would enhance the decision-making ability and precision in 
several clinical settings.
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Aneurysms: Results of a Consecutive 
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 Introduction
PICA aneurysms are rare. Their incidence accounts for 
0.49–3% of all intracranial aneurysms [1–3]. However, 
they are most common within the posterior circulation 
ones after those of the basilar tip. Most are left-sided due to 
the prevalence of the vertebral artery. The saccular geome-
try is usually the most frequent, but dissecting or fusiform 
aneurysms are also relatively more common than in other 
cerebral arteries [2, 3]. PICA has a complex and variable 
course among all of the intracranial arteries, it has a small 
diameter, projecting  along the brainstem and cerebellum. 
According to Lister et  al., five segments are classically 
described [4]. Because of the proximity to the lower cranial 
nerves and frequent involvement of perforating arter-
ies  from the proximal segments, both microsurgical and 
endovascular treatment of PICA aneurysms are 
challenging.
In 1953, Rizzoli and Hayes first reported successful surgi-
cal treatment of a PICA aneurysm operated in 1947 [5, 6]. 
Since then, several reports on the surgical management of 
PICA aneurysms were published, but  only a  few of them 
were based on a large patient’s cohort. The aim of this retro-
spective study is to analyze the results of 25 PICA aneurysms 
surgically treated, mainly focusing on the choice of the 
approach and technical nuances.
 Materials and Methods
Between 2008 and 2018, 25 patients harboring 25 PICA 
aneurysms were  surgically treated by the senior author 
(R.G.) at two institutions: San Salvatore City Hospital, 
L’Aquila, Italy, and Foundation IRCCS Policlinico San 
Matteo, Pavia, Italy. Only patients harboring saccular aneu-
rysms were selected and retrospectively reviewed. Aneurysms 
were classified according to the five PICA segments reported 
by Lister et  al. [4]. Proximal aneurysms were defined as 
those arising from the vertebral artery-PICA junction to the 
tonsillo-medullary segment, the remnants being been con-
sidered as distal. Factors affecting the choice of the approach 
were also analyzed. Overall neurological outcome was 
reported as good, moderate, severe, and death, on the basis of 
an mRS score of 0–2, 3–4, 5, and 6, respectively. The out-
come evaluation was also reported according to the clinical 
onset and the involved PICA segment. The angiographic out-
come was evaluated on the basis of the complete exclusion of 
the aneurysm at the sixth-month follow-up.
 Results
Nineteen patients were females and the average age was 
43 years (range 18–69). Nine patients suffered from hyper-
tension, two from diabetes, three from hypercholesterolemia, 
and one from obesity. Nineteen patients were smokers. In one 
patient, familiar history of aneurysms was found. Admission 
computed tomography (CT) angiography and digital sub-
traction angiography (DSA) were performed by default in all 
patients. A contrast-enhanced MRI was performed in all large 
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and giant aneurysms to reveal intraluminal thromboses. In 15 
aneurysms (72%) subarachnoid hemorrhage (SAH) was the 
onset, four of which being been associated with a life-threat-
ening cerebellar hematoma. Three giant aneurysms presented 
with vertigo and gait  instability and seven further aneurysms 
were incidental. Table  1 summarizes demographics and 
clinical presentation data of the present series (Tab. 1) Nine 
aneurysms were small (<7  mm), 11 medium  (7–14  mm), 
two large (15–24 mm) and three giant (>25 mm). Nineteen 
aneurysms were proximal and, among these, ten involved 
the VA-PICA junction. Six involved the anterior-medullary 
segment and three the lateral- medullary segment. Of the 
remaining distal aneurysms, two were located on the tonsillo-
medullary segment, one on the telovelotonsillary segment, 
and one on the cortical segment. Peculiar patient character-
istics involving PICA segment and bony anatomy were the 
main factors influencing the choice of approach. Far-lateral 
approach was the approach of choice for all proximal aneu-
rysms, while median or paramedian suboccipital approaches 
were used for distal ones. An early surgery (within 24  h) 
was performed in all ruptured aneurysms. Since 2012, in all 
elective cases, intraoperative neurophysiological monitoring 
involving somatosensory, motor, and brainstem auditory-
evoked potentials was implemented, adopting a defined 
protocol that is also used in all intracranial aneurysms and 
brain arteriovenous malformations [7–15]. But we strongly 
believe that neurovascular training is the most important tool 
by far to improve the technique and avoid complications [16] 
Exclusion of the aneurysm was achieved in 23 cases treated 
by clipping. Two complex aneurysms underwent to an in situ 
PICA-PICA bypass before the trapping. Table 2 reports the 
overall data about the surgical management of the present 
series  (Tab.  2). Neuronavigation and endoscope-assisted 
techniques were commonly employed, the latter being been 
useful for both the aneurysms having a huge blind spot and 
those very close to perforating arteries. Micro-Doppler 
(20 MHz System, Mizuho Medical Co., Ltd., Tokyo, Japan) 
ultrasound-based evaluation of the flow was implemented. 
Indocyanine green video angiography (Flow 800 Infrared 
Module, OPMI Pentero 800, Zeiss, Oberkochen, Germany) 
and fluorescein angiography (Yellow 560 Fluorescence 
Module, Kinevo 900, Zeiss, Oberkochen, Germany) were 
also introduced since 2009 and 2018, respectively. Sixth- 
month postoperative DSA was available in all but one patient. 
Total exclusion of the aneurysm was achieved by means of 
a single procedure in 22 cases. In three cases, a remnant was 
revealed imposing a redo surgery. No recurrences occurred 
during the follow-up.
A good overall outcome was achieved in all but one 
unruptured aneurysm and in 60% of those ruptured. A mod-
erate outcome was observed in 16% of patients, whereas a 
severe outcome occurred in one patient who suffered by a 
permanent deficit of the lower cranial nerves. One patient, 
having  a giant ruptured proximal PICA aneurysm, died. 
Table  3 reports the overall outcome of the present 
series (Tab. 3).
 Illustrative Cases
Case 1 The case of a medium  VA-PICA aneurysm is 
reported (Fig.  1). A 35-year-old patient had an incidental 
finding of a left VA-PICA unruptured aneurysm after a mild 
traumatic brain injury (Fig. 1a). CT angiography and DSA 
demonstrated the involvement of PICA (Fig. 1b, c). A left 
far-lateral transcondylar approach was performed and the 
aneurysm was clipped (Fig. 1e, f). Postoperative CT angiog-
raphy documented the complete exclusion of the aneurysm 
with a preserved flow into the left PICA (Fig. 1g). Patient 
had a good recovery (mRS 1).
Case 2 The case of a giant distal PICA aneurysm is reported 
(Fig. 2). A 64 years-old patient suffering from a severe head-
ache and dizziness underwent to an MRI showing a giant 
thrombosed aneurysm causing a right cerebellar compres-
sion (Fig. 2a). CT angiography and DSA demonstrated the 
involvement of the distal PICA (Fig. 2b, c). A median suboc-












Females 19 (76%) 11 8
Males 6 (24%) 4 2
Age: mean 43 years old 
(18–69)
Comorbidities
Hypertension 9 7 2
Diabetes 2 2 1
Hypercolesterolemia 3 2 –
Obesity 1 1 –




  Hunt Hess scale I–III 11
  Hunt Hess scale IV 3
  Hunt Hess scale V 1





  Vertigo and gait 
instability
3
  Asymptomatic 7
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cipital approach was performed and the aneurysm was 
clipped after thrombectomy, the indocyanine green video 
angiography confirmed the patency of the PICA (Fig. 2d–g). 
Postoperative CT and CT angiography documented the com-
plete exclusion of the aneurysm (Fig.  2h, i). Patient had a 
good recovery (mRS 0).
 Discussion
Historically speaking, posterior circulation aneurysms were 
always considered a tough dare for surgeons. In 1829, 
Cruvelhier reported the first description of a spherical aneu-
rysm arising from the PICA-vertebral junction [17]. 
Afterward, in 1854, Fernet reported the first case of a distal 
PICA aneurysms [1]. The rarity of PICA aneurysms justifies 
the few large series reported [18–21]. Still today, with 146 
cases, that of Peerless and Drake remains the largest ever 
reported series about PICA aneurysms. In these aneurysms, 
the need for treatment is dictated by their high risk of rup-
ture, high mortality, and the usual younger age of the affected 
patients [19]. The mean reported age range is from 44.6–
51 years [22, 23]. The average age was slightly lower in the 
present series, with a prevalence of female sex.
Interestingly, all but one of the distal aneurysms were rup-
tured, three of which of small size. Indeed, as already reported 
about distal aneurysms at all, this aspect has to be probably 
related to the thinner walls of the distal ones [24–26]. The 
well-known risk of rebleeding of ruptured PICA aneurysms, 
up to 78%, imposes an early treatment. In this series, all hem-
orrhagic patients underwent surgery within 24 hours and, for 
patients with an impending-life hematoma, the indication for 
surgery was mainly based upon an evidence- based manage-
ment algorithm about intracerebral hemorrhages reported 
by our group [27]. Regardless of the clinical onset, all the 
patients underwent CTA and DSA.  A 4- or 6-vessel DSA 
is recommended for all PICA aneurysms, depending by the 
need for flow replacement, is recommended for all PICA 
aneurysms, also because of the well- known risk to miss very 
distal ones [28]. Indeed, one of the authors reported a very 
rare case of an extra-cranial small aneurysm of the PICA 
which was initially missed by CT angiography. The labyrinth 
of neurovascular bundles present in the posterior fossa makes 
the surgical exposure of PICA aneurysms really challenging. 
A careful preoperative evaluation of the patient’s vascular and 
bony anatomy is needed to tailor any approach, especially 
to assess the relationships between VA-PICA complex, the 
jugular tubercle, and the occipital condyle. The choice of the 
correct surgical approach has to be considered the crossroads 
in the microsurgical treatment of these aneurysms. In this 
series, 19 proximal aneurysms were exposed through a far-
lateral approach without drilling of the condyle in most cases. 
Conversely, Bertalanffy et al. used the transcondylar approach 
as a rule [29]. Ambrosio et al. suggest the routine use of the 
extreme- lateral approach to reach the proximal PICA from a 
corridor remaining below the lower cranial nerves [30].
In the elective treatment of proximal PICA aneurysms, 
the use of the endoscope as an adjuvant tool has to be 
 considered. Our group have already stressed the importance 
of endoscope-assisted techniques in the treatment of several 
neurosurgical pathologies [31, 32], but particularly in aneu-
rysm surgery where, often, the endoscope view allows spar-
ing perforating branches within blind spots.
Table 2 Overall data of the surgical management
Aneurysms
Aneurysms no. Approach Treatment
Size
Small (<7 mm) 9 9 Clipping
Medium (7–14) 11 11 Clipping
Large (15–24) 2 1 Clipping
1 Trapping + PICA-PICA by-pass
Giant (>25 mm) 3 2 Clipping
1 Trapping + PICA-PICA by-pass
Anatomical distribution
VA-PICA 10 Far lateral
Anterior medullary 6 Far lateral
Lateral medullary 3 Paramedian suboccipital
Tonsillomedullary 2 Paramedian suboccipital
Telovelotonsillary 1 Median suboccipital
Cortical 1 Median suboccipital
Table 3 Overall patient outcomes
mRS Ruptured aeurysms Unruptured aneurysms
Proximal Distal Proximal Distal
0 – 1 3 1
1 2 3 4 –
2 4 1 – –
3 3 – 1 –
4 1 – – –
5 1 – – –
6 1 – – –
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Fig. 1 CT angiography and DSA revealing a VA-PICA unruptured 
regular aneurysm (a–c). Left far-lateral transcondylar approach and 
clipping of the aneurysm (d, e). Postoperative CT and CT angiography 
documenting the complete exclusion of the aneurysm with a preserved 
flow into the left PICA (f, g)
Fig. 2 MRI angiography showing a giant thrombosed aneurysm caus-
ing a right cerebellar compression (a). CT angiography and DSA dem-
onstrating the involvement of the distal PICA (b, c). Median suboccipital 
approach, exposure of the thrombosed aneurysm, dissection, clipping 
and virtual videoangiography with indocyanine green (d–g). 
Postoperative CT and CT angiography documenting the complete 
exclusion of the aneurysm (h, i)
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The six aneurysms arising from the distal PICA were 
approached by a median or paramedian suboccipital crani-
otomy according to the length and the tortuosity of PICA.
The results of the present series, although made up of 25 
cases, endorse the prominent role of microneurosurgery for 
PICA aneurysms, both proximal and distal, especially in 
young patients. In experienced hands, direct clipping allows 
for a definitive and durable exclusion of the aneurysm. 
Outcomes are strictly related to the preoperative neurologi-
cal status.
The charm of PICA aneurysms is strictly related to the 
high anatomical variability of this artery and to their rarity. 
Surgeons who want to deal with them must have a deep 
knowledge of skull base approaches, vascular anatomy, and 
a profound familiarity with all the microsurgical techniques 
of vessel reconstruction.
Ethical Approval This study was approved by the Internal Advisory 
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Posterior Circulation Aneurysms: 
A Critical Appraisal of a Surgical Series 
in Endovascular Era
Sabino Luzzi, Mattia Del Maestro, and Renato Galzio
 Introduction
Posterior circulation aneurysms have a worse natural his-
tory than anterior aneurysms, mainly because of their 
higher risk of rupture and poor outcome [1]. This aspect 
imposes the need for treatment in most cases, especially in 
younger patients. The advent of the endovascular era and 
its constant refinement through the continuous improve-
ment of the devices has dramatically changed the treat-
ment standard for many but not all of the posterior circle 
aneurysms. Exceptions are aneurysms involving the distal 
segments of the cerebellar arteries, most basilar tip aneu-
rysms, and the giant ones for which microneurosurgery 
remains a rational option. The aim of this study is a critical 
appraisal of the overall results of a retrospective surgical 
series aimed to identify those posterior circulation aneu-
rysms for which microneurosurgery still today maintains a 
key role.
 Materials and Methods
Collected data concerned demographics, clinical onset, 
the prevalence of site and size, approaches, and outcome of 
149 patients surgically treated because they harbored one or 
more posterior circulation aneurysms have been retrospec-
tively reviewed. All the patients were operated on  by the 
senior author (RG) in three different hospitals over a period 
of 28  years between January 1990 and December 2018. 
Aneurysms were classified as proximal and distal. The prox-
imal ones involved vertebral artery (VA), basilar artery (BA), 
and the proximal segments of the posterior cerebral artery 
(PCA) and cerebellar arteries. The remaining sites were con-
sidered as distal. For outcome evaluation, the patients were 
divided in to two groups: <65 and ≥65  years old. 
The Angiographic outcome was evaluated based on the com-
plete exclusion of the aneurysm at a  six-month follow-up. 
The Neurological overall outcome was reported according to 
patients’ age, clinical onset, and site, and size of the aneu-
rysms. Glasgow Outcome Score (GOS) 1 and 2 were consid-
ered as “good recovery,” whereas GOS 3, 4, and 5 were 
considered as “moderate disability,” “severe disability,” and 
“death-vegetative state,” respectively.
 Results
 Patients Demographics and Clinical Data
Average patient age was 56.7  ±  14.2  years. Admission 
contrast- enhanced computed tomography (CT) angiogra-
phy was the rule for all patients. Preoperative digital sub-
traction angiography (DSA) was performed in all 
unruptured or complex aneurysms. In elective cases, the 
need for a balloon test occlusion (BTO) was assessed on a 
case-by-case basis. A contrast-enhanced MRI was per-
formed in all very large and giant aneurysms to reveal 
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eventual intraluminal thromboses. In 98 patients, a hemor-
rhagic onset occurred. The Average admission Hunt-Hess 
score was 2.17  ±  0.8 and the  mean Fisher grade was 
1.9 ± 0.8. One hundred thirty-seven aneurysms were clas-
sified as proximal and 20 as distal. Table  1 reports the 
prevalence of proximal and distal posterior circulation 
aneurysms according to site and size (Table 1). About rup-
tured aneurysms—apart from rare cases of young patients 
having an impending life hematoma, for whom the indica-
tion for surgery was based mainly upon an evidence- based 
management algorithm about intracerebral hemorrhages 
reported by our group [2]—mainly patients with an admis-
sion Hunt-Hess score of 1–3 underwent surgery. In 92% of 
cases, an early surgery (within 24 h) was performed. One 
hundred fifty-seven aneurysms were consecutively oper-
ated  on; six patients had two aneurysms and one patient 
harbored three different aneurysms. In three cases, two dif-
ferent procedures were performed on the same patient. A 
total of 152 procedures were performed.
 Surgery
 Approach Selection
Approaches were selected according to site and angioarchi-
tecture. Pterional and cranio-orbitary approaches were uti-
lized to basilar tip, proximal (P1) PCA, and superior 
cerebellar artery (SCA). For these aneurysms, pterional 
approach was usually “extended” to comprehend wide 
drilling of the lesser sphenoid wing, a large opening of the 
sylvian fissure, an extradural or intradural anterior clinoid-
ectomy, and an intradural posterior clinoidectomy. Cranio-
orbitary corridors were preferentially employed in large 
and giant aneurysms. Al-Mefty’s combined petrosal 
approach [3] was employed for the  midbasilar trunk and 
proximal anterior inferior cerebella artery (AICA). The Far-
lateral retrocondylar approach was the corridor of choice 
for aneurysms involving VB junction, VA, and the proximal 
PICA, although the transcondylar variant was rarely neces-
sary. Regarding the distal localizations, a subtemporal 
trans-tentorial approach was commonly used to treat P2-P3 
PCA aneurysms. Conversely, aneurysms involving the dis-
tal segments of AICA, SCA, and PICA were elegantly 
treated by a retrosigmoid route.
 Direct vs. Indirect Treatment
In all but three aneurysms a direct treatment was possible. A 
total of 128 aneurysms were successfully clipped. Trapping 
was the solution to aneurysms that were not amenable for 
clipping, under two conditions: if the patient tolerated the 
BTO, and the aneurysms were far distal having no need for 
revascularization. In one elective case of complex giant pos-
terior projecting basilar tip aneurysm, an extracranial to intra-
cranial (EC-IC) occipital artery (OA)—right P3 PCA bypass, 
with a radial artery graft, was performed. In two other elective 
patients, an intracranial to intracranial (IC-IC) PICA-PICA in 
situ bypass was carried out preceding, in both cases, the trap-
ping of a complex VB junction aneurysm. Table 2 reports the 
types of treatment and the surgical techniques comprehen-
sively employed in the current series (Table 2).
 Temporary Clipping and Neurophysiological 
Monitoring
In the present series, the anesthesia protocol used by our 
group was specifically designed to allow the intraoperative 
neurophysiological monitoring during neurovascular surgery 













Proximal Basilar tip + PCA (P1) + SCA 91 (58%) 17 (18.7%) 57 (62.6%) 7 (7.7%) 10 (11%)
Midbasilar trunk + proximal AICA 9 (5.7%) 2 (22.2%) 4 (44.4%) 2 (22.2%) 1 (11.1%)
VB Junction 10 (6.4%) 2 (20%) 5 (50%) 2 (20%) 1 (10%)
VA (V4) + proximal PICA (anterior + lateral 
medullary segment)
27 (17.2%) 5 (18.5%) 16 (59.3%) 3 (11.1%) 3 (11.1%)
Distal PCA (P2-P3) 7 (4.5%) 1 (14.3%) 2 (28.6%) 1 (14.3%) 3 (42.9%)
Distal SCA 3 (1.9%) – 1 (33.3%) 1 (33.3%) 1 (33.3%)
Distal AICA 4 (2.5%) 2 (50%) 1 (25%) – 1 (25%)
Distal PICA (tonsillo- medullary 
+ telovelotonsillar + cortical segment)
6 (3.8%) – 2 (33.3%) 2 (33.3%) 2 (33.3%)
Tot. 157 29 (18.5%) 88 (56.1%) 18 (11.5%) 22 (14%)
PCA (P1) proximal segment of the posterior cerebral artery, SCA superior cerebellar artery, AICA anterior inferior cerebellar artery, VB junction, 
vertebro-basilar junction, VA (V4) intradural segment of the vertebral artery, PICA posterior inferior cerebellar artery, PCA (P2-P3) distal segments 
of the posterior cerebral artery
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and was the same as employed for brain arteriovenous mal-
formations and giant aneurysms in general [4–13]. A com-
bined somatosensory-motor-brainstem auditory evoked 
potentials and EEG-based intraoperative neurophysiological 
monitoring were implemented in 2012. Neurophysiological 
Monitoring was performed in all proximal or complex aneu-
rysms electively treated.
 Technological Adjuvants and Flow Assessment 
Techniques
Neuronavigation and endoscope-assisted techniques were 
commonly employed, the latter being useful for both the 
aneurysms having a huge blind spot and those very close to 
perforating arteries. Since 2007, a micro-Doppler (20 MHz 
System, Mizuho Medical Co., Ltd., Tokyo, Japan) ultrasound- 
based evaluation of the flow was implemented. Indocyanine 
green video angiography (Flow 800 Infrared Module, OPMI 
Pentero 800, Zeiss, Oberkochen, Germany) and fluorescein 
angiography (Yellow 560 Fluorescence Module, Kinevo 
900, Zeiss, Oberkochen, Germany) were introduced in 2009 
and 2018, respectively.
 Neurological Outcome
The best outcome was achieved in patients <65  years old 
harboring an unruptured aneurysm. Table 3 reports the over-
all outcome according to the clinical onset and patient age 
(Table 3). The best results were also observed in small-to- 
regular aneurysms involving basilar tip, distal branches of 
the cerebellar arteries, VA, and the proximal PICA. Figures 1 
and 2 report the overall patient outcomes in proximal and 
distal aneurysms, respectively, according to their site and 
size (Figs. 1 and 2).
 Angiographic Outcome
Six-month postoperative angiography was available in all 
but 17 patients. If no remnants were revealed at the first post-
operative angiography, patients underwent a CT angiogra-
phy for further annual follow-ups.
In 88.5% of patients, total exclusion of the aneurysms was 
achieved using a single procedure. In three cases, a remnant 
was revealed, causing a redo surgery. Along with an average 
follow-up of 67.1 ± 61 months, no recurrences occurred.
 Illustrative Case
The case of a left giant VA-PICA aneurysm is reported (Fig. 3). 
A 42-year-old patient suffering from long-lasting dizziness 
underwent a contrast-enhanced MRI that showed a left giant 
VA causing a brainstem compression (Fig. 3a). CT angiogra-
phy and DSA demonstrated the involvement of PICA (Fig. 3b, 
c). No crossflow was revealed by BTO (Fig. 3d). A left far-lat-
eral retrocondylar approach was performed and the aneurysm 
was clipped using stacking-seating technique (Fig.  3e, f). 
Postoperative DSA documented the complete exclusion of the 
aneurysm with a preserved flow into the left PICA (Fig. 3g). 
The patient had a good recovery (GOS 5).
Table 2 Type and Prevalence of the Employed Surgical Techniques
Type of treatment Technique N (%)
Direct Clipping 128 (81.5%)
Trapping 19 (12.1%)
Wrapping 7 (4.5%)
Indirect OA-P3 PCA bypass 1 (0.6%)
PICA-PICA bypass 2 (1.3%)
Tot. 157
OA occipital artery, P3 PCA P3 segment of the posterior cerebral artery, 
PICA-PICA posterior-inferior cerebellar artery to posterior-inferior cer-
ebellar artery side to side in situ by pass
Table 3 Patients’ overall outcome according to the clinical onset and the patients’ age
Outcome
Clinical onset Patients’ age
Hemorrhagic Non-hemorrhagic <65 years-old ≥65 years-old
Good Recovery
[No. of patients (%)]
80 (81.6%) 45 (88.2%) 66 (83.5%) 33 (47.1%)
Moderate disability
[No. of patients (%)]
4 (4.1%) 2 (3.9%) 8 (10.1%) 14 (20%)
Severe disability
[No. of patients (%)]
3 (3.1%) 1 (2%) 1 (1.3%) 9 (12.9%)
Death-vegetative state
[No. of patients (%)]
11 (11.2%) 3 (5.9%) 4 (5.1%) 14 (20%)
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 Discussion
Although not free from possible complications, neuroen-
dovascular techniques have reached a level of effective-
ness that certainly makes them suitable for a large part of 
posterior circulation aneurysms. Conversely, microneu-
rosurgery still has a very important role in the treatment 
of aneurysms involving distal segments of the cerebellar 
arteries, giant aneurysms, a large number of aneurysms 
affecting basilar tip and proximal SCA, an equally large 
part of VA-PICA aneurysms and, more generally, com-
plex aneurysms not amenable to endovascular treatment 
[6, 14–22]. Particularly, the well-established role that 
microneurosurgery plays in the treatment of distal 
infratentorial aneurysms is the same, in terms of durabil-
ity, as its role in treating distal supratentorial ones [23]. 
The present retrospective series also confirms these data, 
suggesting that microneurosurgery should be considered 
as the treatment of choice especially for elective patients 
younger than 65 years old. Some technical aspects as fol-
low ought to be considered to achieve the best results: 
First, a detailed static and dynamic preoperative evalua-
tion of the aneurysm’s angioarchitecture and the flow-
related aspects are both imperative to plan the treatment 
strategy. A 4- or 6-vessel DSA, depending on the need for 
flow replacement, is recommended for all the posterior 
circulation aneurysms, and also addresses the well-
known risk of missing very distal PICA ones [24]. Indeed, 
one of the authors reported a very rare case of an extra-
cranial small aneurysm of the PICA which was initially 
missed by CT angiography. Second, a careful preopera-
tive evaluation of the patient’s vascular and bony anat-
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Fig. 1 Bar graph showing the overall patient outcome in proximal aneurysms according their site and size
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omy allows practical tailoring of any approach. The third 
remark regards the technological adjuvants, which are 
part of the surgeon’s armamentarium. For instance, our 
group has already stressed the importance of endoscope-
assisted techniques in the treatment of several neurosur-
gical pathologies, but particularly aneurysm surgery 
where, often, the endoscope view prevents perforating 
branches within blind spots [25, 26]. Noteworthy, apart 
from the aforementioned aspects, a constant microneuro-
surgical training remains essential for aneurysms surgery, 
as already reported by our group [27].
The results of the present series confirm that microneu-
rosurgery continues to have a paramount role in the  treat-
ment of many posterior circulation aneurysms, especially in 
young patients. In experienced hands, direct clipping allows 
for a definitive and durable exclusion of the aneurysm. 
Microneurosurgery also leads to a flow replacement before 
trapping for those aneurysms not amenable to coiling, stent-
ing, or clipping.
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Microneurosurgery for Paraclinoid 
Aneurysms in the Context of Flow 
Diverters
Sabino Luzzi, Mattia Del Maestro, and Renato Galzio
 Introduction
Paraclinoid internal carotid artery (ICA) lies between the 
distal dural ring and the origin of the posterior communicat-
ing artery. Aneurysms involving this segment pose extraor-
dinary challenges regarding the achievement of proximal 
hemodynamic control and safe intracranial exposure. The 
advent of the endovascular era, but especially the imple-
mentation of flow diverter (FD) stents in the last few years, 
have apparently shifted the treatment of paraclinoid aneu-
rysms away from microneurosurgery. However, the not neg-
ligible number of reported complications related to 
endovascular techniques, the lack of randomized clinical 
trials, the relative brevity of experience with FD stents, their 
questionable use in hemorrhagic cases, and their yet unde-
fined risk of ophthalmic artery occlusion, cause one to con-
tinue to consider microneurosurgery as a valuable option 
especially in young, visually symptomatic patients harbor-
ing large or giant aneurysms.
While admitting the actual achievements of FDs, the 
present study is aimed to critically review the results of 
microneurosurgery in a retrospective surgical series of para-
clinoid aneurysms to differentiate those more indicated for 
surgery from those instead of more suitable for endovascu-
lar therapy.
 Materials and Methods
The present series employed Barami’s classification of para-
clinoid aneurysms (Table 1) [1]. Data about demographics, 
clinical onset, Barami’s type site and size, approaches, as 
well the neurological and visual outcome of 53 patients con-
secutively operated for one or more paraclinoid aneurysms 
have been retrospectively reviewed. All the aneurysms were 
operated by the senior author (RG) in three different hospi-
tals between January 1993 and December 2018. Because of 
their different natural history and particular characteristics, 
blister aneurysms were excluded from this study. Type IIIb 
and IV were also ruled out since  nowadays these are cer-
tainly best managed by endovascular treatment. Neurological 
outcome was evaluated with the modified Rankin Scale [3], 
whereas angiographic outcome was evaluated upon the com-
plete exclusion of the aneurysm at six-month follow-up. 
Visual outcome was measured based on the perimetry assess-
ment at six-month follow-up.
 Results
 Demographics and Clinical Data
The Average patient age was 47.2 ± 12.6 years. Admission 
contrast-enhanced computed tomography (CT) angiogra-
phy and digital subtraction angiography (DSA) were per-
formed in all aneurysms, the former also providing details 
of the relationship between the aneurysm and anterior cli-
noid process. In non-hemorrhagic cases, the need for a 
DSA balloon test occlusion (BTO) was assessed on a case-
by-case basis. A contrast-enhanced MRI was performed in 
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all giant aneurysms to reveal eventual intraluminal throm-
boses. In 21 patients, subarachnoid hemorrhage was the 
clinical onset, the average admission Hunt-Hess score 
being 2.1  ±  1 and mean Fisher grade 1.8  ±  0.9  in these 
patients. Most of the aneurysms (47.4%) ranged between 7 
and 12 mm in size, and Barami’s type I was predominant. 
Table 2 reports the prevalence of Barami’s types according 
to size (Table 2). In hemorrhagic cases, patients having an 
admission Hunt-Hess score ranging between 1 and 3 
mainly underwent surgery. Exceptions regarded rare cases 
of young patients having an impending life hematoma. In 
these rare instances, the indication for surgery was based 
mainly upon an evidence-based management algorithm 
about intracerebral hemorrhages reported by our group 
[4]. In 94% of cases, an early surgery (within 24 h) was 
performed, the remaining cases being been deferred 
because of evidence of vasospasm or poor neurological 
status. A total of 57 aneurysms were consecutively oper-
ated  on; six patients had two aneurysms and one patient 
harbored three different aneurysms. In three patients, sur-
gery was performed after initial endovascular coiling was 
ultimately incomplete or unsuccessful. Conversely, four 
previously operated patients underwent an endovascular 
treatment because of the need for retreatment of the same 
aneurysm or for a different aneurysm.
 Surgery
 Approach Selection and Proximal Hemodynamic 
Control
Pterional approach was used as a rule, although in selected 
cases of complex or giant aneurysms involving the back wall 
of the ICA, cranio-orbitary approaches were useful to maxi-
mize the handling.
Exposure of the cervical ICA was reserved to complex 
or giant aneurysms, especially if a hemorrhagic onset 
occurred. It also allowed for both for an eventual temporary 
occlusion and for the retrograde suction decompression, 
Dallas technique [5], used in some giant aneurysms. 
Intradural anterior clinoidectomy was always preferred to 
that extradural to decrease the risk of aneurysm rupture.
 Direct vs. Indirect Treatment
A direct treatment was possible in 52 aneurysms (91.2%) 
and, in all these cases, it consisted of a clip ligation. In five 
aneurysms, an extracranial to intracranial high-flow bypass 
was performed before the trapping. The saphenous vein 
and the radial artery were the conduits in two and three 
cases, respectively. During direct treatment, temporary 
clipping of the parent vessel and bipolar aneurysm shrink-
ing were the most frequently used techniques. Furthermore, 
stacking- seating clipping technique, retrograde suction- 
decompression, aneurysmorrhaphy, and aneurysmectomy 
were commonly employed, particularly for giant aneu-
rysms. A total of 57 aneurysms were successfully treated.


















Type Ia 35 
(61.4%)
7 (20%) 16 
(45.7%)
5 (14.3%) 7 (20%)












2 (33.3%) 1 
(16.7%)






3 (23.1%) 2 
(15.4%)
Type IIIb – – – – –
Type IV – – – – –




10 (7.5%) 11 
(19.3%)
Table 1 Barami classification of paraclinoid aneurysms [1]
Type
Carotid segment
(according to Bouthillier 
Classification) [2] Surface Relation Comments Scheme






Ib C6 Superior None Lateral to ON
II C6 Ventral None Dome projects into CS roof





IIIb C5 Medial SHA Transitional aneurysms. 
Infradiaphragmatic
IV C5, C6 Ventral None Giant aneurysms extending between C5 
and C6 segments.




CS cavernous sinus, DS diaphragma sella, ON optic nerve, SHA superior hypophyseal artery
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 Temporary Clipping and Neurophysiological 
Monitoring
In all cases of temporary clipping carried out in elective con-
ditions, anesthesia protocol used for burst suppression and 
intraoperative neurophysiological monitoring was the same 
already reported by our group for most of the neurovascular 
pathologies [6–14]. A combined somatosensory-motor 
evoked potentials and EEG-based monitoring was intro-
duced in 2012 and, since that time, routinely employed for 
all complex ICA aneurysms electively treated.
 Technological Adjuvants and Flow Assessment 
Techniques
The Endoscope-assisted technique was utilized by default 
in all the aneurysms involving the back wall of the ICA. A 
rigid 0° or 30°, 4-mm endoscope was employed in all cases. 
The details of the endoscope-assisted technique for ICA 
aneurysms have been described elsewhere by our group 
[15, 16]. Flow assessment techniques were essential in all 
cases. They involved micro-Doppler ultrasound (MDU) 
(20 MHz System, Mizuho Medical Co., Ltd., Tokyo, Japan) 
since 2007, indocyanine green (ICG) video angiography 
(Flow 800 Infrared Module, OPMI Pentero 800, Zeiss, 
Oberkochen, Germany) since 2009, and fluorescein angi-
ography (Yellow 560 Fluorescence Module, Kinevo 900, 
Zeiss, Oberkochen, Germany) since 2018. Charbel micro-
flow probe (Intracranial Charbel Micro-Flow Probe, 
Transonic Systems Inc., New York, USA) was also used in 
some cases.
 Neurological Outcome
An overall mRS of 0–2 was achieved in 77.3% of patients, 
87.5% of which were elective. The best outcome was 
achieved in non-hemorrhagic cases and in patients <50 years 
old. Table 3 reports the overall outcome according to clinical 
onset (Table 3).
 Visual Outcome
In patients suffering a preoperative visual impairment con-
cern, visual field test appeared improved or unchanged in 
36.3% and 63.6% of cases, respectively. Campimetry was 
unchanged also in 76.1% of patients who had a preoperative 
normal visual field. Table  4 reports the visual overall out-
come in unruptured aneurysms according to preoperative 
visual impairment (Table 4).
 Angiographic Outcome
All but four patients underwent postoperative angiogra-
phy at six-month follow-up. Apart from cases of rem-
nants, all the patients underwent a CT angiography for 
further follow-ups. The total exclusion of the aneurysms 
with a single procedure was achieved in 93% of the 
patients. In four cases, two elective and two hemorrhagic, 
a remnant of a single aneurysm was revealed, and the 
patient underwent endovascular treatment. No recurrences 
were documented during an average follow-up of 
54.1 ± 34 months.
 Illustrative Cases
Case #1 Unruptured Giant Barami Type II Aneurysm in 
a Visually Symptomatic Patient. A 34-year-old female suf-
fered a right eye progressive visual impairment (Fig. 1). CT 
angiography and DSA revealed a right giant Barami type II 
paraclinoid aneurysm (Fig. 1a–c). She also had a small basi-
lar tip aneurysm (Fig. 1d). The patient passed the BTO of the 
right ICA and underwent surgery. A right pterional approach, 
comprehending an intradural anterior clinoidectomy, was 
performed, and the aneurysm was successfully clipped with 
three Yasargil standard clips (Fig. 1g). Basilar tip aneurysm 
was clipped also. The patient was discharged on the fifth 
postoperative day. At six-month DSA, a very small remnant 
was revealed, and the patient underwent radiological follow-
 up (Fig. 1i). Three months after surgery, the patient had com-
pletely recovered the preoperative visual field deficit 
(Fig. 1m, n).
Case #2 Ruptured  Very Large Barami Type II 
Aneurysm. A 37-year-old female was diagnosed with a 
subarachnoid hemorrhage (Fig.  2). CT angiography and 
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DSA revealed a right very  large Barami type II paracli-
noid ICA aneurysm (Fig.  2a–c). Early surgery was per-
formed, and the patient underwent a right 
fronto-temporo-orbitary approach with an intradural ante-
rior clinoidectomy after having exposed the ICA at the 
neck. The aneurysm was easily clipped with two tandem 
angled fenestrated clips (Fig. 2d–i). The Postoperative CT 
scan did not show ischemic complication (Fig. 2l) and the 
patient was discharged 10 days later without deficits. The 
six-month DSA confirmed the complete exclusion of the 
aneurysm (Fig. 2m, n).
 Discussion
The natural history of paraclinoid aneurysms is character-
ized by progressive and slow-growing until it reaches large 
or giant size without rupture. Hunterian ligation, with or 
Fig. 2 Illustrative Case #2, regarding a 37-year-old female who was 
diagnosed with a subarachnoid hemorrhage (a). CT angiography (b) 
and DSA (c) of the right ICA showing a right large Barami type II 
paraclinoid aneurysm. An intradural clinoidectomy with a piezoelectric 
bone scalpel (d) during a fronto-temporo-pterional-orbitary approach 
allowed to fully expose the aneurysm (e, f). (g, h) Clipping of the aneu-
rysm with the tandem angled fenestrated clipping technique. (i) 
Intraoperative ICG videoangiography confirming the complete exclu-
sion of the aneurysm. (j) Late postoperative CT scan showing no isch-
emic complication. (k, l) DSA of the right ICA in anterior-posterior 
projection showing the optimal visualization of the paraclinoid ICA 
and ophthalmic artery and the exclusion of the aneurysm
Fig. 1 Illustrative Case #1, regarding a 34-year-old female with a right 
eye progressive visual impairment. (a) CT angiography and DSA (b) of 
the right ICA in anterior-posterior and lateral (c) projection showing a 
right giant Barami type II paraclinoid ICA aneurysm. (d) DSA of the 
left VA showing a basilar tip aneurysm. (e) Intradural clinoidectomy 
during a right pterional approach. (f, g) Clipping of the aneurysms with 
the stacking-seating technique. (h) Intraoperative ICG videoangiogra-
phy showing the complete exclusion of the aneurysm. (i) Postoperative 
DSA of the right ICA in anterior-posterior projection showing a very 
small remnant of the aneurysm. (j) DSA of the vertebrobasilar system 
revealing a complete exclusion of the basilar tip aneurysm. Preoperative 
(k) and postoperative (l) visual field test of the right eye, confirming a 
dramatic improvement
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without revascularization, has in the past been the treat-
ment of choice for most of these lesions. However, as 
opposed to distal aneurysms, for which it has been reported 
to be usually decisive [17, 18], the straightforward proxi-
mal occlusion of the ICA is associated with an early recan-
alization of the aneurysm throughout the backflow. 
Accordingly, surgery shifted toward a direct treatment of 
this type of the aneurysms. The advent of the endovascular 
era has dramatically increased the spectrum of possible 
treatments for intracranial aneurysms, paraclinoid ones 
included. Moreover, with the introduction of FD stents, 
which find their main application right in ICA aneurysms, 
a quiet revolution within the endovascular techniques hap-
pened. A wide volume of literature confirms today the 
effectiveness and safety of FDs, especially for ICA aneu-
rysms, therefore supporting them as the first-line treatment 
for most paraclinoid aneurysms [19–22]. Recently, FDs 
have also been associated with a high rate of visual improve-
ment in symptomatic patients, without differences in terms 
of worsened vision or iatrogenic visual impairment as com-
pared with clipping and coiling techniques [23]. While 
admitting the practical role of FDs in the treatment of a 
large part of ICA aneurysms as those wide- necked, fusi-
form, dissecting, blister-like, or ventral giant, the enthusi-
astic attitude toward the flow diversion ought to be 
counterbalanced by a series of drawbacks to be taken into 
account. First, FDs have been reported to be associated 
with a not negligible number of serious complications [24]; 
second, their use in hemorrhagic cases is still pioneering; 
third, the associated risk of ophthalmic artery occlusion in 
paraclinoid aneurysms is yet undefined; fourth, their actual 
effectiveness is not supported by high-quality evidence 
[25]. Last but far from least, FDs require long-term or 
chronic anticoagulation, which is extremely inconvenient 
for patients with a long life expectancy.
All these aspects compel one to consider microneurosur-
gery as a still valuable option, especially in young and visu-
ally symptomatic patients harboring large or giant 
aneurysms. In addition to the undoubtedly proven durabil-
ity of the microneurosurgical treatment, the results of the 
present series documented a very good neurological and 
visual outcome in patients <50 years old harboring dorsal 
paraclinoid ICA aneurysms but also type II ventral ones. 
These cases are essentially those for which microneurosur-
gery is primarily indicated because it offers some unques-
tionable advantages compared with flow diversion. 
Conversely, FDs should be considered as the first option in 
the  superior hypophyseal artery and carotid cave aneu-
rysms, especially if these are small, unruptured, or occur in 
older and asymptomatic patients. Although not reported in 
the present series, blister aneurysms also seem to have a 
clear indication to flow diversions even in hemorrhagic 
cases [26]. From a technical standpoint, the key aspect in 
the management of these aneurysms is the anterior clinoid-
ectomy. Regardless of the surgeon’s preference for an 
extradural rather than an intradural approach, it should be 
stressed that anterior clinoidectomy plays the same role for 
paraclinoid aneurysms that condylectomy of jugular 
tuberculectomy play in the vertebro-basilar junction or ver-
tebral artery-posterior inferior cerebellar artery aneurysms: 
both have been reported as an essential step to achieve the 
widest and most unobstructed view possible of the target 
[27, 28]. Indeed, the paramount concept of maximizing the 
bony removal to avoid mechanical retraction of the neuro-
vascular structures is common to both skull base and neuro-
vascular surgery.  Paraclinoid aneurysms constitute a 
formidable challenging for which the mastery of neurovas-
cular and skull base surgery techniques are mandatory, they 
being both achievable uniquely by means of a constant 
microneurosurgical training, as stressed by our group [29]. 
In conclusion, elective patients <50 years old, visually symp-
tomatic, and harboring a Barami’s type Ia, Ib or II paraclinoid 
aneurysm, especially if large or giant, are the best candidates for 
microneurosurgery. Conversely, older patients having a superior 
hypophysial, carotid cave, or blister aneurysm seem to be more 
likely for endovascular therapy, FDs first. Hemorrhagic cases 
are still a subject of discussion, however, and worthy of a multi-
disciplinary evaluation on a case-by-case basis.
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 Introduction
Moyamoya disease (MMD) is a unique cerebrovascular dis-
ease with unknown etiology characterized by progressive 
stenosis of the terminal portion of the internal carotid artery 
(ICA) and abnormal vascular network formation at the base 
of the brain [1–3]. Surgical revascularization by superficial 
temporal artery (STA)-middle cerebral artery (MCA) anasto-
mosis is a standard surgical procedure especially for adult 
patients with MMD [1, 3–6]. The STA-MCA anastomosis 
not only prevents cerebral ischemic attack by improving 
cerebral blood flow (CBF), but could also reduce the risk of 
re-bleeding in patients with posterior hemorrhage who were 
known to have extremely high re-bleeding risk [7, 8]. 
Regarding surgical procedure, recent study indicates the 
superiority of direct/indirect combined revascularization sur-
gery such as STA-MCA anastomosis with indirect pial syn-
angiosis [9]. Despite its long-term favorable outcome, 
however, local cerebral hyperperfusion syndrome and peri-
operative cerebral infarction are potential complications of 
this procedure [10–16]. Therefore, routine hemodynamic 
study and intensive perioperative management, including 
strict blood pressure control and administration of neuropro-
tective agents, are essential to provide favorable outcome [3, 
17, 18]. In the present study, we sought to clarify the charac-
teristic pattern of cerebral hemodynamic changes in the 
acute stage after combined revascularization surgery for 
adult MMD patients, who were treated by modern periopera-
tive management protocol.
 Materials and Methods
 Inclusion Criteria of Patients and Surgical 
Procedure
The postoperative changes in CBF were investigated in 54 
consecutive adult patients with MMD (21–76  years old, 
43.1 average) surgically treated in 65 hemispheres by the 
same surgeon (M.F.) between July 2017 and June 2018. 
Surgical indication for MMD included all of the following 
items: the presence of ischemic symptoms (minor com-
pleted stroke and/or transient ischemic attack [TIA]) and/or 
posterior hemorrhage, the presence of hemodynamic com-
promise, independent activity of daily living (modified 
Rankin scale scores 0–2), and absence of major brain dam-
age that exceed the vascular territory of one major branch 
of MCA.
Preoperative CBF was quantified by the autoradio-
graphic method in most cases, and the CBF in each sub-
region using N-isopropyl-p-[123I] iodoamphetamine 
single-photon emission computed tomography (123I-IMP-
SPECT) [10, 13]. All patients underwent STA-MCA 
(M4) anastomosis with encephalo-duro-myo-synangiosis 
(EDMS) [4]. Craniotomy was performed around sylvian 
fissure end, approximately 8  cm in diameter, and the 
stump of STA was anastomosed to the M4 segment of 
MCA, which was followed by EDMS. All patients satis-
fied the diagnostic criteria of the Research Committee on 
Spontaneous Occlusion of the Circle of Willis, of the 
Ministry of Health, Labor, and Welfare, Japan [1, 3].
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 Postoperative CBF Measurement 
and Perioperative Management Protocol
CBF was routinely measured by 123I-IMP-SPECT at postop-
erative day (POD) 1 and 7 after surgery in all patients. The 
temporal profile of the postoperative cerebral hemodynamics 
was qualitatively classified into three patterns. First, the 
“local hyperperfusion-redistribution pattern” was defined as 
transient local hyperperfusion at the site of the anastomosis 
(POD1) and subsequent distribution of the improved CBF in 
wider vascular territory (POD7). Second, the “gradual CBF 
improvement pattern” was defined as none of minor improve-
ment of CBF (POD1) which was followed by the moderate 
improvement of CBF on the affected hemisphere (POD7). 
All of the patterns that did not satisfied the above two pat-
terns were defined as “others.” Postoperative computed 
tomography (CT) scan was routinely performed immediately 
after surgery and one day after surgery in all cases. 1.5-T or 
3-T magnetic resonance imaging (MRI) and magnetic reso-
nance angiography (MRA) were routinely performed within 
three days after surgery. MRI included diffusion-weighted 
images (DWI), T2-weighted images, and T2*-weighted 
images in all cases. The fluid attenuated inversion recovery 
was also performed in most cases. The criteria for “local 
hyperperfusion” included all of the following items: (1) The 
presence of a significant local CBF increase at the site of the 
anastomosis that exceeded the CBF value of the other supra- 
tentorial region of the bilateral hemispheres. (2) Apparent 
visualization of STA-MCA bypass by MRA. (3) The absence 
of other pathologies such as compression of the brain surface 
by the temporal muscle inserted for indirect pial synangiosis 
and CBF increase secondary to seizure.
All 54 patients operated on 65 hemispheres were pro-
spectively subjected to prophylactic intensive blood pres-
sure lowering (100–130 mmHg of systolic blood pressure) 
according to standardized postoperative management proto-
col to prevent cerebral hyperperfusion syndrome using 
1–10  mg/h continuous intravenous drip infusion of nicar-
dipine hydrochloride as previously described [17]. All 
patients were managed by intraoperative and postoperative 
intravenous administration of minocycline hydrochloride 
(200 mg/day) until 7 days after surgery, in order to avoid the 
deleterious effects of cerebral hyperperfusion, and to reduce 
the potential risk of cerebral ischemia at remote area [18]. 
To avoid the unfavorable effect of intensive blood pressure 
lowering on the contralateral hemisphere and/or ipsilateral 
remote areas, we routinely administered anti-platelet agents 
(100  mg  aspirin/day) starting the day after surgery in all 
cases [17, 18]. Based on the temporal profile of 123I-IMP- 
SPECT and MRI/MRA findings, we gradually allowed a 
return to normo-tensive conditions within 7–10 days after 
surgery [17, 18].
 Results
The outcome of 65 surgeries was favorable in all cases except 
for one (1.5%), which manifested as delayed intracerebral 
hemorrhage due to local hyperperfusion and did not affect 
the patient’s long-term activity of daily living. The postop-
erative 123I-IMP-SPECT revealed the characteristic CBF 
improvement pattern with local hyperperfusion (POD1) and 
subsequent distribution of CBF in wider vascular territory 
(POD7) on 37 hemispheres (56.9%, 37/65). “Gradual CBF 
improvement pattern” was found on 20 hemispheres (30.8%, 
20/65), and eight hemispheres were classified into the “oth-
ers” (12.3%, 8/65). The result is summarized in Table 1, and 
the representative case with “local hyperperfusion- 
redistribution pattern” is shown in Figs. 1 and 2. None of the 
patients developed perioperative cerebral infarction, while 
one patient suffered transient ischemic change by DWI at the 
cerebral cortex adjacent to the site of the anastomosis that 
resolved within 2 weeks.
 Discussion
The present prospective study by routine 123I-IMP-SPECT 
revealed the characteristic CBF improvement pattern in 
the acute stage after STA-MCA anastomosis with indirect 
pial synangiosis for adult MMD patients. We found that 
local hyperperfusion at the site of the anastomosis (POD1) 
and subsequent distribution of CBF in wider vascular ter-
ritory (POD7), so-called “local hyperperfusion-redistribu-
tion pattern,” was the most common hemodynamic pattern 
as evident on 37 hemispheres (56.9%, 37/65) after com-
bined revascularization surgery for adult MMD. Under the 
strict perioperative management by blood pressure control 
(100–130  mmHg of systolic blood pressure) and the 
administration of neuro-protective/anti-inflammatory 
agent (minocycline hydrochloride) [17, 18], the outcome 
of 65 surgeries was generally favorable despite the pres-
ence of transient local hyperperfusion, except for one 
(1.5%, 1/65) manifesting as delayed intracerebral hemor-
rhage due to local hyperperfusion. We thus recommend 
intensive perioperative care with routine CBF measure-
Table 1 Patterns of cerebral hemodynamic changes after 65 consecu-






Gradual increase in CBF (POD1-POD7) 20/65 30.8%
Others 8/65 12.3%
CBF cerebral blood flow, POD postoperative day
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ment to avoid the deleterious effect of transient local 
hyperperfusion within 7 days after STA-MCA anastomosis 
for adult MMD patients.
Surgical complications of MMD include perioperative 
cerebral ischemia and cerebral hyperperfusion syndrome [1, 
3, 5]. Perioperative cerebral ischemia could be caused by at 
least three distinct mechanisms: “watershed shift phenome-
non” [14, 19], thrombo-embolism at the site of the anasto-
mosis [13], and mechanical compression of the brain surface 
by swollen temporal muscle used for indirect bypass proce-
dure [20]. Besides perioperative cerebral ischemia, rapid 
local increase in CBF at the site of the anastomosis could 
result in focal hyperemia associated with vasogenic edema 
and/or hemorrhagic conversion, especially in adult MMD 
Fig. 1 Intraoperative microscopic view of right superficial temporal 
artery (STA)-middle cerebral artery (MCA) anastomosis for a 47-year- 
old patient. (a, b, d) The stump of STA was anastomosed to M4 seg-
ment of left MCA with 1.1  mm in diameter, with the temporary 
occlusion time of 26 min. (c) Intraoperative indocyanine green video- 
angiography after the anastomosis showing apparently patent STA- 
MCA bypass
Fig. 2 (a) Magnetic resonance angiography on postoperative day 2 
showing the patency of right STA-MCA bypass (arrow). (b, c) 
N-isopropyl-p-[123I] iodoamphetamine single-photon emission com-
puted tomography on postoperative day 1 (b) showing focal cerebral 
hyperperfusion in the right frontal lobe (arrow), which is significantly 
relieved with favorable distribution 7 days after surgery (c)
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[11–13, 15, 16]. We have reported that the incidence of 
 cerebral hyperperfusion syndrome after STA-MCA bypass 
was significantly higher in MMD patients than that in 
patients with atherosclerotic occlusive cerebrovascular dis-
eases [13]. Prognosis of the focal neurological deficit due to 
hyperperfusion is generally favorable, but it could lead to 
delayed intracerebral hemorrhage in a rare occasion [12]. In 
fact, the present study included one complication case with 
delayed intracerebral hemorrhage even under the modern 
perioperative management protocol. In light of the risk fac-
tors for hyperperfusion syndrome in MMD such as adult-
onset [11, 16], increased preoperative cerebral blood volume 
[16], hemorrhagic-onset [11], operation on the dominant 
hemisphere [18], and smaller diameter of the recipient artery 
[18], it is particularly important to manage adult MMD 
patients with these factors promptly to avoid deleterious 
effects of hyperperfusion during the perioperative period.
In conclusion, the direct/indirect combined revasculariza-
tion surgery is generally a safe and effective treatment for 
adult MMD under modern perioperative management. In 
light of the characteristic CBF improvement pattern with 
local hyperperfusion (POD1) and subsequent distribution of 
CBF in wider vascular territory (POD7) on 37 hemispheres 
in the present series (56.9%, 37/65), transient local hyperper-
fusion should be strictly managed by intensive perioperative 
care in adult MMD patients.
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 Introduction
Intracranial atherosclerotic stenosis is an important etiologi-
cal factor for cerebral infarction, and its incidence is report-
edly high in Asians [1]. According to the Japanese Stroke 
Databank 2015, intracranial atherosclerotic stenosis was 
observed in approximately 18% of patients with cerebral 
infarction. For medical treatment of symptomatic intracra-
nial atherosclerotic stenosis, antiplatelet drugs are primarily 
used, but the recurrence rate is high and the annual inci-
dence of cerebral infarction is approximately 10% [2] 
(Figs. 1 and 2).
Regarding neuroendovascular treatment for intracranial 
atherosclerotic stenosis, the usefulness of balloon angio-
plasty was reported following the development of balloon 
catheters for the intracranial cerebral blood vessels in the 
early 1990s [3, 4]. Thereafter, the development of intracra-
nial stents was promoted, and the results of a randomized 
controlled trial of Stenting and Aggressive Medical 
Management for Preventing Recurrent Stroke in Intracranial 
Arterial Stenosis (SAMMPRIS) showed that aggressive 
medical management was superior to angioplasty and stent-
ing with the use of the Wingspan stent system. Indeed, the 
30-day rates of stroke and death were 14.7% (10.2% isch-
emic, 4.5% hemorrhagic) with stenting versus 5.8% with 
aggressive medical management. However, even in the med-
ical management group, the risk is high. When the periopera-
tive strokes were excluded, the rates of subsequent ischemic 
strokes were almost the same in the two groups.
On the other hand, in Japan, the Wingspan stent was 
approved in July 2014, and it has been increasingly used. In 
this study, we retrospectively compared the results of neuro-
endovascular treatment for symptomatic intracranial athero-
sclerotic stenosis before and after Wingspan stent approval at 
our hospital.
 Materials and Methods
At our hospital, 256 sessions of neuroendovascular treatment 
were performed for 217 patients with symptomatic intracra-
nial atherosclerotic stenosis between 1999 and 2017. This 
treatment was indicated for patients meeting the following 
conditions: (1) ≥70% stenosis, (2) a history of cerebral 
infarction or repeated transient ischemic attacks (TIAs), and 
(3) written informed consent obtained from the patient or 
his/her family. Furthermore, acute-phase patients within 
three days after the onset of cerebral infarction were 
excluded. In addition, indication criteria for a Wingspan 
stent in Japan include: (1) emergency treatment for vascular 
dissection or acute/impending occlusion during angioplasty 
and (2) additional treatment after angioplasty under circum-
stances in which there is no other effective treatment method.
The subjects were divided into two groups: early-phase 
(from August 1999 until June 2014, before Wingspan stent 
approval) and late-phase (from July 2014 until December 
2017, after Wingspan stent approval) groups. We compared 
initial treatment results and perioperative complications 
within 30 days after treatment between the two groups. In the 
late phase, we also examined restenosis and recurrent cere-
bral ischemic events.
Neuroendovascular treatment was performed under 
local/intravenous anesthesia. For femoral artery punc-
ture, a 6-F guiding sheath or 8-F guiding catheter was 
used. As the stenotic blood vessel-dilating procedure, 
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balloon angioplasty alone was performed for initial 
treatment, as a rule. For balloon angioplasty, dilation at 
6 atm at maximum was conducted for 60–90 s using a 
balloon catheter measuring 1.5–4.0  mm in diameter 
(Gateway balloon catheter, Stryker, Maple Grove, MN, 
U.S.A. or Unryu balloon catheter, Kaneka Medics, 
Tokyo, Japan). When dilation after balloon angioplasty 
was insufficient or when acute occlusion related to vas-
cular dissociation occurred, a stent for the coronary 
artery was used in the early phase and a Wingspan stent 
(Stryker, Maple Grove, MN, U.S.A.) was used in the 
late phase for treatment.
Fig. 1 A 73-year-old patient with a history of minor stroke and recur-
rent right hemispheric transient ischemic attacks under double anti-
platelet therapy. (a) Angiography demonstrates high-grade stenosis of 
the left middle cerebral artery. (b) Residual stenosis after balloon angio-
plasty. (c) Widening of the lumen after deployment of the Wingspan 
stent
Fig. 2 A 68-year-old patient with recurrent brain stem and cerebellar 
infarction under double antiplatelet therapy. (a) Angiography shows 
high-grade stenosis of the left vertebral artery. (b) After balloon angio-
plasty and deployment of the Wingspan stent, there is minimal residual 
stenosis. (c) The radio-opaque stent end-makers are well visualized
T. Ueda et al.
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Two antiplatelet drugs were administered for 1 week prior 
to treatment. Two-drug administration was continued for 
1  month after surgery for patients who underwent balloon 
angioplasty, and for 6  months to 1  year after surgery for 
those who underwent stenting. Subsequently, this therapy 
was switched to monotherapy. Magnetic resonance imaging 
(MRI) was performed before treatment and within 3  days 
after treatment. In the late-phase group, cerebral angiogra-
phy was conducted 6 months after treatment if possible.
 Results
In the early phase, 188 sessions of treatment were performed 
for 163 patients (mean age: 63.5 ± 10.2 years, 125 males). In 
the late phase, 68 sessions of treatment were performed for 
54 patients (mean age: 66.4 ± 13.3 years, 45 males) (Table 1). 
In the early phase, the treatment procedures consisted of bal-
loon angioplasty for 157 patients (83.5%) and stenting for 31 
(16.5%). In the late phase, the former was selected for 33 
patients (48.5%) and the latter for 35 (51.5%); the number of 
patients treated by stenting increased. In the early phase, the 
internal carotid, middle cerebral, basilar, and vertebral arter-
ies were treated in 46, 77, 19 and 21 patients, respectively. In 
the late phase, they were treated in 19, 18, 5, and 11 patients, 
respectively.
The initial success rates of balloon angioplasty and stent-
ing were 96% and 100%, respectively. Patients with a per-
cent stenosis of ≤50% were regarded as achieving successful 
results. In the late phase, Wingspan stents were used in 14 
patients with internal carotid artery stenosis, in eight with 
middle cerebral artery stenosis, in three with basilar artery 
stenosis, and in 12 with vertebral artery stenosis.
Perioperative complications related to treatment within 
30  days consisted of minor stroke in six patients (3.2%) 
(peripheral embolism: three patients, penetrating vessel 
infarction: two patients and cerebral infarction related to vas-
cular dissociation: one patient) and major stroke in three 
(1.6%) (cerebral hemorrhage related to hyperperfusion dis-
order: two patients and cerebral infarction related to vascular 
dissection: one patient) in the early phase. In the late phase, 
minor stroke was observed in two patients (2.9%) (peripheral 
embolism: one patient and guidewire-perforation-related 
subarachnoid hemorrhage: two patients), and major stroke in 
one (in-stent thrombosis) (Table 2).
In the late phase, ≥50% restenosis was noted in 11 
patients during the follow-up period: eight patients (24.2%) 
who underwent balloon angioplasty and three (8.5%) who 
underwent stenting. Recurrent cerebral infarction was 
observed in one patient and TIAs in two. In 8 of the 11 
patients, additional treatment was performed (Wingspan 
stent insertion: six patients and balloon angioplasty: two 
patients).
 Discussion
In Japan, a balloon catheter for stenotic intracranial blood 
vessels was approved in 1991, earlier than in Europe and the 
United States. However, the catheter initially had a single 
lumen, and the incidence of perioperative complications was 
high. The results of treatment were not always favorable. In 
2002, a double-lumen balloon catheter for intracranial blood 
vessels was approved, and stent-free balloon angioplasty has 
since been primarily selected in Japan. The reported inci-
dence of perioperative complications related to minimally 
invasive procedures is relatively low, whereas that of reste-
nosis is high [5, 6]. However, there are no data to prove the 
efficacy of endovascular treatment for patients with symp-
tomatic intracranial stenosis so far.
In the United States, the Wingspan stent for intracranial 
stenosis was approved by the FDA in 2005. In 2011, a ran-
domized, controlled study (SAMMPRIS) of vasodilation 
with a self-expandable-type stent for intracranial blood ves-
sels, the Wingspan stent (Stryker, U.S.A.), which was newly 
developed to treat symptomatic intracranial artery stenosis, 
reported positive medical outcomes [7]. The subjects were 
451 patients with ≥70% stenosis with an interval of ≤1 month 
from the onset of TIA or mild cerebral infarction. Primary 
endpoints were stroke and death within 30 days. In the medi-
cal treatment and stenting groups, their incidences were 
Table 1 Comparison of patient characteristics between early and late 
phases
Early-phase Late-phase Total
N 163 54 217
Procedures 188 68 256
Balloon angioplasty 157 33 190
Stenting 31 35 66
Age, mean ± SD, years 63.5 ± 10.2 66.4 ± 13.3
M/F 125/38 45/9
Artery, N (procedures)
ICA 46 (53) 19 (24) 65 (77)
MCA 77 (88) 18 (23) 95 (111)
BA 19 (23) 5 (6) 24 (29)
VA 21 (24) 11 (15) 32 (39)
Table 2 Comparison of complications within 30 days after the proce-




Minor stroke/TIA 6 (3.2%) 2 (2.9%) 8 (3.1%)
Major stroke 3 (1.6%) 1 (1.5%) 4 (1.8%)
Total 9 (4.8%) 3 (4.4%) 12 
(4.7%)
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5.8% and 14.7%, respectively, demonstrating a significant 
difference. Regarding perioperative complications, the inci-
dence of ischemic stroke was 10.2% and that of hemorrhagic 
stroke was 4.5%. Among ischemic complications, 
penetrating- vessel-infarction-associated complications were 
observed in 15 patients (6.7%), embolic-infarction- associated 
complications in six (2.7%), and stent thrombosis in two 
(0.9%) [8]. As etiological factors for the complications, the 
use of a thick, hard delivery system was indicated, and 
patients treated in the acute to subacute phases after the onset 
of cerebral infarction were included. On the other hand, the 
recurrence rate ≥30 days after treatment in the two groups 
was approximately 5.8%, demonstrating no difference. In 
addition, the long-term results of the SAMMPRIS trial sug-
gested no significant difference in the incidence of new isch-
emic events after the perioperative period between the 
stenting and medical treatment groups [9].
In the United States, the Wingspan stent was initially indi-
cated for drug-therapy-resistant patients with ≥50% stenosis 
and ischemic cerebrovascular disorder, including TIA, 
related to intracranial artery stenosis. However, after 2008, 
the indication criteria were strictly modified based on the 
results of the SAMMPRIS trial: ≥70% stenosis, resistance to 
drug therapy, a history of ≥2 strokes, excluding TIA, and an 
interval of ≥8 days from onset. Regarding stenting with a 
Wingspan stent for stenosis of the middle cerebral artery, the 
reported incidence of complications was high in the learning 
stage, whereas there was a 50% decrease in the incidence in 
the acquired stage [10, 11].
Intracranial angioplasty with stenting initially started 
using the coronary balloon-mounted stents. A recent multi-
center registry study recruiting 300 patients demonstrated 
that the 30-day rate of stroke, TIA, and death after intracra-
nial stenting with a balloon-mounted coronary stent or the 
Wingspan stent was 4.3%. Patients treated with a balloon- 
mounted stent were less likely to have MCA stenosis and 
had a lower degree of residual stenosis than the Wingspan 
stent. However, a randomized clinical trial (the Vitesse 
intracranial stent study for ischemic stroke therapy: VISSIT), 
which compared balloon-expandable stent treatment with 
medical therapy in symptomatic intracranial stenosis, indi-
cated that the 30-day primary safety end point occurred in 
more patients in the stent group (24.1%) than in the medical 
group (9.4%) [12].
Both SAMMPRIS and VISSIT trials were not able to 
establish the efficacy of intracranial artery stenting compared 
with medical treatment. A SAMMPRIS post hoc analysis 
failed to show any subgroup of patients with intracranial artery 
stenosis who significantly benefited from stenting, even those 
at particularly high risk of stroke on aggressive medical ther-
apy. Further clinical trials may consider selection of patients 
demonstrating hemodynamic compromise as the mechanism 
of their ischemic stroke related to intracranial artery stenosis. 
In addition, balloon angioplasty without stenting technique 
may be another effective option for the treatment.
Our study has several limitations. This is a small retro-
spective study in which bias may have been introduced in the 
selection of patients and lack of medical arm. Other limita-
tions are the single-center design of study, insufficient fol-
low- up data, and only Japanese population data. Angiographic 
follow-up was usually performed once at 6 months after the 
procedure and MRA was performed mainly after that. 
Finally, this study consists of the experience of operators in 
an academic hospital, which may limit the generalizability of 
our results.
Balloon angioplasty and stenting for patients who have 
symptomatic intracranial atherosclerotic stenosis may have 
the potential of better clinical outcome if patients are prop-
erly selected and treated by an experienced operator at a 
high-volume center. However, prospective studies with a 
large population and long follow-up should be done to evalu-
ate the conclusion. Furthermore, well-designed randomized 
controlled trials will be necessary to show the value of endo-
vascular treatment (when compared to medical treatment) 
for patients with symptomatic intracranial atherosclerotic 
stenosis.
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 Introduction
Arteriovenous malformations (AVM) are considered to be 
sporadic congenital vascular lesions, consisting of abnormal 
blood vessels forming direct connections between arteries 
and veins without capillary network. Brain AVMs affect 
0.1% of the population [1] with an incidence of 1.3 per 
100,000 persons a year [2]. Cerebral AVMs can be asymp-
tomatic, but when they are symptomatic, patients can present 
with intracranial hemorrhage (ICH), seizures, neurological 
deficits, and headache [3, 4]. The most frequent presenting 
symptom is ICH, detected in 50% of cases [4]. Hemorrhages 
are usually intraparenchymal, but subarachnoid location is 
also common: brain AVMs are responsible for 9% of sub-
arachnoid hemorrhages [5] and represents the leading cause 
of ICH in young adults [4]. The overall annual rupture risk 
was reported to be 2.3–3%, 1.3–2.2% for unruptured, and 
4.5–4.8% for ruptured cases respectively [4, 6]. Patients with 
a history of ruptured AVM are at higher risk of hemorrhage 
than those without it. Seizures are present in 11–33% of 
cases [7]. The 5-year seizure risk for asymptomatic patients 
with AVM is 8%, although when presenting with ICH or 
focal neurologic deficits the same risk rises to 23% [8]. 
Headache was reported to be associated with cerebral AVM 
in 17–50% of cases [9], while neurological deficits may be 
present in 3–10% [10]. Mortality rates range between 0.7% 
and 2.9% per year [11].
Treatment options include conservative therapy, neuro-
surgical elimination, radiosurgery, endovascular techniques, 
and combinations of these options. The therapeutic approach 
to AVMs is controversial. Only one randomized controlled 
trial was published in the literature on the management of 
unruptured AVMs. According to the findings of the ARUBA 
trial it is suggested not to perform interventional treatment in 
such cases due to worse clinical outcome compared to those 
cases with medical treatment alone [12]. Many authors are 
arguing with these results due to their professional experi-
ence, controversial results of other reports, and the main 
limitations of the trial: application of a variety of treatment 
modalities without specifying the selection strategy, inclu-
sion of a variety of different size and type of AMVs, and the 
short follow- up period [13, 14]. Nevertheless, the results of 
the non-randomized Scottish Audit of Intracranial Vascular 
Malformation with a follow-up of 12 years also supports the 
findings of the ARUBA trial [15]. Altogether because of the 
lack of evidence-based guidelines for management options, 
the therapeutic approach is highly individual, should be mul-
tidisciplinary, and has to be based on as much information as 
possible. According to the ARUBA trial, as well as in clinical 
practice, the primary consideration for decision-making in 
cases with untreated AVMs is the risk of hemorrhage, dis-
ability and mortality [13, 15, 16]. The impact of an untreated 
AVM on the quality of life (QOL) is generally not consid-
ered. Reports on outcome regarding QOL are uncommon in 
the literature, with most of the publications not focusing on 
cases with untreated AVM [17, 18], although disability 
doesn’t always correlate with the QOL. Therefore, its assess-
ment can provide important additional information for thera-
peutic decisions. The application of QOL assessment is 
increasingly accepted as a major endpoint in clinical trials 
and has a more important role in decision-making in neuro-
surgical practice as well [19, 20]. Hereby we report our 
observational results of patients with brain AVM without 
interventional treatment based on their QOL.
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Twenty female and 16 male patients were enrolled in our 
study with a mean age of 45 ± 16 years. Subjects were iden-
tified retrospectively from the AVM database of our hospi-
tal. Patients with unruptured cerebral AVM without 
interventional treatment over the age of 18 met our inclu-
sion criteria. We excluded patients with other intracranial 
pathology potentially responsible for the symptoms. The 
AVMs were detected between 2000 and 2018. All patients 
have visited either the outpatient or the inpatient ward of the 
National Institute of Clinical Neurosciences in Budapest, 
where the diagnosis of AVM was either made or confirmed. 
After physical examination, AVM was detected by either 
contrast- enhanced computed tomography (CT) or magnetic 
resonance imaging (MRI). Digital subtraction angiography 
(DSA) was performed for precise characterization of the 
AVM in each case. Treatment decision (conservative or 
invasive) was made by the patient or chosen individually by 
the treatment team.
We used the standardized EQ-5D-5L questionnaire for 
measuring the QOL [21]. It was designed by the EuroQol 
Group to estimate the patient’s health-related state with the 
help of a descriptive system and a visual analogue scale 
(VAS). The EQ-5D-5L descriptive system consists of a 
5-level scale (according to the severity of symptoms) in five 
dimensions (mobility, self-care, usual activity, pain/discom-
fort and anxiety/depression). The VAS registers the patient’s 
actual level of general health on a scale from 0 to 100, assum-
ing 0 as the worst and 100 as the best imaginable health state. 
Our subjects were interviewed by telephone in 2018 retro-
spectively. No previous QOL tests were performed in their 
cases prior to our study.
As a control group we used the results of the Research 
Report (RR) of the National Health Survey from 2002 [22]. 
This Hungarian nationwide report used the EQ-5D-3L ques-
tionnaire [23] to measure the QOL on a cohort of 5534 
healthy subjects. This questionnaire was also designed by the 
EuroQol Group as a less sensitive tool than the EQ-5D-5L 
version; it uses a 3-level scale instead of 5 in case of every 
dimension of the descriptive system. Level 1 is chosen if the 
subject doesn’t have any problem in the designated dimen-
sion, Level 2 if there is some trouble regarding the category, 
and Level 3 if severe impairment is present. The EQ-5D-3L 
descriptive system results of the RR were categorized in two 
groups for statistical analysis in every dimension: the first 
group contained the answers of Level 1, while Levels 2 and 
3 represented the second group. To facilitate an adequate 
comparison we categorized our results likewise: the first 
group represented patients with no complaint (Level 1) and 
subjects with any complaint (Level 2–5) became the mem-
bers of the second group. The aforementioned RR discussed 
their findings in three age groups (18–34, 35–64 and older 
than 65) and considered females and males separately. We, 
therefore, made the same subdivisions. The RR summarized 
their findings on VAS as well, though they were not reported 
by age groups; therefore, we lacked data for adequate 
comparison.
We compared the results of the descriptive system of the 
RR with our findings, but statistical analysis wasn’t made 
due to the small number of our subjects. For illustrating our 
results, we prepared diagrams to demonstrate the numeric 
differences between the two groups. Our observations on the 
VAS were also provided in details and demonstrated visu-
ally, but we missed data for comparison.
The study was approved by the Institutional Committee of 
Science and Research Ethics of the National Institute of 
Clinical Neurosciences. All participants gave written 
informed consent of participation.
 Results
Thirty-six patients (n = 20 female and n = 16 male) met our 
inclusion criteria with a mean age of 45 ± 16 years. Their 
average follow-up time was 57.4  ±  49  months. Headache 
was present in 15 patients with a female predominance 
(n = 12 female and n = 3 male), thus proving to be the most 
common AVM-related sign in our cohort (41.6%). Epileptic 
seizures occurred in nine cases (25%), more commonly 
affecting male subjects (n  =  7 male and n  =  2 female). 
Neurological deficit was detected in 33% of our cohort 
(n = 12; n = 8 female and n = 4 male). Table 1 shows the 
patient characteristics.
 Results of the EQ-5D-5L Descriptive System
 Mobility
We observed a tendency toward decrease in the mobility of 
our female subjects by age, which occurred also in the con-
trol population, but less frequently. Although we expected 
the same tendency for men, older male subjects proved not to 
Table 1 Patient characteristics. Division by the sex of the patients
Female (n) Male (n) All (n; %)
Age
18–34 6 5 11 (30.5%)
35–64 10 8 18 (50%)
>65 4 3 7 (19.5%)
Symptoms
headache 12 3 41.6 (40%)
epileptic seizures 2 7 9 (25%)
neurological deficit 8 4 12 (33%)
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have any problem in this regard, middle-aged patients had 
less complaint than the subjects of the RR, and young males 
showed significantly more severe impairment in their mobil-
ity compared with the control group (we observed an eight-
fold difference) (Fig. 1).
 Self-Care
Although the results of the RR show an increasing impair-
ment by age in the question of self-care, our female subjects 
and younger male patients proved not to be limited by this 
factor. In case of our male subjects older than 65 years of 
age, we observed a severe impairment in comparison with 
the control group (twofold difference) (Fig. 2).
 Usual Activity
Decline in usual activity showed a male dominance in our 
cohort. The most significant difference between the control 
group and our patients was seen in the case of young (22-fold 
difference) and middle-aged males (2.8-fold difference). 
Only middle-aged female subjects exceeded their healthy 
controls. Altogether usual activity impairment seems to be a 
more limiting factor in male patients under the age of 
65 years (Fig. 3).
 Pain and Discomfort
Pain and discomfort have an increasing impact on the QOL 
of the general population by age according to the results of 
the RR.  Women are affected more frequently in all age 
groups compared with male subjects. Our patients demon-
strated a different behavior. Young women (18–34  years) 
exceeded by 3.6-fold the level of their healthy controls, while 
female subjects older than 35 years of age stayed below the 
level of the control group. Middle-aged male patients also 
surpassed the control males by 1.4. The greatest difference 
(fourfold) was seen in case of young male subjects (18–
34 years). In conclusion, cerebral AVM has the most remark-
able effect on pain and discomfort in case of young patients, 
especially in male subjects (Fig. 4).
 Anxiety and Depression
Very similarly to the pain and discomfort results we found 
anxiety and depression to affect young patients (18–34 years) 
the most, surpassing the RR population. Eighty percent of 
men and 50% of women of the youngest age group answered 
that anxiety and depression were important factors in their 
lives due to their diagnosed AVM. Different sex ratios, how-































Fig. 1 (a) Female mobility impairment according to age groups in our 
patients (blue columns) compared to the control cohort (red columns). 
(b). Male mobility impairment according to age groups in our patients 































Fig. 2 (a) Female self-care impairment according to age groups in our 
patients (blue columns) compared to the control cohort (red columns). 
(b) Male self-care impairment according to age groups in our patients 
(blue columns) compared to the control cohort (red columns)
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Middle-aged males also surpassed the control group, but 
only with a 1.25-fold difference. In conclusion, brain AVM 
also has a significant effect on anxiety and depression with a 
male predominance in case of younger patients (Fig. 5).
 Impact of the Different Factors on QOL
We found that anxiety/depression and pain/discomfort are 
the most significant factors influencing the QOL in our 
cohort (47.2% and 41.6% respectively). Twenty-five percent 
of our patients responded that they had troubles in perform-
ing their usual activities, while mobility and self-care were 
affected less frequently (11% and 2.7% respectively) (Fig. 6).
 Results of the EQ-5D-5L VAS
The mean result of the VAS in our cohort was proved to be 
84.6 ± 22 points. According to age groups, the youngest and 
middle-aged patients were found similar (83% and 86%), 
while older subjects rated themselves to a lower level (70%). 
Forty-four percent of our cases rated themselves above 95 
points, while 30.5% of them considered their actual level of 
general health less than 80 points. The RR findings on VAS 
were not reported by age group; therefore we lack data for 
comparison (Table 2).
 Discussion
Untreated unruptured brain AVMs do have an impact on the 
QOL. Due to the judgement of more than 30% of our sub-
jects, living with cerebral AVM represents a significant limi-
tation in their QOL. Multiple conditions are responsible for 
the decreased level of health, but anxiety, depression, pain, 
and discomfort seem to be the most common influencing fac-
tors, especially in young male subjects. Female patients with 
untreated AVMs demonstrate a greater dependence than men 
in all age groups. Males with a predominance of young age 
have a more significant impairment in their usual activities 
when compared to women. Older patients are affected more 
significantly in their self-care, while the impact of discom-
fort and anxiety is more severe in the younger population. 
The impairment of mobility was seen to surpass significantly 































Fig. 3 (a) Female usual activity decline according to age groups in our 
patients (blue columns) compared to the control cohort (red columns). 
(b) Male usual activity decline according to age groups in our patients 































Fig. 4 (a) Female frequency of pain and discomfort according to age 
groups in our patients (blue columns) compared to the control cohort 
(red columns). (b) Male frequency of pain and discomfort according to 
age groups in our patients (blue columns) compared to the control 
cohort (red columns)
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In summary, untreated cerebral AVMs seem to have the 
most demonstrative impact on young male patients, 
although the limiting factors are highly individual. QOL 
assessment is, therefore, an important tool and needs to be 
considered in the therapeutic decision-making in patients 
with brain AVM.  Future studies are necessary to confirm 
our findings.
The main limitation of our study is the low number of 
cases, especially in the subgroup calculations, so compelling 
statistical analysis could not be done when comparing with 
the control group. Another weakness is the high scatter in the 
follow-up time and the time between the diagnosis and QOL 
assessment. Further investigations are needed with larger 
cohorts and longer follow-up times, though the rarity of the 
disease represents a great limiting factor.
The strength of our study is the demonstration of the out-
come of QOL in the natural course of the disease focusing on 
purely untreated cases.
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Complications in AVM Surgery
Marco Cenzato, Davide Boeris, Maurizio Piparo, 
Alessia Fratianni, Maria Angela Piano, Flavia Dones, 
Francesco M. Crisà, and Giuseppe D’Aliberti
Surgery of cerebral arteriovenous malformations (AVM) is 
considered to be high-risk. This means that the risk of having 
complications during or soon after surgery is substantially 
elevated. This article describes the possible peri-operative 
complications for surgery of arteriovenous malformations 
and some suggestions to avoid their onset.
Brain malformation surgery has predominantly three 
kinds of complications that may result in possible neurologi-
cal deficits for the patient:
 1. Direct lesion of eloquent areas.
 2. Postoperative bleeding due to the presence of a residual 
that has not been removed during surgery.
 3. Postoperative hyperemia.
 Direct Lesion of an Eloquent Area
Defining the limits between what is eloquent and what is not 
eloquent is not always so simple. Traditionally, eloquence 
has been referred to the cortical areas assigned to a specific 
function, essentially the motor areas, the areas of language 
and visual function, in addition, of course, to the brain stem 
and the deep structures. Magnetic resonance imaging with its 
high definition allows us to accurately understand the corti-
cal areas affected by the arteriovenous malformation and the 
contiguous ones that may be damaged by surgery.
Functional resonance in arteriovenous malformations is 
questionable [1] and probably not reliable, because the 
excessive flow surrounding the AVM can alter the BOLD 
effect. Transcranial magnetic stimulation may be a more pre-
cise method to identify the eloquent function. [2].
A malformation that affects eloquent cortical areas is 
hardly indicated as susceptible to surgical treatment. In these 
cases, the use of the Gamma Knife is the preferred alterna-
tive to surgery [3, 4].
Concerning eloquence, until a decade ago, white matter 
did not deserve great attention from neurosurgeons. Over the 
last decade the study of magnetic resonance with tractogra-
phy allowed a more precise definition of the deep tracts of 
white matter [5, 6] and how eloquent they are. Before the 
introduction of the non-stick bipolar, one of the biggest prob-
lems to deal with, during arteriovenous malformations sur-
gery, was to control the bleeding from the deep medullary 
vessels. That typically comes from the deep of the white 
matter [7]. These deep medullary vessels were extremely 
challenging to coagulate and required a meticulous and 
patient coagulation technique that was often laborious and 
difficult to obtain. Managing these fragile vessels was diffi-
cult because of the disproportion between the size of the ves-
sel and the thickness of the protein wall. These vessels must 
often be pursued in the depth of the white substance to obtain 
a secure hemostasis. This often caused a damage of eloquent 
white matter tracts. Conventional bipolar forceps were effec-
tive only within a narrow range of humidity obtained by the 
irrigation of the surgical field. An excessive washing made 
the coagulation ineffective, while an insufficient washing led 
to an adhesion of the vessel to the tips of the bipolar forceps 
with subsequent rupture.
Today the hemostasis techniques are significantly 
improved. The introduction of the non-stick bipolar permits 
a more effective coagulation and does not require irrigation 
(dry coagulation). This allows the surgeon to be more effec-
tive at lower-current intensities without sticking the wall of 
the fragile deep vessels to the tip of the bipolar.
The use of non-stick dry coagulation, possibly in associa-
tion with the “dirty coagulation” described by Hernesniemi, 
now makes coagulation of these medullary vessel easier and 
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more effective. Dirty coagulation is a technique that, when the 
vessel wall is very thin, uses a small part of brain tissue adja-
cent to the vessel to increase the amount of protein to be sub-
jected to coagulation [8]. This changed the risk of damaging 
eloquent deep white matter and permits more selective excision 
of the arteriovenous malformation within the interface malfor-
mation-brain tissue. We have found also that Thulium laser 
proved to be very useful in coagulating these very fragile deep 
vessels. It is a very versatile tool that allows a coagulation of 
the vessels without direct contact [9]. We prefer to avoid the use 
of contact hemostatic agents in AVM surgery, as often postop-
erative bleeds are related to residues and cannot be avoided 
with overlying hemostatic agents that can actually cause the 
spread of the bleeding into the parenchyma instead of the sub-
arachnoid space. If a vessel has to bleed, it is preferable for the 
blood to spill in the cavity rather than within the brain.
Moreover, in the last few years the strict interaction with 
neuroradiologists promoted the selective use of presurgical 
embolization to close specific deep vessels that we anticipate 
will be difficult to reach during the excision of the AVM, 
instead of a massive nidus embolization. The previous strat-
egy of embolizing the nidus with Onyx through the large 
feeders keeps the deep feeders open, often with an increased 
flow, complicating the control of bleeding [10]. Selectively 
embolizing the deep feeders reduces the need to follow a 
bleeding vessel in the deep white matter. Difficulty control-
ling hemostasis of these vessels was one of the main causes 
of postoperative neurological damage. The introduction of 
non-stick bipolar dramatically improved the outcome of 
AVM surgery by allowing a more selective resection with a 
faster and safer surgery.
Obtaining a good hemostasis of the deep vessels is essen-
tial to avoid direct damage to the white substance but is also 
the key to avoiding postoperative hemorrhages. A last detail 
can be suggested regarding arteriovenous malformations 
with deep feeders involving branches from the choroidal 
arteries: When safe, try to reach the ventricle, where the 
medullary vessels coming from the choroidal arteries are 
more easily identifiable and controllable.
 Postoperative Hematoma
Postoperative bleeding usually occurs very early, in the first 
postoperative hours after surgery for arteriovenous malfor-
mation. Out of 214 AVM treated in the last 7 years, we had 
only two episodes of postoperative bleeding that occurred 
after 24 h.
The main causes of postoperative bleeding are:
• An inaccurate hemostasis of the aforementioned deep 
feeding vessels.
• A bleeding from a large-sized vessel where coagulation 
ceases after a while. We experienced re-bleeding from 
vessels that appeared to be well coagulated and then 
caused postoperative hematomas. We observed that 
relevant- sized collateral originated a few millimeters 
before the previously coagulated end of the cut vessel. 
The collateral therefore maintained high pressure near a 
too-short coagulated tract of the vessel. We therefore rec-
ommend in these cases to use a micro clip to control the 
bleeding. It is important to keep a long-coagulated tract of 
the vessel where the blood can stagnate and then stabilize 
the clot. If this is not possible, and if the vessel has a sig-
nificant caliber, it is advisable to use micro clips for AVM 
to ensure a better seal of the clot.
• A third element that can lead to postoperative bleeding is 
the presence of a residual of the malformation that has not 
been removed during surgery because it is hidden by 
brain tissue. In our experience this has happened close to 
eloquent areas that we want to preserve, or has been 
caused by lack of awareness of the full extent of the mal-
formation. The presence of a residual in the postoperative 
angiography has a high risk of bleeding, so our modus 
operandi is to return to the operating room and complete 
the removal of the malformation in the same setting, if 
this is possible. It is important to reduce intraoperatively 
the chances that this will occur. Tools that allow us to 
detect the presence of a hidden residual at the end of the 
surgical procedure are:
 – Intraoperative Fluorangiography (FA) with Indocyanine 
green is useful to check the flow in the vessels in real 
time. A recognized limit of FA is that it shows only 
what is on the surface. What is beyond the surface 
remains hidden. Nevertheless, the key sign to look for 
in the presence of a hidden residual of AVM is the early 
filling of a visible vein in the surgical field [11].
 – Intraoperative Ultrasound doppler and enhanced 
Ultrasound imaging with microbubbles contrast. High 
definition ultrasound is a new, valuable instrument in 
the OR. It is cheap and in real time. It can be of valu-
able in AVM surgery. Doppler ultrasound can show a 
high flow beyond the surface. The use of contrast with 
microbubbles allows us to identify beyond the visible 
surface the possible presence of a small residue. It is a 
technique that requires training and confidence with 
the instrument, but can be a precious help [12].
 – The intraoperative micro-Doppler can be used to 
explore the entire surgical cavity. If high flow is identi-
fied, it can indicate a residual malformation that is 
worthwhile to explore [13].
 – Obviously the most suitable instrument to identify 
AVM residuals is a catheter angiography; therefore, a 
hybrid surgical room equipped with intraoperative 
angiography represents the best solution. They are 
rare and only few centers have the luxury of an inte-
grated operating room. If the hybrid O.R. is not avail-
able, we suggest obtaining an angiographic 
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examination immediately at the end of the surgical 
procedure even if this may prove time-consuming. 
The last element that can favor a postoperative bleed-
ing is an increase in the arterial pressure during the 
postoperative awakening or transport of the patient. 
During the awakening phase, the patient can feel pain 
and the arterial pressure can increase, or the patient 
may cough and increase the venous pressure. Both 
situations are dangerous when you must rely on frag-
ile vessels just coagulated. For this reason, it is prefer-
able to maintain the patient asleep for at least 12 h in 
intensive care, especially in complex malformations 
and those where intraoperative hemostasis has been 
more difficult. This allows for the stabilization of the 
clot in the closed vessels.
 Postoperative Hyperemia
This complication typically occurs 3 or 4 days after the inter-
vention. It is a hemorrhagic infarction of the surrounding 
brain that progressively evolves and that may require reop-
eration or even bone-flap removal for brain decompression.
The underling process is explained by three different 
theories:
 – Normal perfusion pressure breakthrough [14, 15]
 – Occlusive hyperemia [16]
 – Venous engorgement [17–19]
The Normal perfusion pressure breakthrough theory is a 
term coined by Spetzler in 1978. He used it to indicate a 
postoperative hyperemia responsible for hemorrhagic infarc-
tion. According to the theory developed by Spetzler, the 
brain tissue around an arteriovenous malformation has lost 
the ability of self-regulating based on CO2. The chronic dila-
tation in the presence of chronic ischemia prevents an 
increase in the resistance of the capillaries once the malfor-
mation has been removed. The chronically dilated low- 
resistance vessels are therefore unable to resist the suddenly 
increased flow once the flow is redirected in the surrounding 
tissue after the AVM is removed.
The second theory is the occlusive hyperemia theory, pro-
posed by al-Rodhan in 1993. It is based on two interrelated 
mechanisms: the first refers to stagnation of the arterial flow 
in the vessels that previously supplied the malformation and 
its collaterals; the second refers to an obstruction of the 
venous drainage in the adjacent brain tissue, resulting in a 
venous engorgement.
The theory on venous engorgement refers to stagnation 
only into the venous compartment. This theory was pro-
posed in 1993 by Wilson and sustained by Schaller in 
2002 and by D’Aliberti in 2013. If the malformation has 
one or more large venous outflows, these veins tend to 
thrombose when the AVM is removed. If these veins drain 
the venous outflow of the surrounding cerebral paren-
chyma, thrombosis may extend so as to cause venous out-
flow obstruction, and therefore venous infarction of the 
surrounding brain tissue.
In our experience, postoperative hyperemia is a rare phe-
nomenon. Out of 266 cases it occurred only three times. In 
these three cases there was a large venous pattern that sug-
gested that the third hypothesis may reflect the underlying 
mechanism best.
We consider it extremely important to pay attention to the 
venous drainage of arteriovenous malformations. When the 
cerebral venous discharge involves the large draining veins 
of the malformation, the surgical risk of having postopera-
tive infarction is relevant. A direct surgical access to the mal-
formation must therefore be evaluated and eventually 
postponed (Fig. 1). Our strategy, depending on the character-
istic of the malformation, is to treat the malformation with an 
embolization in order to reduce the flow through the vein, 
and then wait a few months, if possible, to reduce the caliber 
of the main drainage vein. The second alternative is to treat 
the malformation with Gamma Knife to reduce the flow, 
allowing the venous outflow to redistribute. The possible 
residual can be operated after a few years.
Finally, in a few cases where there was a single large 
draining vein that collected also normal brain vein drainage 
and where we were worried that the thrombus can spread to 
functionally useful veins, we used a technique to reduce the 
caliber of the main draining vein of the malformation. On 
four occasions we treated the vein intraoperatively with 
Tullium laser, shrinking the vein and obtaining a reduction in 
the caliber to almost half of the diameter. The goal of this 
procedure was to increase the flow velocity and therefore 
prevent stagnation and thrombosis in the postoperative 
period (Fig. 2).
 Conclusions
Surgically related complications in AVM treatment, in many 
cases, can be avoided by paying attention to details:
 1. Careful selection of the patient:
 (a) addressing a patient with eloquent AVM to Gamma 
Knife treatment
 (b) preoperative treatment with selective embolization of 
the accessible deep feeders
 (c) preoperative gamma knife or embolize those patient 
with an over-expressed venous pattern
 2. Meticulous coagulation of deep medullary feeders:
 (a) Using dirty coagulation
 (b) Using dry non-stick coagulation
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 (c) Using micro clips
 (d) Using laser
 (e) Reaching the choroidal vessel in the ventricle when 
possible
 (f) Avoiding occlusive coagulation with hemostatic 
agents
 3. Check and avoiding any residual of the AVM
 4. Keep the patient under pressure control during postopera-
tive period
Fulfilling these steps contributed over time to reduced 
complications in this difficult surgery, leading to a safer 
treatment that compares favorably with natural history of 
brain arteriovenous malformations [20].
Fig. 1 An overexpressed venous pattern of a small temporal AVM. Resecting the AVM in this case, although technically feasible, is very danger-
ous due to the high risk of extensive thrombose of the venous network
Fig. 2 Laser shrinkage of the 
main draining vein to prevent 
spreading of the thrombus 
thorough useful draining 
veins
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Surgical Simulation with Three- 




In AVM surgery, evaluation of angiostructure is essential to 
make a good surgical strategy. With conventional two- 
dimensional digital subtraction angiography (DSA), it is 
sometimes difficult to understand AVM structure stereoscop-
ically. Three-dimensional rotational angiography (3D-RA) 
gives us much more precise information about the relation-
ships of each feeder, drainer, and nidus, but when the AVM is 
supplied by a multiple vascular territory (e.g., middle cere-
bral artery and posterior cerebral artery), all the details can-
not be seen in one image. For the surgical simulation, the 
location of the nidus in the brain is also important so as to 
decide the surgical approach. Recent image fusion technolo-
gies have helped surgeons create virtual surgical fields, espe-
cially in brain tumors [1–3]. In this article the authors 
introduced 3D fusion images in AVM surgeries and evalu-
ated their clinical use.
 Methods
Image data, including 3D-RA, 3D-rotational venography 
(RV), comported tomography (CT), and magnetic resonance 
imaging (MRI), was obtained from AVM patients. Three- 
dimensional- RA and RV were performed with a C-arm angi-
ography unit (Allura XperFD 20/10; Philips Medical 
Systems, Best, the Netherlands). The C-arm rotated through 
240° at 55°/s and obtained 120 images on a 17-in. FOV dur-
ing contrast injection. MRI was performed with a 3.0-T sys-
tem for the head (Ingenia 3.0T; Philips Healthcare, Andover, 
MA.). Fluid-attenuated inversion recovery (FLAIR) in MRI 
was acquired with an eight-channel head coil. CT was done 
with a 64-section CT scanner (Aquilion; Toshiba Medical 
Systems, Tokyo, Japan). The slice thickness was 1 mm.
Image data was coded in digital imaging and communica-
tion in medicine (DICOM) format and was imported to the 
two different imaging applications. In this study, we used 
iPLAN cranial (BrainLab, Germany) and Avizo (Visualization 
Science Group, Bordeaux, France) for 3D image reconstruc-
tion using a previously reported method [1, 2]. In iPLAN, the 
3D model was constructed with a volume rendering method 
with autosegmentation, whereas Avizo used a hybrid method 
combining surface- and volume-rendering methods, and 
manual segmentation was used to distinguish the small ana-
tomical structures, such as the feeding arteries, from sur-
rounding noise.
 Results
The 3D fusion images of the right parietal lobe AVM for a 
representative patient are illustrated in Fig.  1. The fusion 
image with iPLAN has lower resolution and the feeders, 
nidus, and drainers are not distinguishable because these 
three vasculatures are visualized in the same time phase in 
case of arterio-venous shunting disease. Avizo created higher 
resolution images, and feeders, drainers, and normal vessels 
are visualized clearly with different colors. Also, each feeder 
and its supplying territory in the nidus are distinguished, and 
surgical simulation becomes possible after adding the MRI 
(FLAIR) and CT images (Fig. 2). On the other hand, the time 
required for creation is much shorter in iPLAN (approxi-
mately 1 h) than Avizo (more than 3 h).
 Discussion
In AVM surgery, understanding the angiostructure is essen-
tial for planning good surgical strategy. In principle, feed-
ers should be occluded before the dissection and obliteration 
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of the gliotic tissue around the nidus. However, in conven-
tional angiography, and especially with high-flow AVMs, it 
is sometimes difficult to identify each feeder and its ana-
tomical relationship with the nidus and drainers. Three 
dimensional- RA images give us much more precise infor-
mation about the angiostructure of AVMs, and have become 
prerequisites for the surgery. However, in the real surgical 
field, we have to dissect the nidus from the brain, and the 
feeders may be found on the brain surface or in the sulci or 
fissures; therefore it is also necessary to evaluate the ana-
tomical relationship between the AVM and the brain. 
Surgeons must currently use their experience and knowl-
edge to mentally reconstruct 3D fusion images from differ-
ent modalities for this purpose. In this study, we created 
two types of 3D fusion images in AVM patients with differ-
ent imaging software and compared their efficacy in the 
surgical simulations. Images by iPLAN were easily created 
without much time or AVM surgery experience, because 
this software enables the automatic segmentation of 
DICOM data. The resultant 3D fusion image is highly ver-
satile, the quality is similar between creators, and it can be 
introduced to the navigation system (BrainLab), all of 
which make surgical simulation easier for less experienced 
surgeons. On the other hand, the resolution is not so high 
and each feeder and its supplying territory in the nidus are 
not distinguishable. Moreover, it is difficult to find “hidden 
feeders” existing just behind the drainer, which we some-
times encounter in a clinical setting, because feeders and 
drainers are recognized in the same color. In contrast, 3D 
fusion images by Avizo are created by both surface and vol-
ume rendering methods, so that they have a much higher 
resolution and the contrast between feeders, nidus, and 
drainers are much better than with the images by 
iPLAN. Therefore, we can identify all feeders even if they 
are close to the drainers or “en passage” arteries (Fig. 2). 
Avizo can also discriminate not only each feeder but also 
its supplying territory in the nidus with different colors, 
helping us to understand which feeders impinge more on 
the nidus (Fig.  2). According to these data, we can then 
decide which feeders have priority for surgical or endovas-
cular occlusion. Adding MRI data to the Avizo images pro-
duces a virtual surgical field and surgical simulation 
(positioning, craniotomy, exposure of the brain, and the 
dissection of the nidus) becomes easy.
AVM surgical simulation with other virtual reality tech-
nologies has also been published [4, 5]. In these articles, the 
authors created 3D fusion images with a virtual reality simu-
lator (Dextroscope), but they used only MR-angiography 
(MRA) and MR-venography (MRV) as vessel images, so the 
resolution of each vessel was not as high and classification of 
each feeder and its supplying territory in the nidus was 
impossible. To our knowledge, only Avizo provides adequate 
detail to distinguish individual feeder territories, so it may 
have an advantage especially in the surgical simulation of 
large, complex AVMs. On the other hand, the limitation of 
the Avizo imaging technique is that it is time-consuming 
because the segmentation of DICOM data and extraction of 
each feeder must be done manually and requires some 
knowledge of AVM surgery.
 Conclusions
To make the surgical simulation of AVM easier, it is impor-
tant to visualize all vasculatures sterically. Recent technolo-
gies have made this level of detail possible with 3D fusion 
Fig. 1 Three-dimensional fusion images in an 18-year-old female with 
right parietal AVM. (a) Fusion image by iPLAN.  Feeder, nidus, and 
drainer are visualized in the same color. (b) Fusion image by Avizo. 
Each feeder, drainer, and surrounding normal vein is identified sepa-
rately with high resolution
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images. Our study demonstrates that the Aviso 3D fusion 
images may be especially useful in surgical simulations for 
large, complex AVMs, and adoption of this technology may 
contribute to safer AVM surgeries.
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Surgical Treatment of Unruptured Brain 
AVMs: Short- and Long-Term Results
Shalva Eliava, Vadim Gorozhanin, Oleg Shekhtman, 
Yuri Pilipenko, and Olga Kuchina
 Introduction
Brain arteriovenous malformations (bAVM) are one of the 
most common congenital vascular brain malformations, 
which frequently manifests at young age [1]. Besides hemor-
rhages, patients may exhibit seizures (17–40%) and chronic 
headaches (9.8–46%) that decrease the quality of life [2]. 
Growing access to high-quality imaging has increased the 
number of patients with unruptured bAVM. The annual risk 
of bAVM hemorrhage reported previously is 1.7–3.1% [3–
7]. Mortality after rupture reaches 29% and permanent mor-
bidity occurs in more than one-third of cases [8].
Microsurgery remains the most effective treatment option 
and is considered a first-line treatment for ruptured bAVMs 
[9–11]. However, the clinical approach to unruptured AVMs 
remains under discussion. ARUBA randomized trial and the 
following SAIVMS showed that conservative management 
is more beneficial than invasive modalities. Trial results were 
followed by a wave of criticism from neurosurgeons across 
the globe. Many specialists emphasized numerous biases 
that could have affected its results. Further surgical series for 
unruptured bAVMs published in the “post-Aruba era” mostly 
overruled ARUBA conclusions. The presented work reflects 
our experience with unruptured AVM patients operated upon 
in Burdenko National Research Center for Neurosurgery.
 Materials and Methods
The retrospective study included 160 adult patients 
(>18 years old) with unruptured bAVMs admitted for micro-
surgery in 2009–2017. Of these, 93 (58.1%) were males and 
67 (41.9%) were females. Mean age was 33.4  ±  10  years 
(range 18–67 years). No signs of hemorrhage were found on 
brain MRI or CT in all cases. Seizures were the most com-
mon clinical sign, found in 99 patients (61.9%), and 49 
patients (30.6%) had chronic headaches, four (2.5%) had 
transient ischemic symptoms, and in eight (5%) the AVMs 
were asymptomatic. Most patients with seizures (86%) had 
generalized seizures and only three patients had secondarily 
generalized seizures.
The decision for surgical treatment was based on Spetzler- 
Martin score (Grade I–III), clinical signs (permanent 
decrease of quality of life), AVM location (eloquence, sup-
ply, angiomatosis, etc.), and age (in terms of cumulative 
hemorrhage risk). In addition, a small group of patients with 
AVM Spetzler-Martin Grade IV (high risk) who had severe, 
disabling symptoms (pharmacoresistant seizures, persistent 
headache ineffectively controlled with medications) was 
included. Patient data were extracted from the electronic 
medical records (e-med). Before and after surgery patients 
were examined by a neurologist and ophthalmologist and 
electroencephalography (EEG) was done for seizure patients. 
AVM morphology was evaluated with cerebral angiography 
(CA) or spiral CT angiography (CTA). All patients had a 
control angiography postoperatively. Outcomes were 
assessed with modified Rankin scale (mRS) at discharge 
(10–14 days). Follow-up exams were carried in the outpa-
tient department or over the phone.
 Results
The distribution of patients by Spetzler-Martin score, AVM 
size, and location is presented in Table 1. Mean AVM size 
was 3.3 ± 1.07 cm (1.5–10 cm). Patients with AVM in the 
temporal (72%) and frontal (70%) lobes had a higher ten-
dency for seizures. Of all patients with occipital AVMs, 13 
manifested with headaches and five had photopsias (all 
AVMs were  <  4  cm). In six patients with occipital AVM, 
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visual field defects that could not be associated with hemor-
rhages were found before surgery (homonymous hemiano-
pia—five, quadrant hemianopia—one). These defects may 
have been congenital or due to asymptomatic ischemic 
changes).
Surgery. Microsurgical resection of AVM was performed 
in 128 (80%) patients, resection with preoperative emboliza-
tion in 31 (19.4%). In one case, surgery was limited to AVM 
afferent clipping due to critical M-response decrease. In 
three cases simultaneous epilepsy resection using ECoG 
monitoring (amygdalohippocampectomy or temporal lobec-
tomy) was performed. AVMs were located in the mediobasal 
temporal lobe in two patients and in the hippocampus in one 
patient.
In 33 cases (20.6%) minor hemorrhage signs (“silent” 
hemorrhage) were identified during surgery. Commonly, 
these included local hemosiderin deposits limited to the one 
or two sides of the lesions. No typical parenchymal hemor-
rhages in the form of hematomas residuals or post- 
hemorrhagic cysts were identified. Results of surgical 
treatment are summarized in Fig.  1. Favorable outcomes 
(mRS  =  0–2) at discharge were achieved in 149 patients 
(93.1%), and satisfactory outcomes (mRS—3) in 9 (5.6%) 
patients. Two patients died (1.25%), one due to the severe air 
embolism, the other from the complicated pre-surgical 
embolization (glue migration).
The long-term treatment outcomes were evaluated in 97 
(60.6%) patients. Mean duration of follow-up was 
59.3 months (13–108 months). At follow-up, the number of 
patients with excellent outcomes (mRS = 0–1) increased to 
80.4%, and the total number of favorable outcomes 
(mRS  =  0–2) reached 94.8%. Two (2%) patients died of 
causes unrelated to surgery.
The long-term outcomes were followed in 59 of 99 
patients (55.6%) with seizures. Engel class I was achieved in 
50 patients (84.8%) (complete regression—64.4%, improve-
ment—30.5%); Engel class IIA was achieved in two (3.4%), 
Engel class IIIA in four (6.8%), and Engel class IV in three 
patients (5.1%). The headache intensity over the time was 
evaluated in 65 of 87 patients (74.7%). Headache intensity 
decreased after surgery in 41 patients (63%) , frequency 
decreased in two (3.1%), headache worsened in twelve 
(18.5%), and remained unchanged in ten (15.4%).
Complications. Hemianopia was the most common post- 
surgical neurological deficit (in some a combination with 
central scotomas were observed) and was reported in 55 
cases (64.7%) (homonymous hemianopia—39, quadrant 
hemianopia—16). Visual field defects occurred in 100% of 
AVMs found in the mediobasal temporal lobe (n = 6) and in 
the occipital-temporal area (n = 8); in 92.3% of AVMs found 
in the occipitoparietal area (n = 12), and in 86.3% (n = 19) of 
those found in the occipital lobe AVMs. In 13.7% of patients 
with occipital AVM, visual fields after surgery remained 
unchanged. Postoperative visual field defects were followed 
in 22 of 55 patients (40%) (mean follow-up duration was 
61.7  months), including ophthalmologist examination and 
perimetry. Complete recovery of visual defects was reported 
in six patients (27%), partial recovery in eight (36%), vision 
was unchanged in seven (32%), and in one patient visual 
field defects worsened.
Other postoperative neurological complications included 
motor deficit in nine patients, aphasia in six patients, cogni-
tive disorders including behavior changes in six patients, and 
cerebellar or vestibular dysfunctions in two patients. In two 
cases hemorrhages occurred after AVM embolization. 
Hematomas and AVMs were successfully removed with a 
good outcome in both cases.
 Discussion
Generally, surgical treatment for unruptured bAVMs is rec-
ommended for young patients with high life expectancy (in 
this study, 77% of patients were aged <40  years) and low 
surgical risks (S-M I–III). A separate category, not analyzed 
in our work, is young women planning a pregnancy. As 
Table 1 Distribution of AVMs by Spetzler-Martin score, size, and 
location
Spetzler-Martin score and AVM size, n (%)
I 18 (11.3%) Small (1–3 cm) 55 (34.4%)
II 71 (44.4%) Medium (3.5–5.5 cm) 87 (54.4%)
III 60 (37.5%) Large (≥6 cm) 18 (11.2%)
IV 11 (6.8%)
Location, n (%)
Frontal lobe 60 (37.5%) Parietal lobe 10 (6.2%)
Temporal lobe 42 (26.3%) Occipitotemporal 8 (5%)
Occipital lobe 22 (13.8%) Cerebellum 4 (2.5%)
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Fig. 1 Surgical outcomes for unruptured bAVM at discharge and at 
follow-up
S. Eliava et al.
89
K. Fukuda showed, the first AVM hemorrhage may be fatal 
to 28% of women and 14% of fetuses, as well as causing 
early miscarriage [12, 13]. Although the influence of labor 
on the AVM rupture is still under discussion, some studies 
have identified a higher risk of rupture compared to the gen-
eral population [13, 14].
In most patients, symptomatic epilepsy was an indication 
for surgery. According to our data, favorable outcomes were 
achieved in 84.8% of patients (Engel class I) with complete 
seizures relieved (Engel class IA) in 64%. AVM resection 
does not ensure full seizure resolution; therefore, we recom-
mend continuation of anticonvulsants for 6–12  months. 
According to the published reports, AVM resection is a quite 
effective treatment and results in seizure control (Engel class 
I) in 52–100% of patients [15–18].
Correlation between bAVMs and chronic headaches is 
unclear and remains a subject of further investigation. Of all 
bAVM patients, those with headaches comprise a significant 
percentage, but it is difficult to establish relevant association 
between headache and AVM [19–21]. According to the pub-
lished reports, surgical resection of AVM led to headache 
intensity decrease or complete resolution in 33–83% of 
patients [22–24]. In our series, 66% of patients demonstrated 
various degrees of improvement.
Visual cortex and tracts are the most sensitive areas in 
terms of postoperative neurological defects. High risk fac-
tors for visual compromise are AVM size >3 cm and proxim-
ity to temporal, temporo-occipital or parieto-occipital cortex. 
It is also important to consider AVM angiomatosis that may 
require extended resection that exceeds initially planned 
boundaries. Although the group with follow-up ophthalmo-
logical examination was small (n  =  22), field defects 
improvement was confirmed in more than half (63%) of the 
patients. Further study with more patients is obviously 
needed.
Endovascular embolization reduces the AVM volume and 
thus facilitates subsequent resection. To minimize hemor-
rhage risks between surgical steps it is an established prac-
tice in our department to focus an endovascular session on 
occlusion of hemodynamic aneurysms, embolization of deep 
afferents and AVM parts that are difficult for excision or 
excess during open surgery. A coordinated schedule of 
patient treatment and transportation may reduce time 
between both stages. In future, hybrid operating rooms may 
become a solution to such cases.
Functional outcomes in our study are consistent with the 
published data confirming that surgery for “low-grade” 
AVMs is reasonably safe and not associated with major neu-
rological complications. Indications for surgery for unrup-
tured bAVMs Spetzler-Martin Grade III–IV are individual 
and justified only when better quality of life is expected (e.g., 
improvement of the symptomatic epilepsy) rather than hem-
orrhage prevention. Patients with AVM Spetzler-Martin 
Grade V should be managed conservatively regardless of the 
clinical signs. The effectiveness of the chronic headaches 
(migraine) treatment in patients with AVM is questionable 
and further studies are warranted.
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AUC Areas under the receiver-operator characteristic 
curves
BAVM Brain arteriovenous malformations
CI Confidence interval
CST Corticospinal tract
CTA Computed tomography angiography
DSA Digital subtraction angiography
DTI Diffusion tensor imaging
fMRI Functional magnetic resonance imaging
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Surgical treatment of brain arteriovenous malformations 
(BAVMs) is a radical treatment modality. Safe and radical 
removal is expected to help prevent future hemorrhage and 
symptomatic deterioration. However, there are BAVMs that 
are unsuitable for surgical intervention and an eloquently 
located BAVM is known to increase the surgical risk [1–4]. 
In particular, in the Rolandic area, i.e., the motor and sensory 
areas, surgical morbidity is directly linked to the indepen-
dence of the patient. Hence, it is still challenging to surgi-
cally treat these entities. Indicators for safe removal of 
Rolandic BAVMs are necessary but have not been deter-
mined thus far.
In addition to factors such as well-known hemorrhagic 
onset, unruptured BAVM, size, and deep venous drainage 
that are included in the Spetzler-Martin (S-M) grading scale 
[1–4], several surgical risk factors for eloquent BAVM have 
been reported in recent years, such as cortical reorganization 
and plasticity of motor area visualized via functional mag-
netic resonance imaging (fMRI) [5], BAVM lesion-to- 
corticospinal tract (CST) distance assessed by diffusion 
tensor imaging (DTI) [6, 7], and BAVM lesion-to-activation 
area distance (LAD) assessed by fMRI [8]. They can help 
predict postoperative neurological outcomes in the eloquent 
area and these factors contributed to acceptable long-term 
outcomes [6, 9], along with transient but finally reversible 
surgical morbidity. Thus, there is a possibility of plasticity 
and cortical reorganization of the cortical region. Impairment 
of the CST and deep white fibers may be more critical and 
irreversible in the Rolandic area. However, production of a 
uniform image is sometimes difficult with DTI and fMRI 
because of various methodological limitations [10]. The 
imaging results may differ between institutions and the type 
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of imaging method. Therefore, predictors of surgical risk 
that can be evaluated easily with general imaging modalities 
are necessary. In this regard, we focused on the maximum 
nidus depth as a new indicator, which is a factor measurable 
on general imaging.
The aim of this study was to determine the surgical risk 
factors in patients with eloquent BAVMs, especially in the 
Rolandic area. Furthermore, we analyzed maximum nidus 
depth as a novel indicator and predictor of the surgical out-
come in patients with this challenging entity.
 Material and Methods
The institutional review board of Tokyo Women’s Medical 
University approved this retrospective study. All patients 
provided written informed consent for the surgical 
procedures.
 Patient Selection
This retrospective study included 297 consecutive patients 
with diagnosed BAVMs who underwent treatment at Tokyo 
Women’s Medical University between January 2002 and 
August 2017. Of these, 202 patients were diagnosed with 
BAVM localized in an eloquent area. Furthermore, of these, 
128 patients underwent gamma knife surgery (GKS) alone 
and 74 patients underwent surgical nidus removal. In these 
74 patients who underwent surgical treatment, there were 29 
patients who had BAVMs in the Rolandic motor or sensory 
area, or both. Data of these 29 patients were finally analyzed 
in this study.
 Diagnosis and Treatment Strategy
The diagnoses and locations of BAVMs were established 
based on digital subtraction angiography (DSA) combined 
with magnetic resonance imaging (MRI) and computed 
tomography angiography (CTA) by a board-certified neuro-
surgeon of the Japan Neurosurgical Society. Data were col-
lected from the medical records. The characteristics of 
BAVM included the size, depth, diffuseness, anatomic loca-
tion, and venous drainage. These parameters were evaluated 
with a combination of imaging modalities. The size and 
depth of the nidus were also measured using the imaging 
modalities mentioned above. The maximum diameter was 
defined as the maximum nidus size measured from various 
angles. The maximum depth was defined as the distance 
from the brain surface to the deepest part of the nidus verti-
cally. The nidus depth, if wider than other measurements, 
can be the same as the maximum diameter as well. BAVMs 
were further classified based on the S-M grading scale [1].
Uncontrollable symptoms, including hemorrhage, epi-
lepsy, and severe headache, were considered as the indica-
tions for surgical nidus removal of the BAVM.  However, 
asymptomatic BAVMs were also surgically removed if the 
patients strongly requested it after they were fully informed 
of the natural history and treatment options, including obser-
vation. The same surgical team performed the microsurgical 
nidus removal and managed the patients postoperatively. 
Preoperative endovascular interventions were performed as 
necessary. Each BAVM resection was completed while tak-
ing special care to preserve the functional reaction that was 
assessed using motor-evoked potentials, somatosensory- 
evoked potentials, and cortical/subcortical electrical 
stimulation.
Postoperatively, the patients were maintained in a hypo-
tensive state under sedation. In principle, DSA was per-
formed before and after the surgeries and complete removal 
was evaluated by postoperative DSA.
 Outcome Parameters
Postoperative follow-ups were performed at our institution, 
and the degree of excision and the presence or absence of 
complications were evaluated. In this study, morbidity was 
defined as deterioration in the neurological findings related 
to the surgery and its associated complications. The final 
morbidity was assessed at 3 months postoperatively to evalu-
ate whether the morbidity was a transient or permanent 
symptom. Furthermore, the modified Rankin Scale (mRS) 
score was assessed at 3 months postoperatively to evaluate 
whether it was intact or had worsened postoperatively. 
Permanent morbidity was defined as persistent neurological 
deterioration, and we classified it into two groups: “mRS 
change<2” and “2≤mRS change” compared with preopera-
tive mRS. Transient morbidity was defined as neurological 
deterioration that occurred postoperatively and resolved 
within 3 months. Any death was determined as mortality.
 Statistical Analysis
All statistical analyses were performed using JMP Pro13 
(SAS Institute, NC, USA). Continuous variables were 
expressed as mean ± standard deviation. Univariate analysis 
was performed to identify the risk factors associated with 
postoperative surgical morbidity at 3  months in Rolandic 
eloquent BAVM. When comparing two groups, categorical 
variables were evaluated by Fisher’s exact test and continu-
ous variables were evaluated by Student’s t-test. Significant 
risk factors and variables that were associated with morbid-
ity, defined as p < 0.20 in univariate analysis, were included 
in multivariate logistic regression analysis. Since nidus size, 
eloquent location, deep venous drainage, age, ruptured pre-
sentation and diffuseness were already included as univariate 
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factors in statistical analysis, S-M grade and Lawton-Young 
supplementary grading system containing these factors were 
excluded because they were confounding factors.
Odds ratio (OR) for surgical morbidity was estimated 
from logistic regression analysis, and receiver-operator char-
acteristic (ROC) curves were constructed to obtain the opti-
mal cutoff values for the maximum nidus size and depth in 
predicting surgical morbidity. To confirm the predictive and 
diagnostic ability of the ROC curves, areas under the ROC 
curves (AUCs) were also determined. The significance level 
was set at p < 0.05 and all p values reported in this study are 
two-sided.
 Results
 Patient Demographics and BAVM 
Characteristics
A total of 29 patients with BAVMs in the Rolandic area who 
underwent surgical nidus removal at our institution were 
analyzed in this study. The patient demographics and BAVM 
characteristics are summarized in Table  1. With respect to 
clinical presentation, uncontrollable symptomatic BAVM 
was seen in 22 patients (75.9%) and hemorrhagic onset was 
seen in 11 (37.3%). Four patients (13.8%) underwent pre- 
surgical embolization and six patients (20.7%) pre-surgical 
GKS.  The overall median S-M grading scale score was 3 
(2—4), and the most frequent SM grade was grade III 
(51.7%). All BAVMs were in the eloquent location; in 12 
patients (41.4%) they were related to the motor area, while in 
11 patients (37.9%), they were related to the sensory area, 
and in six patients (20.7%), they were related to both. The 
mean maximum nidus size was 33 ± 17 mm, and the mean 
maximum nidus depth was 37 ± 17 mm. BAVMs with deep 
venous drainage were seen in only a few (13.8%).
 Outcomes
The outcomes after surgical nidus removal are summarized 
in Table 2. Complete removal was achieved in 28 patients 
(96.6%). Partial removal was achieved in one patient; the 
patient suffered from perioperative hemorrhage and 
required reoperation. Postoperative hemorrhage due to nor-
mal perfusion pressure breakthrough visualized by cold-
Xenon computed tomography was recognized in two 
patients. There was no incidence of hemorrhage after the 
perioperative period. Overall, 14 patients (48.3%) suffered 
from postoperative morbidity, including transient morbid-
ity in nine patients (31.0%) and permanent morbidity in 
five patients (17.2%). The deterioration in neurological 
findings related to the surgery was often resolved during 
the follow-up after a few weeks. Motor and sensory disor-
ders, dysarthria, and higher brain dysfunction were recog-
nized as neurological complications. Although renal failure 
occurred in one patient, there were no major systemic com-
plications leading to mRS deterioration. There was no mor-
tality. Deterioration of two or more on mRS was observed 
in two patients.
 Univariate and Multivariate Analyses 
of Predictors of Surgical Morbidity 
for Rolandic BAVM
To identify the risk factor for surgical morbidity in Rolandic 
area BAVMs, several variables were analyzed between the 
total morbidity group and no morbidity group using univari-
ate analysis (Table 3). The patients in both groups were well- 
matched with respect to age, sex, and preoperative 
mRS. Asymptomatic BAVM was a significant risk factor for 
surgical morbidity (p = 0.0229), but hemorrhagic onset was 
Table 1 Characteristics of patients with Rolandic BAVM
Variable Total Rolandic BAVM
No. of patients 29
  Age 35.0 ± 13.1
  Male/female 15 (51.7%)/14 (48.3%)
Clinical presentation
  Seizures 5 (17.2%)
  Headache 4 (13.8%)
  Asymptomatic 7 (24.1%)
  Hemorrhagic onset 11 (37.3%)
Preoperative mRS
  0–2 25 (86.1%)
  3 1 (3.6%)
  4–5 3 (10.3%)
BAVM characteristics
  Spetzler-Martin grade
  II 11 (37.3%)
  III 15 (51.7%)
  IV 3 (10.3%)
  Maximum nidus size (cm) 3.3 ± 1.7
  Maximum nidus depth (cm) 3.7 ± 1.7
  Deep venous drainage 4 (13.8%)
  Diffuseness 4 (13.8%)
  Eloquent location 29 (100%)
  Motor area 12 (41.4%)
  Sensory area 11 (37.9%)
  Motor and sensory area 6 (20.7%)
  Laterality (right/left hemisphere) 16 (55.2%)/13 (44.8%)
Treatment
  Surgical removal alone 19 (65.5%)
  Presurgical embolization 4 (13.8%)
  Preoperative gamma knife 6 (20.7%)
mRS modified Rankin Scale, BAVM brain arteriovenous malformation
Values are expressed as mean ± standard deviation for quantitative vari-
ables or as absolute number (percentage) for qualitative variables
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not (p = 0.3156). Of the BAVM characteristics, the  maximum 
nidus size, deep venous drainage, diffuseness, and laterality 
were not significant risk factors, but maximum nidus depth 
was a significant risk factor for surgical morbidity 
(p = 0.0204).
For multivariate analysis (Table  4), significant vari-
ables and two variables that were associated with mor-
bidity based on p value <0.20  in univariate analysis 
(preoperative mRS, laterality) were included in the mul-
tivariate logistic regression analysis. As mentioned in the 
methods section, S-M grade and Lawton-Young supple-
mentary grading systems were excluded because they 
were confounding factors. The maximum nidus depth 
was the only risk factor of surgical morbidity in this anal-
ysis (OR  =  2.78598, 95% confidence interval [CI]: 
0.8866–8.7535, p = 0.0357).
 Optimal Cut-off Values for Surgical Morbidity
From the results of logistic regression analysis (Table 5, 
Fig. 1a, b), maximum nidus depth was identified as a pre-
dictor of total morbidity (OR = 2.82190, p = 0.015) and 
permanent morbidity (OR  =  8.34984, p  =  0.002), and 
maximum nidus size was identified as a predictor of per-
manent morbidity (OR = 2.46749, p = 0.027). The optimal 
cutoff values identified from the ROC curve analysis 
included maximum nidus size of 30  mm for permanent 
morbidity, maximum nidus depth of 36 mm for total mor-
bidity, and 41  mm for permanent morbidity (Table  5). 
AUC of total morbidity, indicating the predictive accuracy 
of the ROC curve, was 0.7428 for maximum nidus depth 
and 0.5785 for maximum nidus size. AUC for permanent 
morbidity was 0.8833 for maximum nidus depth and 
0.7625 for maximum nidus size. AUC was higher for the 
maximum nidus depth compared with that for the maxi-
mum nidus size, for both total and permanent morbidities 
(Table 5, Fig. 1c, d). As illustrative cases, the patient (case 
1) with sensory and motor area BAVM (S-M grade II) pre-
sented with headache, with maximum nidus size of 21 mm 






No. of patients 29 14 15
mRS at 3 months after the surgery
  0–2 23 
(79.3%)
12 (85.7%) 11 (73.3%)
  3 2 (6.9%) 0 (0%) 2 (13.3%)
  4–5 4 
(13.8%)
2 (14.2%) 2 (13.3%)
Partial removal 1 (3.4%) 1 (7.1%) 0 (0%)
Complete removal 28 
(96.6%)
13 (92.8%) 15 (100%)
Postoperative hemorrhage 3 
(10.3%)
3 (21.4%) 0 (0%)
  Perioperative period 3 
(10.3%)
3 (21.4%) 0 (0%)
  Postoperative follow-up 
period




  None 15 
(51.7%)
0 (0%) 15 (100%)
  Transientb 9 
(31.0%)
9 (64.2%) –





  Permanentc; mRS change 
≥2
2 (6.9%) 2 (14.2%) –
Mortality 0 (0%) 0 (0%) –
mRS modified Rankin Scale
Values are expressed as percentages for qualitative variables
aMorbidity was defined as deterioration in the neurological findings 
related to the surgery
bTransient morbidity was defined as neurological deterioration that was 
transient after the surgery and resolved within 3  months after the 
surgery
cPermanent morbidity was defined as neurological deterioration that 
was present at 3 months after the surgery
Table 3 Univariate analysis of surgical risk factors for morbidity
Variable Morbiditya (+) Morbiditya (−) p Value
No. of patients 14 15
Age 37.9 ± 3.5 32.3 ± 3.4 0.2513
Male/female 8 / 6 7 / 8 0.5726
Asymptomatic (%) 6 (42.7%) 1 (6.67%) 0.0229
Hemorrhagic onset (%) 4 (28.6%) 7 (46.7%) 0.3156
Preoperative mRS – – 0.1358
  0–2 14 (100%) 11 (73.3%)
  3 0 (0%) 1 (6.8%)
  4–5 0 (0%) 3 (20.0%)
Maximum nidus size 
(mm)
36 ± 3 31 ± 3 0.2903
Maximum nidus depth 
(mm)
41 ± 3 32 ± 3 0.0204
Deep venous drainage 3 (21.4%) 1 (6.7%) 0.2493
Diffuseness 3 (21.4%) 1 (6.7%) 0.2493
Location – – 0.5717
  Motor area 7 (41.4%) 4 (33.3%)
  Sensory area 4 (28.6%) 7 (46.7%)
  Motor and sensory 
area










2 (14.3%) 2 (13.3%) 0.9408
Preoperative gamma 
knife
3 (21.4%) 3 (20.0%) 0.9244
mRS modified Rankin Scale
Values are expressed as mean ± standard deviation for quantitative vari-
ables or percentage for qualitative variables
aMorbidity was defined as deterioration in the neurological findings 
related to the surgery
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Table 4 Multivariate analysis of surgical risk factors for morbidity
Variable
Multivariate analysis
OR 95% CI p Value
Asymptomatic 4.70294 0.2782–79.4948 0.2610




Laterality 2.82367 0.3786–21.0554 0.2971
mRS modified Rankin Scale, OR odds ratio, CI confidence interval
Table 5 Cut-off values
Variable
Morbidity Logistic regression analysis ROC curve analysis
OR 95% CI p Value Cut-off value (mm) AUC
Maximum nidus size Total 1.40708 0.7531–2.62873 0.269 30 0.5785
Permanent 2.46749 1.0031–6.069696 0.027 30 0.7625
Maximum nidus depth Total 2.82190 1.0632–7.489138 0.015 36 0.7428
Permanent 8.34984 1.2308–56.64248 0.002 41 0.8833

























































































Fig. 1 Surgical risk factor 
and cutoff values in Rolandic 
brain arteriovenous 
malformations (BAVMs). (a 
and b) Maximum nidus depth 
was significantly correlated 
with surgical morbidity 
(p = 0.02), but maximum 
nidus size was not a 
significant factor. The 
distribution charts 
demonstrate the relationship 
between the maximum nidus 
size and surgical morbidity 
(a), and the maximum nidus 
depth and surgical morbidity 
(b). Green rhomboids indicate 
the mean and 95% confident 
intervals. (c and d) Receiver 
operating characteristic curve 
analyses for maximum nidus 
depth and surgical morbidity; 
total morbidity (c) and 
permanent morbidity (d). The 
area under the curve was 0.74 
and the cutoff value was 
36 mm (c). The area under the 
curve was 0.88 and the cutoff 
value was 41 mm (d)
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and maximum nidus depth of 35  mm (Fig.  2a, b). 
Activation was found adjacent to the nidus on fMRI 
(Fig.  2c, d). Transient morbidity was observed after the 
surgery. In the patient (case 2) with asymptomatic sensory 
area BAVM (S-M grade III), maximum nidus size was 
36 mm and maximum nidus depth was 44 mm (Fig. 3a, b). 
Permanent morbidity was observed after the surgery.
 Discussion
In this series of 29 patients with BAVM who underwent sur-
gical nidus removal, we found that nidus depth may be more 
useful than nidus size as a predictor of the surgical risk for 
postoperative surgery-related morbidity in eloquent BAVM, 
especially with BAVMs in the motor and sensory areas. As 
the maximum nidus depth from the brain surface increased, 
the morbidity rate elevated, suggesting that the morbidity 
was permanent.
Many grading scales and scores to indicate the surgi-
cal risk associated with BAVM removal, on behalf of 
S-M  grading scale, have been previously reported [1–4, 
11–13]. From these reports, it is well known that the 
surgical risk is higher with eloquent BAVM. Most of the 
grading scores include nidus size as a surgical risk fac-
tor, and its importance has been previously reported 
[1–4, 11–13]. There is no doubt that the surgical risk 
increases with increasing size of the BAVM nidus. 
However, regardless of the nidus size, there are reports 
of morbidity due to surgery even with a smaller nidus. 
Thus, in BAVMs in eloquent areas, the surgical risk is 
higher from the very beginning [1, 2]. Furthermore, 
there are no reports that have evaluated the assessment 
of eloquence in detail. Therefore, certain problems still 
remain, such as the lack of inclusion of white matter 
eloquent fibers in the grading systems, lack of defini-
tion of the width and depth of the eloquent area, and 
lack of quantitative variables to describe the relation-
ship between the nidus and eloquence [14].
Following the findings of a randomized control trial 
(RCT) for unruptured BAVM [15], the treatment for elo-
quent BAVM is still considered challenging. However, there 
are also some cases wherein BAVM resulted in hemorrhage 
with high morbidity and presented with uncontrollable 
symptoms, suggesting that surgical treatment should be con-
sidered for eloquent BAVM.  As was reported previously, 
although symptoms appear transiently after surgical removal, 
they often resolve during follow-up [5, 8, 16, 17]. It appears 
that there may be risk factors other than nidus size. If there is 
a factor that can predict whether eloquent BAVM is treatable 
or not, then the decision for surgical intervention can be bet-
ter judged.
 Nidus Depth as a New Indicator of Surgical 
Risk for Eloquent BAVM
In previous reports, the following variables have been 
reported as risk factors for surgical removal in BAVM: 
BAVM size, eloquence, deep venous drainage, diffuseness, 
perforating artery supply, and unruptured presentation [1–4, 
11–13]. It is also known that relatively good outcomes are 
obtained with surgical treatment of BAVM with hemorrhagic 
onset [5, 18]. Particularly with regard to the nidus size, it is 
easy to predict that BAVM localization will dominate the 
critical area as it gets bigger, and it will lead to an increase in 
the risk. However, in measuring the size, the obtained values 
and implications vary depending on the direction used to 
measure on the image since the size can be measured in all 
directions. There are no uniform guidelines on assessing this 
measurement. Therefore, we focused on the nidus depth and 
performed the analyses for surgical morbidity for eloquent 
BAVM in this study. Although it seems like common sense 
that more extensive and deeper AVMs in eloquent locations 
will be associated with more surgical morbidity, to the best 
of our knowledge there are no reports in the literature that 
investigated and mentioned BAVM depth. Various factors 
that were previously reported to be significantly correlated 
with postoperative morbidity were not found to be signifi-
cantly correlated in this study; the p values of the factors, 
though relatively low, were not significant. It is suggested 
that the maximum nidus depth may be more useful as a pre-
dictor in the surgical treatment of BAVM in the Rolandic 
area (Table 3 and Fig. 2).
 Optimal Cutoff Value of Maximum Nidus Depth 
for Surgical Morbidity
To determine the optimal cutoff values for the maximum 
nidus depth and size in relationship with surgical morbidity, 
ROC curves were generated. The cutoff value for the maxi-
mum nidus depth was 36 mm for total morbidity and 41 mm 
for permanent morbidity (Table 4). Therefore, the deeper the 
maximum nidus depth, the higher the surgical risk. The cut-
off value for the maximum nidus size for permanent morbid-
ity was 30  mm. The AUC of the maximum depth (total 
morbidity: 0.74, permanent morbidity: 0.88) was larger than 
that of the maximum size (total morbidity: 0.58, permanent 
morbidity: 0.76); therefore, maximum nidus depth is a more 
useful predictor than the maximum nidus size (Table  4, 
Fig. 2).
These findings raise the question of the underlying mech-
anism that can explain how the nidus depth affects the surgi-
cal risk. Frequently this is due to small arterioles arriving at 
the deep part of the AVM nidus, or due to small draining 
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venules, which are bleeding notoriously and are difficult to 
coagulate at the same time. It is also already known that the 
deeper a BAVM is, the more the nidus involves the CST [9] 
and is closer to the perforating supply area. In previous 
reports, lesion-to-CST distance measured by DTI [6, 7] and 
LAD measured by fMRI [8] have been reported as surgical 
risk factors for vascular malformations of the eloquent area. 
Furthermore, the plasticity and cortical reorganization of the 
Fig. 2 Illustrative case 1. Axial T2-weighted image (a) and coronal 
maximum intensity projection image of time of flight magnetic reso-
nance angiography (b) showing sensory motor area brain arteriovenous 
malformation (Spetzler-Martin grade II). The maximum nidus depth 
was 35 mm. The yellow dotted line indicates the maximum nidus depth 
relative to the tangential line of the brain’s surface. The activations 
related to left-hand gripping (c) and right-hand gripping were found 
adjacent to the nidus (d) on fMRI
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eloquent cortical area were also reported [5, 16, 17], and it 
was suggested, based on fMRI, that significant activation did 
not lie within the nidus of BAVM [16]. The anatomic loca-
tion alone of a BAVM may not provide any information on 
the functional reorganization. In fact, we have encountered 
cases where translocation of the eloquent area was found on 
intraoperative direct stimulation. Thus, the plasticity may 
contribute to the transient deterioration in the cortical regions 
after the surgery. On the other hand, impairment of CST and 
deep white fibers may be more critical and irreversible, 
resulting in permanent deterioration. Therefore, the nidus 
depth can be a risk factor as it reflects the association between 
a BAVM and the deep white fibers.
Although DTI and fMRI are useful for the prediction of 
the surgical outcomes, they are often complicated. It is often 
difficult to perform imaging accurately because of method-
ological limitations and technical difficulties like different 
stepwise procedures between institutions, false-positives and 
false-negatives, and hemorrhage and edema that can affect 
the results [10]. On the other hand, nidus depth, as proposed 
in this study, is an easily measurable parameter that does not 
require special images. It can be measured with routine 
images that do not vary significantly between institutions.
ARUBA trial was the only RCT in unruptured BAVMs 
with a negative stance on interventions [15], and it suggested 
that interventions for unruptured BAVM should be cautious; 
however, there have been objections to that report [19, 20]. 
In this study, asymptomatic presentation was a significant 
risk factor in univariate analysis but not in multivariate anal-
ysis. Maximum nidus depth was the only significant factor in 
multivariate analysis. Its cutoff value obtained in this study 
does not strongly recommend the surgical removal of elo-
quent BAVMs; however, it can be one of the indicators of the 
surgical risk in cases that require treatment. This study does 
not deny the importance of the size of the nidus as a risk fac-
tor since there were cases wherein the measured maximum 
size was in the same direction as the depth. Therefore, the 
direction in which the maximum size is measured is also 
important.
Many outstanding questions and issues pertinent to this 
study remain. The results obtained in this study are from lim-
ited locations of eloquent BAVMs, specifically the Rolandic 
area. However, it is unclear as to which area is better—the 
motor or sensory area. The significance of the depth in other 
eloquent areas like the language area remains unknown. 
Furthermore, we do not discuss the relations between DTI 
tractography and closeness of the nidus. Although the effec-
tiveness of GKS and multimodal treatment for high-grade 
BAVM has been reported in recent years [21–23], the current 
study is not a comparative one between the modalities of 
treatment. The question remains whether surgical removal is 
superior to GKS or another multimodal strategy. As another 
limitation, this study was a retrospective one and the sample 
size was small. Further analyses and experiments are needed 
in this regard. This small subset of patients may overestimate 
the value of nidus depth compared with other variables that 
are well known to be factors in development of perioperative 
morbidity, including hemorrhagic status and size, primarily, 
and others. However, this is an interesting case series of an 
uncommon entity: surgically operated motorsensory cortex. 
We think that it is a meaningful report derived from rare 
cases.
From our results, the radicality of surgical removal was 
extremely high and the requirement for surgery cannot be 
Fig. 3 Illustrative case 2. Axial T2-weighted image (a) and axial and 
coronal maximum intensity projection image of time of flight magnetic 
resonance angiography (b and c) showing brain arteriovenous malfor-
mation (Spetzler-Martin grade III) in the sensory area. The maximum 
nidus depth was 44 mm. The yellow dotted line indicates the maximum 
nidus depth relative to the tangential line of the brain’s surface
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completely ruled out. In the future, downgrading using mul-
timodal treatment may also be promising as a new strategy to 
prevent surgical morbidities in such challenging entities. 
Thus, critical deep lesions or eloquent locations should first 
be eliminated with relatively noninvasive treatment modali-
ties with higher priority [24], resulting in downgrading by 
decreasing the maximum nidus depth and affected eloquent 
area followed by surgical treatment. It is necessary to con-
sider new treatment strategies for safe and highly radical 
BAVM treatment. Maximum nidus depth is more likely to be 
associated with surgical morbidity in BAVMs in the eloquent 
Rolandic areas. Although surgical treatment should be care-
fully considered, the maximum nidus depth is a simpler and 
stronger predictor of the outcome than maximum nidus size 
in patients with this challenging entity.
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Brain arteriovenous malformations are complex develop-
mental malformations that primarily affect the leptomenin-
geal vessels. AVMs are subject to a dynamic process that 
leads to dilation of arteries and veins and to the pathological 
modification of their elastic and muscular laminae. 
Involvement of perforating vessels may add damage of the 
adjacent neural tissue. In typical plexiform AVMs, the nidus 
of the malformation is composed of a network of abnormal 
vessels interposed between the feeding arteries and the drain-
ing veins [1].
Hemorrhage is the most frequent onset symptom, although 
AVM can also occur with epileptic seizures, progressive 
focal neurological deficits, and neurocognitive deficits. 
Surgery is still considered the most effective and definitive 
treatment; endovascular occlusion and radiosurgery can be 
considered as alternatives in specific cases. However, each 
treatment might carry potential transient or permanent post-
operative sequelae. Patient selection should therefore weigh 
the natural history of AVMs against treatment-related risks. 
It is a difficult process complicated by the variety of angioar-
chitecture, size, location, and clinical features of AVMs. It is, 
however, the key to achieving a good outcome.
A good classification system should assess therapeutic 
risks, surgical challenges, and operative morbidity. After 
validation, its first purpose is to guide the physician to pres-
ent to the patient the optimal treatment option. At the same 
time, it may facilitate communication among researchers on 
the best care. An ideal scheme should be assessed at bedside 
and contemplate few variables; otherwise it may be cumber-
some. However, even oversimplification has some draw-
backs and does not exclude the risk of over-grading or 
under-grading for the interobserver variability. For instance, 
it is common experience that neuroradiologists tend to under- 
grade, whereas the neurosurgeons tend to over-grade a brain 
AVM classified by Spetzler-Martin (S-M) grading [2]. 
Furthermore, agreement on the overall grade differed 
depending on imaging modalities; the best agreement came 
from using Computer Tomographic Angiography and 
Magnetic Resonance Imaging rather than Digital Subtraction 
Angiography [3].
 Classification Schemes on AVM Operability
The first and most common classification systems are those 
that assess AVMs’ operability by balancing the risks of surgi-
cal treatment (Fig. 1). These schemes are based on predictive 
factors extrapolated from the neuroradiological exams and 
the clinical features of the patient. The most important ana-
tomical factors appear to be the size and the location of the 
AVM’s nidus. An arterial supply prevalent from perforating 
arteries and the location in an eloquent area can complicate 
surgery. A deep venous drainage is used as an indicator of 
deep-seated extension of AVMs and of the presence of small 
choroidal vessels around the vein in the white matter that can 
cause some technical difficulties and promote postoperative 
focal neurological deficit [4–7].
In addition, the more compact the AVM’s nidus, the easier 
the surgical resection. Hemodynamic predictive factors have 
been related to the onset of hyperemic complications, repre-
sented by the formation of vasogenic edema or bleeding in 
the territories surrounding the AVM after its removal. The 
onset of these events is related to a venous hyperemia result-
ing from the occlusion of venous drainage and an arterial 
hyperemia related to the reperfusion of previously hypoper-
fused brain areas due to blood steal phenomena. D’Aliberti 
et al. correlated the onset of hyperemic complications with 
venous times measured in angiography. The “early venous 
time” was defined as the time of appearance of the nidus and 
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of the veins directly draining the AVM, while the “intermedi-
ate venous time” was defined as the time of appearance of 
the recruited veins, namely the veins draining the brain 
parenchyma afferent to a drainage of the AVM. These venous 
times were considered altered when very short or when there 
was a prolonged interval with the “late venous time,” namely 
the time of appearance of normal brain veins. The altered 
times were closely correlated with the incidence of hyper-
emic complications, which accounted for about 50% of 
adverse events in the series [8].
Furthermore, clinical factors negatively correlated with 
the outcome are the advanced age, the presence of neurologi-
cal deficits or an alteration of the state of consciousness at 
the time of treatment, and the presence of a previous bleed-
ing [7].
 Pre-Spetzler-Martin (S-M) Classifications
The first relevant classification was developed by Luessenhop 
and Gennarelli in 1977 [9]. Data were exclusively related to 
supratentorial AVM. AVMs were divided into four degrees 
according to the number of arterial pedicles in a single vas-
cular territory. Lenticulostriate arteries and Heubner’s recur-
rent artery were considered separate feeders. The greater the 
number of peduncles involved, the greater the difficulty of 
resection. Grade IV AVMs were considered inoperable. The 
presence of subarachnoid hemorrhage was managed as an 
unfavorable factor, and an eloquent area was considered rel-
evant for morbidity. In 1984, Luessenhop and Rosa simpli-
fied the grading of the previous classification [10]. Assuming 
that the size of the AVM’s nidus is related to the number of 
arterial pedicles, the grade was defined according to the 
diameter of the nidus: > 2 cm was grade I, 2–4 cm grade II, 
4–6  cm grade III, and >6  cm grade IV.  Cerebellar AVMs 
were included. Surgical results indicated that in grade I and 
II the mortality and morbidity of surgical treatment were 
probably lower than the natural risk of the disease. In 1986 
Shi and Chen presented an alternative classification [11]. 
More factors were included in the classification: dimension, 
location, complexity of arterial supply, and venous drainage. 
Each of the four factors was subclassified in grade I–
IV. When all the criteria matched, the AVM was of that grade. 
When only one of the criteria was of a higher degree, the 
AVM was of intermediate grade. However, when at least two 
criteria were of the same highest grade, the AVM would have 
been of the latter degree. Therefore, three intermediate 
degrees were possible in addition to the four main degrees. 
The authors demonstrated an increased risk with increasing 
AVM grade with a 20% mortality in grade III-IV AVMs.
 Spetzler-Martin Classification and Following 
Edits
In 1986, Spetzler and Martin published a new classification 
with the aim of simplifying the analysis and reducing the 
variables while maintaining a good predictive value [12]. 
The basis for simplification was the concept that many of the 
predictive factors are interrelated. This scheme has become 
the predominant pattern in the classification of cerebral 
AVMs. The only criteria included in scoring were the nidus 
size, the venous drainage pattern, and the AVM location. 
Each factor had an independent score that was added to the 
others. The dimensions of the nidus were separated into three 
grades: when <3 cm, one point was assigned; if between 3 to 
6  cm, two points; over 6  cm, three points. The authors 
implied that the greater the size of the nidus, the greater the 
brain tissue exposed at risk during surgery. Size was also 
directly related to the number of vascular afferent peduncles, 
to the flow and to the degree of blood steal. When the venous 
drainage pattern included only the cortical veins, it was 
regarded as superficial, and no points were therefore 
assigned. Conversely, when it involved the deep venous sys-
tem (internal cerebral veins, basal veins, precentral cerebel-
lar vein), one point was assigned. A deep venous drainage 
was related to the surgical accessibility to the AVM because 
deep veins are difficult to coagulate and can retract into the 
adjacent cerebral parenchyma and into the ventricle. Lastly, 
one point was assigned to AVMs located in eloquent areas. 
Elective areas were considered the sensory motor cortex, the 
area of  language, the visual cortex, the hypothalamus and the 
thalamus, the internal capsule, the brain stem, the cerebellar 
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The grade of the AVM was derived from the sum of the 
scores assigned for each category. Therefore, AVMs of grade 
I–V were identified. The simplicity of application of this 
classification system certainly contributed to its diffusion. 
Moreover, a low number of variables increased the statistical 
power of scientific studies, enlarging the number of subjects 
assigned to each category. Some drawbacks, however, have 
been identified: The compactness of the nidus and the 
involvement of deep arterial afferents, although important to 
define the surgical complexity, were not considered. 
Furthermore, the definition of eloquence of a brain area can-
not be always accurate. It is known that, especially for 
higher-level cognitive functions, structural anatomy often 
does not fully correspond to functional anatomy. Eventually, 
S-M grading did not take into account the patient’s clinical 
and neurological status.
The weakest point of this classification consisted in its 
lower power to define an accurate outcome in Grade III 
patients. Indeed, grade III AVMs were not a homogeneous 
group, with varying risks of morbidity and mortality. For 
these reasons, in 1998 de Oliveira et al tried to subclass the 
grade III AVMs by defining a grade IIIa and a grade IIIb [13]. 
In grade IIIa, the score was given by the large size of the 
nidus (>6 cm), while in grade IIIb the score was determined 
by the deep drainage and/or the eloquent area. The authors 
advised against surgical treatment for grade IIIb AVMs, 
albeit with some exceptions. In 2003, Lawton further subdi-
vided grade three AVMs into four subtypes [14]. According 
to his classification, AVMs <3 cm with deep drainage and 
located in an eloquent area (grade III-) had a low surgical 
risk, similar to that of low-grade AVMs. The 3–6 cm AVMs 
with deep drainage (plain grade III) had an intermediate risk, 
while the 3–6 cm AVMs in an eloquent area had a high surgi-
cal risk, similar to that of high-grade AVM. AVMs >6 cm 
with superficial drainage in a non-eloquent area were absent 
in the surgical series described (grade III *). The authors rec-
ommended surgical resection in Grade III and III-AVMs.
Since experience showed that the AVMs of Grade I and II 
and IV and V of the score of Spetzler and Martin perform 
similarly, in 2011 Spetzler and Ponce condensed the origi-
nal classification into only three degrees [15]. Grade I and II 
AVMs were merged into grade A, Grade III AVMs were 
assigned grade B, Grade IV and V grades were condensed 
into grade C. The predictive power on surgical outcome was 
identical to the original classification. The authors generally 
recommended surgical treatment for grade A AVMs, multi-
modal treatment for grade B, and observation for grade C, 
reserving treatment for cases of recurrent hemorrhages or 
progressive neurological deficits due to blood steal phenom-
ena. This scheme offered the advantage of increased samples 
for statistical analysis, but it did not dissolve the lack of 
homogeneity of Grade III AVMs.
Two alternative schemes were developed after the 
Spetzler-Martin classification: the University of Toronto 
Prediction Model and the Lawton-Young Grading System. 
Both contested the excessive simplicity of the classification 
of Spetzler-Martin in an effort to increase the discriminative 
power on the outcome of AVM patients after surgery.
The former model was published in 2006 after a retro-
spective analysis of 175 patients [16]. The authors added 
nidus morphology to significant predictors of short- and 
long-term neurological outcomes in addition to the eloquent 
area and deep venous drainage. A diffuse nidus morphology 
was defined as a nidus including normal brain parenchyma, 
with no defined margins, as opposed to a compact nidus. On 
the other side, the size of the nidus >3 cm, the deep arterial 
supply, and the presence of associated aneurysms were not 
significant in the retrospective analysis and were excluded 
from the model. The model assigned a relative weight to the 
three factors considered: the eloquent area was assigned four 
points, the diffusivity of the nidus three points, the deep 
venous drainage two points. Low-risk patients (0–2 points), 
medium-risk (3–5 points) and high-risk patients (6–7 points) 
were stratified. The authors showed in the series that the pro-
posed scheme had a superior discriminative power with 
respect to the grading of S-M in predicting permanent neuro-
logical deficits, especially in low-grade AVMs.
In 2010 Lawton and Young analyzed 300 patients under-
going AVM surgical resection and developed a new grading 
system [17]. Three variables were included in the scheme: 
age, hemorrhagic presentation, and nidus compactness. 
Similarly to the S-M scale the scoring ranged from one to 
five points: one point was assigned for age <20 years, two 
points for 20–40 years, three points for >40 years; one point 
was assigned for AVMs with diffuse nidus and one point for 
hemorrhagic presentation. The predictive accuracy of the 
neurological outcome of the proposed model was higher than 
the S-M scale and was even higher by adding the scores 
obtained with the S-M grading and their grading [18]. 
Lawton et al. concluded that the risk of a surgical resection 
was acceptable in patients with grades ≤3 according to the 
Lawton-Young grading system and grades ≤6 according to 
the score obtained from the sum of the their grading and S-M 
scale. Like the Toronto Prediction Model, the study did not 
confirm a predictive value of deep arterial support.
 Other Operative AVM Classification Schemes
Classifications described above are useful for defining the 
risk of microsurgical resection of an AVM according to the 
clinical and angioarchitectural features. However, over the 
past few decades, alternative or combined treatments have 
been developed and refined. Radiosurgery and endovascular 
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surgery are effective on AVM exclusion by the administra-
tion of ionizing radiations and by the obliteration with 
embolic liquids, respectively. Since the techniques men-
tioned obviously use methods other than microsurgery, risk 
assessment criteria used for surgical treatment cannot be as 
valid. For both techniques, specific classifications for pre-
dicting the complication rate and treatment success were 
developed over time [19–26].
All these schemes have shown some limitations. First, 
since treatment is often multimodal, an exact definition of 
the risk is difficult and the comparison between the series is 
complex. In addition, the ARUBA study recently showed 
that the risk of death and stroke in unruptured AVM was 
higher with interventional treatment than with medical ther-
apy. Although this study has been severely criticized for its 
design, conduct, analysis, and interpretation, it has brought 
out the importance of weighing the natural history of the dis-
ease and its most frequent and feared complication, hemor-
rhage, with treatment-related risks. A mere risk stratification 
for a type of treatment may miss that goal. Interestingly, 
Beltramello et al. drew up a score that considers the psycho-
social aspects of the patient and that is valid for all modali-
ties of AVM treatment [27]. The authors proposed an AVM 
Cumulative Score that summed the Intention to Treat Score 
(ITS) and the Treatment Risk Score (TRS). The former was 
composed of the sum of patient clinical features and mor-
phological features of the AVM: age (<50  years: 0 point; 
50–65  years: 1; >65  years: 2); previous bleeding (yes: 0 
points; no: 2); neurological deficit unrelated to previous 
bleeding (yes: 0 points; no: 1); patient’s firm purpose to be 
treated (yes: 0 point; no: 1); AVM size <10  cm3 (yes: 0 
points; no 1); deep location (yes: 0 points; no: 1); deep 
venous drainage only (yes: 0 points; no: 2); varices or associ-
ated aneurysms (yes: 0 points; no: 2). The ITS therefore 
ranged from 0 to 12. The TRS was instead calculated differ-
ently according to the chosen treatment and ranged from 0 to 
5. When a surgical treatment was indicated, the S-M scales 
that divides patients into five categories was used, with the 
difference that the grade III AVM with vascular supply from 
the lenticulostriate arteries marked 4 points instead of 3. The 
authors based the radiosurgical risk prediction exclusively 
on the size of the nidus (<5  cm3: 1 point; 5–10  cm3: 2; 
10–20 cm3: 3; 20–30 cm3: 4; >30 cm3: 5); however, they sub-
tracted one point in low-flow AVMs, as they believed that 
this aspect was associated with a higher rate of obliteration 
in shorter time. Eventually, factors considered in the endo-
vascular risk prediction were the AVM volume (<10 cm3: 1 
point; >10 cm3: 2); the eloquent area (yes: 1 point; no: 0); the 
presence of perforating feeders (yes: 1 point; no: 0); and an 
unfavorable AVM angioarchitecture (yes: 1 point; no: 0). 
The Cumulative Score was formed by the sum of ITS and 
RTS.  The authors recommended treatment when ≤10, 
offered it with substantial risk if 11 or 12, advised against it 
when between 13 and 17. The same group then validated this 
classification on 104 treated patients, with only a slight 
change to the points assigned to age (<40  years: 0 point; 
40–60 years: 1; >60 years: 2) [28].
All classifications described so far are useful in elective 
cases. In 2016 Neidert et al. proposed a new grading system 
to predict the outcome of patients with intracerebral hemor-
rhage (ICH) due to AVM rupture [29]. Scoring systems that 
predict outcome in spontaneous ICH may not be reliable in 
AVM patients because the pathophysiology of bleeding is 
different. Indeed, outcome in spontaneous ICH has been 
shown to be worse than in AVM-related ICH. Prognosis may 
then be more linked to the angioarchitectural features of the 
AVM than to the ICH itself. The proposed score included the 
sum of the scores obtained from factors derived from the 
S-M scale and the Lawton-Young grading system (size, deep 
drainage, eloquent area, age, compactness of the nidus) and 
from factors derived from the ICH Score [30], namely the 
GCS score (13–15: 0 points, 5–12: 1; 3–4: 2); volume of 
intracerebral hemorrhage (<30 cm3: 0 points; >30 cm3: 1); 
presence of intraventricular hemorrhage (no: 0 points, yes: 
1). The score therefore ranged from 2 to 13. In a recent vali-
dation it was confirmed that with a score ≥  9 there was a 
favorable outcome in only 5.7% of cases, while in 1.4% with 
a score ≥10 [31].
 Topographic AVM Classifications
Anatomical classifications have been devised for AVM 
located in specific anatomical areas of the brain, highlighting 
some peculiarities that may be useful for the surgeon. AVMs 
of the sylvian fissure were classified by Sugita in 1987 [32] 
into four subtypes: pure sylvian AVMs, located in the sub-
arachnoid space around the middle cerebral artery without a 
parenchymal base; sylvian lateral AVMs, located in the lat-
eral part of the sylvian fissure and in the temporal lobe cor-
tex; medial sylvian AVMs, located in the medial part of the 
sylvian fissure and in the frontal lobe; deep sylvian AVMs, 
located in the deepest part of the sylvian fissure and in the 
insular cortex. Lawton et al. in 2007 published an application 
of the Sugita classification on 28 surgical patients [33]. In 
both papers, the classification itself did not effect a signifi-
cant change in the outcome but was useful to indicate some 
surgical tips. First, deep AVMs required a slight posterior 
extension of the craniotomy to allow a wider opening of the 
sylvian fissure to reach the nidus, since the trunks of the mid-
dle cerebral artery (ACM) normally lay on the surface of the 
nidus. In pure AVMs, branches of the ACM were instead 
under the nidus, while the venous drainage was superficial in 
the middle cerebral veins; in the latter the authors advised the 
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dissection of the sylvian fissure from distal to proximal to 
better preserve the en passage arteries. In medial AVMs, the 
greatest surgical challenge was generally the coagulation of 
the feeding branches from lenticulostriate arteries, while in 
lateral AVMs it was the control of the branches of the ante-
rior choroidal artery.
The San Francisco Group described other specific loca-
tions of the AVMs. AVMs of the midline were classified into 
five subtypes according to location (anterior, middle, or pos-
terior) and depth (superficial and deep) [34]. Compared to 
other AVMs of the convexity, which can be approached per-
pendicularly, surgical excision was judged to be more com-
plex, because dissection of the nidus along the medial side in 
superficial parafalcine AVMs and along all four sides in deep 
parafalcine AVMs must be tangential, though requiring brain 
retraction and mobilization of the nidus. For each subtype, 
the authors described a peculiar strategy of patient position-
ing and operating table movements, in order to help the sur-
geon with gravity retraction to better expose the nidus and 
the afferent arterial branches. The highest risk was attributed 
to superficial-middle AVMs, probably due to the more exten-
sive arterial supply (greater percentage of two or three vascu-
lar territories) and the adjacency to the sensory-motor 
cortex.
AVMs of the temporal lobe were subdivided into five sub-
types [35]. Lateral AVMs were found immediately beneath 
the convexity and could be approached perpendicularly with 
a pterional approach. The other subtypes required more com-
plex approaches (subtemporal for basal, orbytozygomatic 
for medial, transylvian for sylvian and transcortical for ven-
tricular AVMs) and tangential dissections. The classification 
was not found useful for predicting the outcome, described 
as generally good.
For cerebellar AVMs, five anatomic subtypes were identi-
fied: three corresponded to the three cerebellar surfaces 
described by Rhoton (suboccipital, tentorial, petrosal), to 
which the vermian and tonsillar AVMs were added [36]. A 
torcular craniotomy with transverse sinus lift was generally 
performed for vermian and tentorial, a retrosigmoid craniot-
omy for the petrosal, a medial suboccipital craniotomy for 
tonsillar, a lateral suboccipital craniotomy for suboccipital 
AVMs. The outcome was better in the tentorial and tonsillar 
AVMs, worse for the petrosal and vermian ones.
Brainstem AVMs were classified into six subtypes: ante-
rior and posterior midbrain, anterior or lateral pontine and 
anterior or lateral medullary [37]. Lateral AVMs could gen-
erally be resected, whereas AVMs with more anterior local-
ization, or when it was difficult to distinguish between 
normal and feeding perforating branches, were treated with 
“occlusion in situ,” namely closing of the feeding arteries 
and of the drainage veins leaving the nidus in the brainstem. 
The authors recommended surgical treatment only in patients 
with AVMs at high risk of rupture.
 Conclusions
Over the years, several classifications for AVMs have been 
proposed, some favoring simplification and others preferring 
accurateness, at the expense of a lower feasibility. So far, the 
Spetzler-Martin classification has been used most often to 
quickly assess the operability of AVMs. However, AVM 
treatment is increasingly multimodal and evolving, so 
parameters to consider are changing. Clinical and neurora-
diological evaluation will in the near future be complemented 
by genetic and molecular factors; thus, clinical trials will 
assess the individual response to each therapeutic option. On 
the other hand, the increasing insights into the anatomic sub-
types of AVMs in recent years has allowed surgeons to 
approach surgically, with acceptable risks, AVMs located in 
territories previously considered inoperable.
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The Preoperative Functional 
Downgrading of Brain AVMs
Sabino Luzzi, Mattia Del Maestro, and Renato Galzio
 Introduction
Treatment options for brain arteriovenous malformations 
(AVMs) include microsurgical resection, transarterial or 
transvenous catheter-based embolization, radiosurgery, or a 
combination of these. From the surgical standpoint, 
Spetzler- Martin (SM) grade III AVMs pose more special 
challenges than doing grades I and II because of their fre-
quent deep- seated location, common vascular supply from 
the lenticulostriate, or thalamostriate arteries, and a not 
unusual racemose nidal angioarchitecture. On the other 
hand, deeper arterial feeders have been reported to be piv-
otal in determining the morbidity and resectability of mid-
dle-sized AVMs [1–4]. In principle, the preoperative 
embolization of the deeper arterial feeders, as well as the 
increasing of the compactness of the nidus, may both lead 
to an easier dissection, helping the hemostasis and ulti-
mately reducing intraoperative blood loss. Although the 
literature reports many studies about the utility of the pre-
operative embolization of brain AVMs, too few of them 
stay focused on the technical details to be implemented to 
maximize the effectiveness and safety of the treatment.
Throughout a retrospective review of an institutional 
series, the present study is aimed to report the key technical 
aspects of the preoperative endovascular-based functional 
downgrading of SM grade III brain AVMs, as well as those 
factors underlying its effectiveness and safety.
 Material and Methods
Data of 97 patients consecutively treated for a brain AVM 
were retrospectively reviewed. Only SM grade III malforma-
tions that underwent a combined endovascular-surgical treat-
ment were selected, resulting in 31 overall treated cases. 
Table 1 summarizes patients’ demographics, the prevalence 
according to the location, and the clinical onset of the ana-
lyzed surgical series (Table  1). By default, preoperative 
imaging included CT scan, T1-, T2-, and time-of-flight- 
weighted gadolinium contrast-enhanced MRI, and four- 
vessels, or six-vessels in case of cortical location, brain 
digital subtraction angiography (DSA). In cases of hemor-
rhagic onset characterized by the presence of an intracerebral 
hematoma, the indication for surgery was built upon a more 
general evidence-based management algorithm about intra-
cerebral hemorrhages reported by our group [5]. Blood oxy-
genation level-dependent functional MRI was performed 
only in cases of elective AVMs involving eloquent 
areas. Based on size (S), involvement of eloquent area (E), 
and pattern of venous drainage (V), the selected grade III 
AVMs were further divided into four main types according to 
the parameters reported in Table  2. AVMs’ volumes were 
calculated on DSA with the method reported by Pasqualin 
and colleagues [6]. As treatment strategy concerns, SM 
grade, angioarchitecture, evidence for flow-related or intra-
nidal aneurysms, and stenosis of the straight sinus basically 
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dictated the decision-making process within a multidisci-
plinary team of neurosurgeons and interventional neuroradi-
ologists. The timeframe between the embolization sessions 
was also discussed on a case-by-case basis and mainly 
decided upon DSA findings. The effectiveness of the staged 
embolization was reported as a percentage ratio between the 
initial and the final post-embolization volume of the nidus.
During surgery, image guidance was used in all cases for 
both planning and intraoperative navigation, while neurophys-
iological monitoring was employed in eloquent area AVMs. A 
rigid 0° or 30°, 4 mm length endoscope was employed in all 
deep-seated or mesial AVMs treated using  an inter-hemi-
spheric approach to check for residuals at the final steps of 
surgery. Flow assessment techniques involved micro-Doppler 
ultrasound (MDU) (20  MHz System, Mizuho Medical Co., 
Ltd., Tokyo, Japan) since 2007, indocyanine green (ICG) 
video angiography (Flow 800 Infrared Module, OPMI Pentero 
800, Zeiss, Oberkochen, Germany) since 2009, and fluores-
cein angiography (Yellow 560 Fluorescence Module, Kinevo 
900, Zeiss, Oberkochen, Germany) since 2018. Operation 
time, blood loss, and admission WFNS grade were evaluated 
as variables in a comparison between a good, modified 
Ranking Scale (mRS) score <3, versus a bad mRS score >2, 
and overall outcome. A Mann-Whitney test for nonparametric 
statistical analysis was performed by means of GraphPad 
Prism software (GraphPad Software, La Jolla, California, 
USA), where the P-value was set at <0.05. All the emboliza-
tion-related complications were described to assess the safety 
of the technique. The Overall outcome was reported as mRS 
[7] at a 6-month follow-up. Modified Ranking Scale scores of 
0–2, 3, and 4–6 were assumed as good, moderate, and bad 
outcomes, respectively. The Overall radiological outcome was 
assessed based on the 6-month DSA.
Table 1 Summary of patients’ demographics, sites prevalence and 
clinical onset
Patients’ demographics N. (±SD)
  Average patients’ age 36.9 (±11.2) years
  Male/female ratio 2.8
Prevalence according to site N.
  Infratentorial 0
  Supratentorial 31
  Main supratentorial site involved
   Site N. (%) N. (%)
    Frontal lobe R – 8 
(25.8%)L 8 (25.8%)
    Parietal lobe R 2 (6.4%) 4 
(12.9%)L 2 (6.4%)
    Central lobe R – 6 
(19.3%)L 6 (19.3%)
    Occipital lobe R 4 (12.9%) 6 
(19.3%)L 2 (6.4%)
    Temporal lobe R 5 (16.1%) 6 
(19.3%)L 1 (3.2%)
    Insular cortex R – –
L
    Central core R – 1 (3.3%)
L 1 (thalamus) 
(3.2%)
Clinical onset N. (%)
  Seizure 6 (19.5%)
  Focal deficits 2 (6.5%)
  Hemorrhage 14 (45%)
  Ischemic stroke –
  Incidental 9 (29%)
Average Admission WFNS 
Grade
N. (±SD)
  Hemorrhagic onset 3.3 (±1.2)
  Non-hemorrhagic onset 1.2 (±0.5)
SD standard deviation, WFNS World Federation of Neurosurgical 
Societies Grading System
Table 2 Typing, prevalence and overall outcome of grade III AVMs according to Spetzler-Martin grading system
SM classification parameters Grade III typing Prevalence Overall outcome
Size 
(cm)
Involvement of eloquent 
area
Type of venous 













3–6 No Deep II (S2E0V1) Medium-deep 12 
(38.7%)
9 (75%) 3 (25%)




6 (19.4%) 1 (16.7%) 5 
(83.3%)
>6 No Superficial IV 
(S3E0V0)
Large 1 (3.2%) – – 1 
(100%)
SM Spetzler-Martin, S AVM size, E eloquent area; V venous drainage, mRS modified Rankin Scale score
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 Results
 Prevalence of Grade III Types
The prevalence of type I (small-eloquent), medium-deep 
(type II), medium-eloquent (type III) and large (type IV) SM 
grade III AVMs was 38.7%, 38.7%, 19.4% and 3.2%, respec-
tively (Table 2).
 Technical Caveats of the Preoperative 
Functional Downgrading of AVMs
Thirty-one AVMs were embolized in 51 endovascular proce-
dures. Only low-density Onyx (Onyx 18, 6% EVOH; Micro 
Therapeutics, Inc., eV3, Irvine, CA) was used as the embolic 
agent in the present series. Through a transarterial transfem-
oral approach, a flow-directed microcatheter (Marathon; 
eV3A) and a tapered microguidewire (Mirage; eV3) were 
advanced until the nidus. After a superselective catheteriza-
tion of the main arterial feeders, a microcatheter was moved 
throughout the target feeders inside the nidus. While prefer-
ring the deep-seated parts, Onyx was injected with a flow 
rate of 0.1 mL/s by means of the “plug and push” technique 
[8]. The first session was always aimed to achieve the widest 
obliteration possible volume, stopping, however, after hav-
ing reached the safest final possible result.
 Effectiveness of the Staged Embolization
Average AVM volume at diagnosis was 19.7 (±3.8) mL ver-
sus a mean volume of 13.6 (±3) at the end of the last preop-
erative embolization session; the  average obliteration rate 
was 29.6 (±14.6)%. The time window between the emboliza-
tion sessions ranged between 10 and 15 days, whereas the 
mean number of the procedures performed per single patient 
was 1.6 (±0.6). The Average time between the last emboliza-
tion and surgery session was 3.7 (±1.8) days. Intraoperatively, 
Onyx allowed for prompt identification of the nidus; also if 
initially racemose, it made it more compact and easier to dis-
sect, and ultimately facilitated the hemostasis and the 
removal of the deepest parts of the malformation. No differ-
ences were found about operation time, blood loss, and 
WFNS grade comparing good versus bad outcome groups.
 Safety of the Staged Embolization
Two mechanical and one hemodynamic endovascular com-
plications were recorded during the embolization sessions; 
the mechanical ones both consisted of a catheter stuck, while 
a hemiparesis occurred in a single patient 8 h after the proce-
dure. The estimated embolization-related morbidity rate was 
3.2% with zero mortality.
 Neurological and Angiographic Overall 
Outcome
At the 6-month follow-up, the overall outcome was as fol-
lows: mRS 0–2, mRS 3, and mRS > 4 in 77.5%, 19.3%, and 
3.2% of the patients, respectively. Two patients (6.4%) had a 
small remnant, which underwent radiosurgery. As grade III 
typing concerns, the best outcome was achieved in small and 
medium-deep AVMs (Table 2).
Table 3 summarizes the overall data about staged emboli-
zation and surgery.
 Illustrative Case
Case #1: SM Grade III AVM Involving the Right 
Primary Visual Cortex Secondary to a mild traumatic 
brain injury, a 48-year-old male was diagnosed with an 
incidental right occipital SM grade III AVM (Fig.  1). 
The Visual field test was normal. DSA of the right ICA and 
VA revealed two main arterial feeders from the distal right 
pericallosal artery (a) and the P3 segment of the right pos-
terior cerebral artery (b and c). Small feeders also came 
from the distal left pericallosal artery (d). The huge nidus 
involved the right primary visual cortex and the venous 
phase showed two cortical veins draining into the posterior 
third of the superior sagittal sinus (e). A first Onyx embo-
lization session was aimed to exclude the feeders from the 
right posterior cerebral artery (f and g), whereas a second 
session, performed after 12 days, allowed to occlude the 
feeders from the right pericallosal artery (h). Post-
embolization preoperative DSA showed a rearrangement 
of the venous outflow (i) and MRI documented no isch-
emic complications (j). The final nidal volume was 
11.3 mL and the estimated overall post-embolization rate 
was 49.7%.
The patients underwent surgery which consisted of  the 
nidus excision by a posterior-interhemispheric approach 
with the patient in a prone position. Intraoperatively, a com-
pact and very easy to dissect nidus was found (k–m). 
Furthermore, the blood loss was insignificant. Final ICG vid-
eoangiography in arterial (n) and venous (o) phase docu-
mented a normal filling of both neighboring arterial vessels 
and previously arterialized veins. No remnants were detected. 
Postoperative DSA confirmed a complete exclusion of the 
AVM (p–t) and the patient was discharged with no deficits on 
the fifth postoperative day.
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20.2 (±4.3) 1.7 (±0.6) 13.9 (±3.3) 30.1 (±13.6) 4.1 (±1.9) 1.1 (±1.4)
mRS modified Rankin Scale score
Fig. 1 DSA of the right ICA (a) and right VA in lateral (b) and anterior- 
posterior (c) projection revealing two main arterial feeders from the 
distal right pericallosal artery and the P3 segment of the right posterior 
cerebral artery. DSA of the left ICA (d). Right VA DSA in venous phase 
(e) showing the presence of two cortical veins draining into the poste-
rior third of the superior sagittal sinus. DSA of the right VA in lateral (f) 
and anterior-posterior (g) projection after the first Onyx embolization 
session. DSA of the right ICA in lateral projection (h) after the second 
Onyx embolization session. (i) Right ICA DSA in venous phase show-
ing the rearrangement and the slowing of the venous outflow. (j) Sagittal 
T2 weighted MRI revealing no ischemic complications after the second 
embolization session. (k, l) Intraoperative pictures during the right pos-
terior inter-hemispheric approach showing the compactness of the 
nidus. (m) Intraoperative picture confirming the complete exclusion of 
the nidus at the final stage of surgery. Intraoperative ICG videoangiog-
raphy in arterial (n) and venous (o) phase. Postoperative DSA of right 
ICA in lateral (p) and anterior-posterior (q) projection confirming the 
complete exclusion of the AVM. Postoperative DSA of the left VA in 
lateral (r) and anterior-posterior (s) projection (t) Postoperative DSA of 
the left ICA in anterior-posterior projection
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 Discussion
SM Grade III represents a heterogeneous group of brain 
AVMs concerning size, the  involvement of eloquent areas, 
venous drainage, and, ultimately, angioarchitecture. Surgery 
has been reported as the option of choice for grade I and 
grade II malformations, but also for grade III ones [9]. 
Nevertheless, a paramount role of preoperative embolization 
has been now recognized and commonly implemented for 
the latter, being the elimination of the deeper feeders at the 
base of easier hemostasis and, lastly, reduced morbidity 
[9–11].
The results of the reported retrospective series fully con-
firm the effectiveness of the Onyx preoperative embolization 
before surgery of grade III AVMs. The good outcome 
observed especially in small-eloquent type I and medium- 
deep type II AVMs led to delineate these types as the best 
candidate for a preoperative endovascular AVM occlusion. 
Additionally, the overall results of the further two types are 
to be considered as other than free from additional and intrin-
sic angioarchitectural factors, eloquence first, which is 
undoubtedly related to higher morbidity [3, 4, 9, 12, 13]. 
echnically, the superselective microcatheterization of the 
feeders is the key starting point to achieve an effective but 
also safe preoperative embolization of the AVM through a 
detailed study of the shunts inside the nidus. Equally impor-
tant is the recognition of the eventual peri-nidal angiogenesis 
in the form of a peripheric tenuous blush since it ought to be 
excluded from the embolization targets. The goal of the first 
session of the embolization should consist of  a functional 
vascular downgrading of the AVM, having to be instead the 
subsequent sessions targeted to the deeper portion.
In our experience, the major advantages of the preopera-
tive embolization came from the exclusion of the deeper 
arterial feeders, these being of utmost importance for affect-
ing the morbidity and resectability of the larger malforma-
tions [1, 2].
Nevertheless, any endovascular overtreatment of the 
nidus ought to be avoided both because it is dangerous and 
because an excessive amount of embolic agent inside the 
nidus has been reported to interfere with the shrinking and 
mobilization of the nidus itself during surgery [1–4, 14–17].
Regarding the timeframe between the embolization ses-
sions, an interval greater than 2 or 3  weeks at maximum 
should be avoided because of the well-known potential for 
the recruitment of new feeders. For the same reasons, sur-
gery should be performed no later than 7 days from the last 
embolization. Within the present series, the implemented 
neurophysiological monitoring protocol, already reported by 
our group for vascular neurosurgery [18–24], was particu-
larly useful also for those malformations located within elo-
quent areas. Equally helpful for checking for residuals at the 
final steps of surgery was endoscopic assistance in all deep-
seated or mesial AVMs, the latter usually treated by means of 
an interhemispheric approach. The advantages of the endo-
scope-assisted technique for deep-seated AVMs are the same 
previously described by our group for the treatment of other 
pathologies characterized by the presence of blind spots [18, 
[25]. Lastly, an essential aspect of AVM surgery lies in con-
stant microneurosurgical vascular training [26].
In conclusion, the results of the reported series confirm 
that preoperative staged embolization is a safe, feasible, and 
useful option in the treatment of both hemorrhagic and non- 
hemorrhagic SM Grade III AVMs.
A careful selection of patients as candidates for combined 
treatment, a detailed evaluation of the angioarchitecture, 
meticulous planning, and an effective and safe functional 
downgrading of the AVM, which should be based upon the 
key technical aspects reported in the present study, are all 
paramount factors the make surgery straightforward and, 
ultimately, to achieve the best outcome.
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Intracranial Dural Arteriovenous 
Fistulas: The Sinus and Non-Sinus 
Concept
Giuseppe D’Aliberti, Giuseppe Talamonti, Davide Boeris, 
Francesco M. Crisà, Alessia Fratianni, Roberto Stefini, 
Edoardo Boccardi, and Marco Cenzato
 Introduction
Dural arteriovenous fistulas (dAVFs) represent 15% of all 
intracranial arteriovenous shunts. In particular, 7% of supra-
tentorial and 35% of infratentorial shunts are dAVFs [1]. 
Dural arteriovenous fistulas are a group of acquired patho-
logical vascular malformations, defined by an abnormal 
communication within the dural leaflets, between arteries 
and dural venous sinuses and/or subarachnoid veins. The 
feeding arteries are commonly branches of the external 
carotid artery, tentorial branches of the internal carotid artery, 
meningeal branches of the vertebral artery or, rarely, pial 
branches of the cerebral arteries [2]. Dural arteriovenous fis-
tulas are more commonly supratentorial than infratentorial 
in  location. The transverse-sigmoid sinus junction is the 
most common location for dAVFs, with a slight left-sided 
predominance. Through the years many classification sys-
tems have been proposed for intracranial dAVFs. These sys-
tems are based on the lesion’s venous drainage patterns, as 
this factor dictates the behavior of the lesion itself. Djindjian 
and Merland first classified dAVFs according to their venous 
angioarchitecture in 1977 [3]. In 1995, Cognard further clas-
sified both cranial and spinal arteriovenous fistulas according 
to their venous outflow with prognostic and treatment impli-
cations [4]. Borden simplified the Cognard classification, 
emphasizing that the major factor in predicting an aggressive 
clinical course is the presence of cortical venous drainage. 
Unlike venous sinuses, cortical veins are not protected by the 
dura and cannot withstand arterial pressures. Therefore, 
dAVFs with cortical venous drainage (Borden types II and 
III) have a higher risk of rupture and hemorrhage [5, 6].
The Vascular Malformations Study Group of Toronto 
identified in 1997 the same rate of bleeding for dAVF and 
cerebral AVMs. Intracranial hemorrhage and neurologic def-
icit is likely in 2% of the Borden classification type I, 39% of 
type II, and 79% of type III dAVFs [7]. However, there is a 
45% mortality rate over 4 years among patients with cortical 
venous drainage, a 19.2% intracranial hemorrhage rate per 
year, and 10.9% new neurologic deficit rate per year. For 
patients who present with hemorrhage, the rate of repeated 
hemorrhage is 35% within the first 2 weeks of the initial ictus 
[1, 6, 8–10]. According to our experience [11–13], we sug-
gest a simplified classification of dAVFs: sinus and non- 
sinus. This classification guides the choice of surgical 
treatment. As previously observed by other authors, posterior 
fossa localization of the fistulas is not a real adjunctive risk- 
factor [14].
 Our Experience
Sinus Fistula: We define as sinus dAVF all the fistulas having 
the dural arteries shunting directly into dural sinus. This 
direct communication between the artery and the sinus can 
subsequently recruit cerebral veins. The classification for 
this type of fistula, despite venous recruitment, does not 
change and still represents a sinus fistula (Fig. 1a).
Non-Sinus Fistula: In non-sinus fistula the sinus main-
tains functional for the venous discharge of the brain. The 
pathological shunt is embedded into the dural leaflet without 
communication with the sinus. Drainage of the fistula 
depends entirely upon cerebral veins (Fig. 1b).
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From 2006 to 2016, at our Neurosurgical Department and 
our Interventional Neuroradiology at Niguarda Hospital, 
Milan, Italy, 477 intracranial dural arteriovenous fistulas 
have been treated: 376 underwent endovascular treatment 
and 101 underwent surgical treatment. Cavernous sinus 
dAVFs and Galen ampulla malformations have been excluded 
from this series, as they represent a different pathology per 
se. Of the 376 dAVFs treated by the endovascular approach, 
180 were sinus and 179 were non-sinus. Of the 101 dAVFs 
treated with the surgical approach: 15 were sinus and 86 
were non-sinus.
This classification was found to be very useful in our 
daily practice. In a sinus fistula there is a direct communica-
tion between the arterious dural branch and one dural sinus, 
and cerebral veins can subsequently be recruited. These 
recruited veins, called by some authors “red veins” due to the 
inverted internal blood flow, are not functioning veins. Red 
veins must be excluded from the circulation together with 
the excision of the portion of sinus interested by the fistula. 
In non-sinus fistula, the shunt is embedded into the dural 
leaflet and it doesn’t communicate with any sinus, whereas it 
drains itself into a cortical vein. Therefore, the sinus is func-
tional for the brain. This draining vein—a red vein—has to 
be occluded proximally (“piè” of the vein) through a surgical 
or endovascular transvenous approach.
Correct individuation of the type of fistula, sinus or not 
sinus, is important in order to plan a proper surgical treat-
ment, regardless of the presence of venous varices in the 
malformation. Those varices, in fact, do not represent an 
anatomopathological variant and do not require a different 
surgical approach [13].
The draining vein in a non-sinus fistula, with one or more 
associated varices on its course, so-called Type IV of some 
classification systems [4], does not configure a different type 
of fistula in terms of another anatomopathological entity, so 
it is not an adjunctive surgical risk factor. Therefore, surgical 
treatment of both infratentorial and supratentorial fistulas is 
the same: clipping or occlusion of the vein at its emergence 
(See “Illustrative Cases”: Fig. 2, Cases 1 and 2)
 Illustrative Cases
Case 1 A 65-year-old man come to observation for ictal 
onset of headache and coma. At admittance in ER, he pre-
sented with GCS 3 and anisocoria ( > right), onset <1 h. A 
CT scan showed a left temporal ICH and a CT-Angio with 
3D reconstruction showed a non-sinus dural fistula of pteri-
onal dura (a–c). The patient underwent an urgent surgery, 
with carotid exposure at neck. A wide craniotomy was per-
formed, the hemorrhage was drained, and non-sinus fistula 
was excluded through multiple clipping of drainage vein, 
after temporary (7 min) occlusion of external carotid artery 
(d). The postoperative stay was good, a postoperative DSA 
showed the complete exclusion of dAVF, and a postoperative 
CT scan showed the results of previous hemorrhage (e–f). At 
2 months follow-up the patient was able to walk alone and he 
had just a slight expressive dysphasia.
Case 2 A 45-year-old female came to our ED for progressive 
onset of nucal headache and instability. A first CT scan 
showed a right, small intracerebellar hemorrhage (g). Six 
hours after admittance, the patient complained of a new head-
ache attack and the onset of a coma. A new CT scan showed 
a new hemorrhage and a DSA showed a falco- tentorial non-
sinus fistula with associated varix on the drainage vein (h, i, 
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Fig. 1 (a) Sinus fistula (drawing). (b) Non-sinus fistula (drawing)






Fig. 2 Case 1. Supratentorial pterional non-sinus fistula (associated with varix) (a–f). Case 2. Infratentorial non-sinus fistula (associated with 
varix) (g–n)
Intracranial Dural Arteriovenous Fistulas: The Sinus and Non-Sinus Concept
116
hemorrhage and clipping of “piè” of the vein. Varix was 
excised with the hemorrhage (m, n). Postoperative stay was 
good with a prompt recovering of consciousness. The patient 
was discharged after 2 weeks with a slight instability.
The different surgical approach in FAVD next to a venous 
sinus depends on the type of the shunt and it doesn’t depend 
on the localization but on type of drainage and on the 
recruited cerebral veins. In the case of a sinus fistula, there-
fore, it is possible the resection of the fistulous sinus tract 
and the occlusion of the recruited nonfunctional veins and 
the absolute preservation of the veins still functional to the 
brain (See “Illustrative Cases”: Fig. 3, Cases 3 and 4).
Case 3 A 48-year-old male came to our observation for an 
intracranial hypertension syndrome with slow onset (some 
months before), with headache and progressive cognitive 
impairment. Some days before the patient complained of a 
severe impairment of awareness and vomiting with associ-
ated visual impairment. A DSA showed a sinus fistula of the 
torcular with engorgement of straight sinus and severe 
recruitment of many cerebral veins, which seemed to persist 
long because of engorgement (a–c). The patient underwent a 
surgical resection of torcular with occlusion of recruited 
veins (red veins), both not functional for the brain. 
Postoperative DSE showed exclusion of the FAVD and the 
non-visualization of straight sinus in arterial phase, for the 
restoring of a normal situation (d, e).
Case 4 A 17-year-old male with a slow onset symptom-
atology (6  months) with headache and visual blurring. A 
DSA showed a sinus FAVD of the middle third of SSS with 
recruitment of cerebral veins (f–h). The anterior one is not 
functional; the posterior one, instead, remains normally 
visible in venous phases of angiography when dAVF is not 
visible. The patient underwent surgical resection of fistu-
lous sinus tract with occlusion of anterior recruited vein (i, 
l, m) and avoidance of the posterior one, functional for the 
brain. The postoperative DSA shows a normal venous 
angiogram (n).
Different types of dAVFs (sinus or non-sinus) in posterior 
cranial fossa may localize in the same place, but they require 
different surgical treatment, in particular those located at the 
petrous bone apex (See “Illustrative Cases”: Fig. 4, Cases 5 
and 6). Finally, non-sinus fistulas with associated varix and 
perimedullary drainage, so-called Type V of Cognard-Gobin 
Classification [4], are not a different type of fistula and they 
do not add an adjunctive surgical risk factor [15] (See 
“Illustrative Cases”: Fig. 5, Cases 7 and 8).
Case 5 A 44-year-old female fashion designer come to our 
observation for a progressive brainstem symptomatology. An 
MRI showed a right ischemic lesion in the pons. Three years 
before, she was treated in another institution with emboliza-
tion of a sinus transverse-sigmoid dAVF with an initial 
recruitment of the superior petrous sinus (a–c). A new DSA 
showed sinus recanalization associated with an evident 
recruitment of the superior petrous sinus and reflux in 
engorged infratentorial veins (d, e). The postoperative 
 angiography showed a disappearance of sinus fistula after 
sinus removal and clipping of main recruited vein (f). After 
6 months of swallowing rehabilitation the patient was able to 
go back to her job.
Case 6 A 48-year-old male journalist come to our obser-
vation for a progressive tetraparesis with sphincter disor-
ders. An MRI showed a severe cervical spine myelopathy, 
and because of the presence of a disk herniation at C4–C5, 
initial diagnosis was spondylotic cervical myelopathy. 
Because of the presence, in MRI, of vascular structures in 
cervical subarachnoid space (g), a second opinion sug-
gested a complete angiographic study of the brain and 
medulla. The latter showed a non-sinus fistula of the apex 
of the right petrous bone, with feeder from the Bernasconi-
Cassinari artery and drainage in a perimesencephalic vein 
with associated engorgement of perimedullary veins (h, i, 
l). The patient underwent surgical intervention through a 
suboccipital craniotomy and clipping of drainage vein at 
the apex of the petrous bone (m, n). Postoperative DSA 
showed the complete exclusion of the dAVF (o). After 
6 months of rehabilitation, the patient went back to work 
with autonomous life and with slight sphincter 
impairment.
Case 7 A 52-year-old male presented with a progressive 
myelopathy, and MRI showed a cervical spine myelopathy 
without a cervical spondylosis and presence of vascular 
structures in posterior subarachnoid space (a). The patient 
underwent complete DSA of brain and medulla, which 
showed a non-sinus fistula on the dura close to the entrance 
into intracranial space of the left vertebral artery and engorge-
ment of perimedullary veins of the cervical tract (b). Through 
a far lateral approach, the “piè” of the vein was exposed in 
the anterior part of the intracranial entry point of vertebral 
artery (c, d). The malformation was excluded through clip-
ping of the drainage vein at its origin. Postoperative DSA 
showed the complete exclusion of the dAVF (e). At 5 months 
follow-up, the patient walked with aid and still had sphincter 
disorders.







Fig. 3 Case 3. Sinus Fistula of Torcular (a–e). Case 4. Non sinus fistula SSS (f–n)







Fig. 4 Case 5. Sinus Fistula of Petrous bone apex (a–f). Case 6. Non-sinus fistula of Petrous bone apex (g–o)






Fig. 5 Case 7 Non-sinus Fistula of Foramen Magnum (a–e). Case 8 Non-sinus fistula of Jugular Foramen (f–m)
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Case 8 A 58-year-old Italian politician come to our obser-
vation for a left tinnitus with onset 1 year previous. Some 
weeks before, the patient experienced onset of progressive 
motor impairment in walking with sensitive deficit. 
Angiography showed a non-sinus fistula close to the jugular 
foramen (f, g). The fistula was excluded through a surgical 
intervention with clipping of “piè” of the vein (h, i, l). Post- 
operative DSA showed the complete disappearance of the 
malformation (m).
 Surgical Results
Surgical series results are described in Table 1. Mortality 
and severe disability was 3% and morbidity less than 4%. 
All patients underwent a postoperative DSA with nearly 
100% of complete occlusion of the fistula. At a mean fol-
low up of 5 years in one case there was a non-sinus fistula 
recurrence, due to the presence of a partial clipping of “the 
shunting foot.” Our surgical experience underlines the fact 
that posterior fossa localization, per se, does not represent 
and adjunctive risk factor for treatment. Moreover, based 
on shunt location, dAVFs can be classified in the same way 
as meningiomas: falcotentorial, straight sinus-vein of 
Galen-torcular, transverse and jugular sinus, CPA and fora-
men magnum (before or at the entrance of the vertebral 
artery).
 Discussion
Dural arteriovenous fistulas (dAVFs) account for 10–15% of 
all intracranial arteriovenous lesions. Symptoms and progno-
sis are highly variable. Some dural AVFs produce neurologi-
cal symptoms depending on the locations and the involved 
structures; others are associated with intracranial hemor-
rhage [1, 7, 16]. It is very important to have a good under-
standing of the natural history of dural AVFs when it comes 
to decision-making about treatment (See Fig. 6). This chal-
lenging and interesting topic has been reviewed since 1984, 
when Malik et al. [17] studied 223 previously reported cases 
and concluded that lesions related to large dural sinuses are 
less likely to bleed than lesions with restricted dural outflow. 
In this first review there were no angiographic features, in 
particular, the pattern of venous drainage taken into consid-
eration. In 1986, Lasjaunias et  al. [18] presented a meta- 
analysis of 191 cases. They analyzed the mechanism of 
neurologic manifestations and concluded that apart from the 
peripheral cranial nerve palsy due to arterial steal phenom-
ena, central nervous system symptoms seem to be related to 
passive venous hypertension. In 1990, Awad et  al. [19] 
reviewed 360 cases reported in the literature and 17 of their 
own cases to compare the angiographic features of 100 
aggressive cases and 277 benign cases. They concluded that 
leptomeningeal venous drainage, variceal or aneurysmal 
venous dilatations, and galenic drainage were indicative of 
possible aggressive neurologic signs. In 1995 Cognard et al. 
[4] reviewed a series of 205 consecutive patients with dural 
AVFs over 18 years. The purpose was to complete and vali-
date the classification of dural AVFs proposed in 1978 by 
Djindjian et al. [3]. In the same year Borden proposed his 
classification system [5], which stratifies lesions on the basis 
of the site of venous drainage and the presence or absence of 
cortical venous drainage. Borden type I lesions have the 
direct communication of meningeal arteries with a menin-
geal vein or dural venous sinus and exhibit normal antegrade 
flow. Type II lesions have shunts between the meningeal 
arteries and dural sinus, with retrograde flow into the sub-
arachnoid veins, causing venous hypertension. Type III 
lesions have direct drainage of meningeal arteries into sub-
arachnoid veins or an “isolated” sinus segment. The latter 
phenomenon is often the result of thrombosis on either side 
of the arterialized sinus segment, which directs retrograde 
flow into the subarachnoid venous system. The Borden clas-
sification scheme further subclassifies lesions as single-hole 
(a) or multiple-hole (b) fistulas. In our experience, the most 
useful classification for a merely surgical point of view is to 
distinguish intracranial dAVFs as sinus or non-sinus, because 
the simple understanding of this point leads to the correct 
treatment. On the basis of venous drainage, Borden [5] clas-
sified intracranial dAVFs into three main types: sinusal, 
sinusal with recruitment of one or more cerebral veins, and 
fistulas draining into cortical cerebral veins.
Table 1 Surgical results
Mortality 2/101 (2%)
Severe morbidity 1/101 (1%)
Minor morbidity 4/101(4%)
Complete obliteration 101/101 (100%)
F.U 5 years: recurrence 1/101 (1%)
DECISION-MAKING
Natural History.









Fig. 6 Decision-making workflow
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Commonly, type I fistulas have a benign behavior and are 
conservatively treated. If a disabling bruit is present, a pallia-
tive transarterial embolization can be indicated, while sur-
gery is chosen in very selected cases.
However, Type II and III dAVFs usually show an aggres-
sive behavior including hemorrhage and progressive neuro-
logical deficits. Davies [1, 7] report an intracranial 
hemorrhage rate of 19.2% lesion/year and non-hemorrhagic 
deficit of 10.7% lesion/year. The complete obliteration of 
Type II or Type III fistula by embolization can be obtained in 
less than 50% of cases via the transarterial route and in more 
than 80% of cases when the venous route is used.
Urtasun, Roy, Link and Lucas [20–23] reported rates of 
72% complete obliteration and 28% partial obliteration in 
patients treated by radiosurgery at 1 and 3 years of follow-
up. On the basis of shunt location, posterior cranial fossa 
dAVFs can be classified in the same way as meningiomas: 
falcotentorial, straight sinus/vein of Galen, torcular, trans-
verse sinus, jugular sinus, CPA, and foramen magnum 
dAVFs (Fig. 7). From a practical surgical point of view we 
suggest to simply classify dAVFs as “sinusal” or “non 
sinusal fistula.” In the former type there is a direct commu-
nication between the dural shunt and one sinus, and cortical 
veins can sometimes be recruited; in the latter type the shunt 
is embedded into the dura and the drainage always involves 
a cerebral vein. As for all diseases, the decision-making pro-
cess must take into account surgeon experience, aggressive-
ness of the lesion, and limits of the treatment. Three different 
approaches can be indicated in dAVFs: surgical, endovascu-
lar (i.e., transarterial/transvenous embolization), and radio-
surgical with Gamma Knife.
Surgical treatment is different in sinus and non-sinus fis-
tulas and comprise involved sinus resection and clipping or 
endovascular occlusion of recruited cerebral veins. 
Recruited veins, the so-called “red veins,” are not functional 
and show an inverted internal blood flow. Distal to the 
involved sinus there could be functional blue veins that must 
be spared. On the other hand, treatment of non-sinusal fis-
tula consists in clipping or endovascular occlusion of the 
draining red vein which, as mentioned before, is a non-func-
tional vein.
 Conclusions
We want to underline the role of venous drainage in the 
management of dAVFs. Prioritization of treatment options 
is crucial to achieving a good result. As a consequence, 
identifying sinus vs non-sinus fistulas is crucial from a sur-
gical point of view. Sinus fistulas require sinus excision and 
clipping and subsequent occlusion of recruited veins. Non-
sinus fistulas require, on the other hand, clipping or endo-
vascular venous embolization of the drainage vein. A 
posterior cranial fossa location does not represent an 
adjunctive risk factor in the treatment of dural fistulas. Type 
IV and V in Cognard and Gobin’s classification are not to 
be considered as independent entities: varices and perimed-
ullary drainage can be seen in both sinus and non-sinus 
fistulas.
Fig. 7 Localization of posterior cranial fossa dAVFs (See Table 2 for 
description)
Table 2 Localization of posterior cranial fossa meningiomas and 
dAVFS
Localization of posterior cranial 
fossa meningioma 
(Castellano-Yasargil-AlMefty)
Localization of posterior cranial 
fossa non sinus-sinus DAVFs 
(D’Aliberti-Cenzato)
Tentorial-Falcotentorial 1. Straight sinus, Vein of Galen 
and Torcular
Petrous-Petroclival 2. Trasverse Sinus
Jugular Foramen 3. Jugular Foramen
CPA 4. Petrous bone apex
Foramen Magnum 5. Foramen Magnum (Before or 
at the entrance of VA)
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Complications of Endovascular 
Treatment of Intracranial Dural 
Arteriovenous Fistulas
Naoya Kuwayama and Naoki Akioka
Dural arteriovenous fistulas (dAVF) are acquired lesions 
whose incidence is reported to be 0.3 per 100,000 per year 
[1]. The locations of the fistula include the cavernous sinus, 
transverse-sigmoid sinus, superior sagittal sinus, inferior and 
superior petrosal sinuses, anterior condylar confluence, ten-
torium, anterior skull base, craniocervical junction, convex-
ity, and spinal cord. These lesions are divided into sinus type 
(the former six lesions) and non-sinus type (the latter five 
lesions).
The principle of dAVF therapy had been endovascular 
treatment for the sinus type and surgical treatment for the 
non-sinus type until Onyx was introduced as an embolic 
material. Nowadays the majority of non-sinus type dAVFs 
can be successfully treated with use of Onyx [2]. Current 
endovascular therapy includes transvenous coil embolization 
of the sinus type and transarterial glue or Onyx embolization 
of the non-sinus type. The aim of this study is to report com-
plications that resulted from endovascular treatment of this 
disease.
 Complication of Transarterial Embolization 
(TAE)
 Migration Via the Arterial Anastomosis
One of the most important and critical complications is cere-
bral ischemia resulting from the migration of embolic mate-
rials via so-called dangerous anastomosis or the network 
between dural and pial arteries. Usually the dural branches 
of the external carotid artery have rich anastomosis with the 
dural and pial branches of the internal and vertebral arteries. 
Liquid embolic materials like NBCA (n-butyl cyanoacry-
late) and Onyx, as well as particulate materials smaller than 
200 μm, are easily migrating to the pial arteries via the net-
work. One must care about another dangerous behavior of 
the liquid materials; it tends to come back to the parent feed-
ing pedicle via the arterial network arising from the feeding 
artery itself (Fig. 1).
 Migration to the Venous Side
Onyx, particularly, tends to penetrate the arteriovenous fis-
tula very easily and go to the venous side. This penetration is 
the essential phenomenon needed for the radical treatment 
and the most advantageous point of Onyx to the particulates. 
However, excessive penetration (migration) could occasion-
ally result in the occlusion of the functioning cerebral veins 
(Fig. 2), causing potential venous infarction.
NBCA tends to make fragmentation in the venous side 
when arterial blood flow comes from the other feeding arter-
ies. If the block of fragment occludes the distal side of the 
draining vein, venous bleeding may occur because of the 
remaining arterial inflow.
 Ischemia of the Vasa Nervosum
NBCA, Onyx, and small particulates (<200 μm) migrating 
into the vasa nervosum will cause cranial nerve palsy. Many 
external carotid branches like the middle meningeal, acces-
sory meningeal, deep temporal artery, and the artery of fora-
men rotundum give rise to branches feeding the cranial 
nerves around the middle fossa. The middle meningeal, 
ascending pharyngeal, occipital artery, and posterior menin-
geal branch of the vertebral artery also feed the cranial nerves 
inside and outside the posterior fossa. The inferolateral and 
meningohypophyseal trunk of the internal carotid artery feed 
many cranial nerves and have a rich collateral anastomosis 
between external carotid artery.
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Fig. 1 A case with dAVF in 
the craniocervical junction 
showing NBCA migration. 
(a) Preoperative vertebral 
angiogram indicating dAVF 
fed by C2 segmental artery of 
the vertebral artery and 
drained into the cerebral vein 
in the brain stem. (b) 
Microangiogram from the 
feeding artery. (c) 
Postoperative CT scan 
indicating migration of the 
fragmented pieces of NBCA. 
(d) Schematic drawing of the 
mechanism of NBCA 
migration; injected NBCA 
came back to the distal parent 
vertebral artery via the other 
feeding pedicle




Fig. 2 A case with Borden 
type-I dAVF involving the 
transverse-sigmoid sinus. The 
shunt was obliterated with 
Onyx injection from the distal 
occipital artery arising from 
the vertebral artery. A balloon 
catheter was inflated in the 
involved sinus to prevent 
Onyx migration to the sinus 
side. (a) Preoperative 
vertebral angiogram. (b) 
Postoperative vertebral 
angiogram indicating 
complete obliteration of the 
shunt. (c) Postoperative 
craniogram showing the Onyx 
cast. (d) Postoperative cone 
beam CT indicating Onyx 
migration to the tinny petrosal 
vein (arrow) via the superior 
petrosal sinus
 Complication of Transvenous Embolization 
(TVE)
 Mass Effect to the Cranial Nerves
Excessive transvenous coil packing of the cavernous sinus 
and anterior condylar confluence causes III, IV, V cranial 
nerve palsy and XII nerve palsy, respectively. Sometimes, 
the delayed ocular palsy will occur and never recover [3]. 
This mechanism still remains unknown but one should 
remind.
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 Venous Infarction and Bleeding
Normal cerebral veins sometimes drain into the involved 
sinus in an antegrade fashion. Venous infarction will occur 
after complete transvenous sinus packing by blocking the 
normal venous drainage (Fig. 3). Cortical venous drainage or 
retrograde leptomeningeal drainage in sinus type dAVFs is 
sometimes seen in Borden type II or III and Cognard type 
IIb. Transvenous sinus packing of these lesions have a potent 
complication of venous bleeding from excessive residual 
drainage to the cortical vein if the packing is incomplete 
(Fig.  4). One must obliterate, at first, the dangerous small 
draining veins like the uncal vein, petrosal vein, and bridging 
veins to the brain stem (Fig. 5).
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Fig. 3 A case with cavernous sinus dAVF treated with transvenous 
packing of the affected sinus. Left: Preoperative external carotid angio-
gram (lateral view) showing the shunt in the cavernous sinus. Center: 
Preoperative internal carotid angiogram (lateral view) showing the 
superficial middle cerebral veins are emptying into the affected cavern-
ous sinus in an antegrade fashion. Right: Venous phase of the postopera-
tive common carotid angiogram (lateral view). Note one of the superficial 
middle cerebral veins (arrow in the center figure) was missing
Fig. 4 A case with cavernous sinus dAVF treated by transvenous coil 
embolization. Left: Preoperative common carotid angiogram. Center: 
Postoperative common carotid angiogram showing incomplete obliter-
ation of the affected cavernous sinus. Note the cavernous sinus was 
packed with coils but the inferior petrosal sinus was still opacified 
(arrow). Right: MRI (FLAIR) examined in the next day showing 
(venous) infarction of the entire brain stem, suggesting the postopera-
tive change of the draining route into the brain stem by incomplete 
transvenous occlusion of the cavernous sinus
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Fig. 5 Examples of the dangerous draining veins. Left: Cavernous 
sinus injection opacified the uncal vein (arrow) connecting with deep 
cerebral veins (vein of Rosenthal and vein of Galen). Center: Cavernous 
sinus injection opacified the petrosal vein (arrow). Right: Carotid 
angiogram showing the cavernous sinus dAVF draining only into the 
tinny vein of the brain stem (double arrows) via the bridging vein 
(arrow)
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ASA Anterior spinal artery
CBCT High-resolution cone beam computed tomo-
graphy
CE-MRA Contrast-enhanced MR angiography
DSB Dorsal somatic branch
DV Initial segment of the draining vein
MRI Magnetic resonance imaging
PSA Posterior spinal artery
SDAVFs Spinal dural arteriovenous fistulas
SEAVFs Spinal epidural arteriovenous fistulas
 Introduction
Spinal dural arteriovenous fistulas (SDAVFs) are the most 
common spinal vascular malformation. The clinical symp-
toms, however, are usually nonspecific. Therefore, the neu-
rosurgeon or neuroradiologist is often the first clinician to 
make the initial diagnosis based on MR imaging, with dif-
ferential diagnoses causing confusion [1–4]. Recent imaging 
technology can visualize the detailed angioarchitecture of 
SDAVFs at the level of the shunt point. We retrospectively 
analyzed 22 consecutive cases of SDAVFs and identified the 
shunt point and the related vasculatures of SDAVFs based on 
the MRI, CE-MRA, high-resolution cone beam CT (CBCT), 
spinal angiography, and 3D-CT. The efficacy and sensitivity 
of these imaging modalities were assessed, and a new con-
cept of classification of SDAVFs was introduced in terms of 
the anatomical point of view.
 Materials and Methods
From 2005 to 2017, 22 consecutive cases of SDAVFs were 
diagnosed with MRI and angiography. Spinal epidural arte-
riovenous fistulas (SEAVFs) located at the lumbar spine 
were excluded from this study. Our population was com-
posed of 21 men and one woman. The mean patient age was 
67 ± 12.4 years (range 42–79 years). High-resolution cone 
beam CT (CBCT) was introduced in 2013  in our institute, 
and a total of 11 cases received CBCT. The visualization of 
anterior spinal artery (ASA), posterior spinal artery (PSA), 
dorsal somatic branch (DSB), and the primary foot of the 
draining vein (DV) were confirmed. If transarterial emboli-
zation was indicated, superselective angiography from the 
dominant feeder was referred to in order to confirm the pre-
cise topographical location of the shunt point. A total of 18 
cases were treated with superselective transarterial emboli-
zation with Histoacryl glue. The other four cases were treated 
by surgical clipping of the arterialized bridging vein after 
laminectomy.
 MR Imaging and Contrast-Enhanced MR-DSA
All 22 patients underwent extensive spinal MR-DSA with 
gadolinium contrast and MR imaging (1.5 T and/or 3 T). The 
extension of the T2 signal hyperintensity and the medullary 
contrast enhancement was qualified by the number of verte-
bral levels shown to be affected on T1 and T2 MR images. 
The appearance of the perimedullary veins was rated subjec-
tively as absent or prominent due to their tortuous and dilated 
appearance in the T1 and T2 images. Contrast-enhanced MR 
angiography (CE-MRA) is similar to contrast-enhanced CT 
angiography, except a gadolinium-based agent (instead of an 
iodine compound) is injected. Just as iodine produces X-ray 
attenuation allowing visualization of vessels on CTA, gado-
linium shortens the T1 of blood, rendering vessels bright on 
CE-MRA (Fig. 1).
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The introduction of multi-detector row computed tomogra-
phy (MDCT) has allowed further refinements in detecting 
microstructures in the spinal cord region. MDCT was per-
formed with a commercially available MDCT scanner 
(Aquilion ONE™/GENESIS Toshiba Medical Systems, 
Tokyo, Japan) with a gantry rotation speed of 0.35 s and a 
detector configuration of 32.0 × 1.0 mm; the moving speed 
of the table was 27 mm/s. All scans were acquired in a cepha-
locaudal direction. Patients underwent MDCT followed by 
arterial and venous phases. Patients received 100  mL of 
iomeprol (Iomeron, 350  mg/mL, Bracco-Eisai, Otsuka, 
Japan) with a monophasic injection technique by means of a 
power injector. Analysis of the three-dimensional (3D) data 
set for the region of interest in all subjects was also done by 
experienced radiological technicians using a commercially 
available workstation (ZIOSOFT, ZIOSOFT Inc., Tokyo, 
Japan). With ZIOSOFT, 3D reconstruction images of the 
shunt point and the artery of Adamkiewicz were created 
using CT images of the arterial phase with a slice thickness 
of 0.5 mm, manually removing adjacent structures such as 
vertebral bony structures and the outside of the spinal canal.
 DSA and High-Resolution CBCT
Digital subtraction angiography (DSA) was performed with 
a femoral approach in a dedicated biplanar neuroangio-
graphic suite. The equipped DSA machine was a flat-panel 
detector biplane angiography unit (Allura Clarity FD20/20; 
Philips Medical Systems). Spinal angiography was per-
formed using the standard angiographic technique and inves-
tigated total spinal level, including bilateral intercostal artery 
and adjacent level of the shunt point. Standardized angiogra-
phy included selective manual injections of 4–5  mL of 
300 mg/mL of iodinated nonionic contrast medium into the 
lumbar and intercostal arteries using a 4 or 5 French in the 
outer diameter of the catheter designed for the spinal angiog-
raphy. Furthermore, injections into both vertebral arteries, 
the costocervical arteries, the thyrocervical trunks, and the 
arterial feeders of the sacral region were added. Once the 
a b
Fig. 1 (a) T1-weighted 
image on sagittal view 
showed the swelling of spinal 
cord with the appearance of 
central myelopathy. (b) 
CE-MRA depicted the shunt 
point at the level of mid- 
thoracic spine. This modality 
enabled effective 




shunt point and the Adamkiewicz artery were identified, the 
high-resolution CBCT was performed in each corresponding 
artery after the complete set of the entire spinal angiography. 
High-resolution CBCT was based on motorized rotational 
angiography acquisition. The shunt lesion and the region of 
interest were positioned in the system isocenter around 
which the C-arm takes a circular trajectory of 220°. The 
motorized frontal C-arm was used to acquire 30 projection 
images/s at 80  kV, the scanning time was 20  s, and the 
 detector format used was 22 cm × 22 cm. All procedures and 
acquisitions were performed under general anesthesia. 
During this acquisition, the anesthesiologist paused the ven-
tilator for around 20 s of apnea to avoid motion artifact. The 
acquisition dataset was transferred to the workstation (Xtra 
Vision; Philips Medical Systems) for the reconstruction pro-
cess. All high-resolution CBCT images were reconstructed 
with 5123 matrixes centered about the regional shunt point 
and optimized for the visualization of the ASA, PSA, DSB, 
and DV. After reconstruction of the three-dimensional vol-
ume of interest, anatomical details were evaluated by multi-
planar reconstructions with volume rendering and 
manipulation of the parameters on the maximum intensity 
projection mode.
 Results
The shunt points were well identified on the DSA and CBCT 
with 100% of sensitivity, while MRI and MR-DSA showed 
the shunt points in only 9% of the cases. 3D-CT showed 18% 
of sensitivity (Table 1).
ASA was well-visualized on DSA and CBCT with 100% 
of sensitivity; however, MRI and 3D-CT could depict ASA 
with less than 60% of the cases (Figs. 1 and 2).
The sensitivity of CBCT was so remarkable that it suc-
cessfully showed the exact location of the shunt point, ASA, 
and DV in 100% of the cases (Fig. 3), but was less able to 
visualize DSB. According to the analysis of the serial axial 
and coronal images based on the slab maximum intensity 
projection (Slab MIP), the exact shunt point in most of the 
cases was located on the surface of the nerve sleeves. DSB 
could also be depicted on this slab MIP mode in 68% of the 
cases (Fig.  4). The basket formation of the anastomosis 
between ASA and bilateral PSA was well visualized on 
CBCT (Fig. 5). It is usually difficult to identify the PSA on 
the conventional DSA; in this series, however, the sensitivity 
to PSA with CBCT was more than 70% (Fig. 6).
Meningeal branches of the radiculomeningeal artery were 
the main feeding arteries in 21 of 22 cases (95.5%). These 
feeding arteries ran medially on the surface of the dural 
sleeve and turned longitudinally along the dura mater of the 
thecal sac. Then they gathered and joined the single vein on 
the inner dural surface. In 16 cases (72%), we observed these 
longitudinal meningeal feeders and a drainage vein that 
resembled the horizontal T sign in an anteroposterior view of 
angiography as well as in CBCT (Fig. 3a).
MRI CE-MRA 3D-CT DSA CBCT
Shunt point 2 (9%) 2 (9%) 4 (18%) 22 (100%) 11 (100%)
ASA 12 (55%) 13 (59%) 13 (59%) 22 (100%) 11 (100%)
PSA 0 (0%) 0 (0%) 1 (4.5%) 16 (73%) 8 (73%)
DSB 0 (0%) 0 (0%) 0 (0%) 13 (59%) 7 (64%)
DV 21 (90%) 21 (90%) 18 (81%) 22 (100%) 22 (100%)
This table shows the number of the prominent and well visible structures on five different radio-
logical images
Table 1 Visibility of the anatomical 
structure on each imaging modality 
associated with SDAVFs
Fig. 2 3D-CT delineated the course of the intercostal artery (short 
arrow) and the terminal feeder toward the shunt point (long arrow) cor-
responding to the meningeal branches of the radiculomeningeal artery
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Fig. 3 (a) Conventional DSA injected from the right intercostal artery 
at the level of T9. It showed the SDAVF with the longitudinal menin-
geal feeders and a drainage vein. The configuration of this longitudinal 
meningeal feeder and a drainage vein resembled the horizontal T sign 
in an anteroposterior view. (b) CBCT depicted the shunt point, pre-
cisely locating it on the lateral surface of the dura mater
a cb
Fig. 4 (a) Right intercostal artery injection of DSA (AP view). (b) 
CBCT after complete elimination of the shunt. (c) Schematic represen-
tation of spine and spinal cord supply at the upper thoracic level. Note 
the contralateral DSB (arrow) is opacified through the anastomosis. The 




In terms of digital images, spatial resolution refers to the 
number of pixels utilized in the construction of the image. 
The higher spatial resolution of medical images is essential 
in the management and giving the indication of therapeutic 
options for SDAVF [2, 3].
Recent advancements in imaging technology improved the 
performance and efficacies of MRI, CE-MRA, and MDCT in 
terms of the definition of the shunt point as well as the adjacent 
vasculatures. These imaging modalities are less invasive and 
are available in the outpatient clinic. However, the degree of 
definition and the sensitivities to the region of interest on these 
modalities are still inferior to the conventional DSA and 
CBCT with the use of invasive catheter angiography.
The discrimination between SDAVFs and spinal epidural 
fistulas (SEAVFs) is very important to the process of making 
a strategy of treatment and indicating the intervention. 
Kiyosue et al. reported on 168 patients with spinal dural and 
epidural arteriovenous fistulas from 31 centers in Japan [5]. 
Six readers analyzed the angioarchitecture. Approximately 
half of the epidural fistulas were incorrectly diagnosed as 
dural fistulas at the individual centers, highlighting the need 
to establish and publish distinguishing features. The shunt 
points of SDAVFs are more commonly located in the tho-
racic spine, whereas SEAVFs have a propensity to be in the 
lumbar spine and are associated with a history of spinal 
injury or surgery [5]. Both are more common in males and 
present with myelopathy. SDAVFs have their shunt point 
medial to the medial interpedicle line that indicates the esti-
mated lateral margin of the thecal sac. They are supplied by 
meningeal branches of the radiculomeningeal artery. 
SEAVFs form epidural venous pouches located in the epi-
dural space and shunt into the perimedullary vein, paraverte-
bral veins, or both. They are supplied by epidural arteries, 
usually the DSB (dorsal somatic branch) [2, 3, 5].
The distinction is also relevant for treatment. Whereas 
dural fistulas are favorable for open surgery and intradural 
Fig. 6 CBCT after complete elimination of the shunt. Note bilateral 
PSA were well-visualized on this plane (arrow)
Fig. 5 CBCT showed the great anterior radiculomedullary artery 
(Adamkiewicz artery) and the basket formation (arrow) at the level of 
conus medullaris
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division of the draining vein, epidural fistulas are better 
served by endovascular embolization [6, 7]. Feeders to 
 epidural fistulas also tend to be straight and more easily 
accessible using the endovascular route.
 Classification of SDAVFs Based 
on the Advanced Images in Terms 
of the Embryological Origin of the Dura Mater
The higher definition images showed that typical SDAVFs had 
the shunt point on the lateral surface of the dura mater of the 
spinal canal, and it was more or less associated with the dura 
mater covering the nerve sleeve. The majority of SDAVFs are 
mainly supplied by meningeal branches from the radiculo-
meningeal artery. These meningeal branches anastomose ver-
tically and drain into the single intradural vein, which typically 
forms horizontal T sign on a frontal view of spinal angiogra-
phy and CBCT.  It is generally thought that SDAVFs are 
located at the dura mater of the spinal nerve root sleeve and 
drain into the radiculomedullary vein. In normal anatomy, the 
drainage veins from the spinal cord, called radiculomedullary 
veins, run along the nerve root and penetrate the dura at the 
spinal nerve root sleeve. These radiculomedullary veins are 
found in 60% of the healthy population [8]. The remaining 
40% show venous drainage of the spinal cord via the bridging 
vein, which runs apart from the nerve root and pierces the dura 
mater of the spinal cord to join the epidural venous plexus. 
SDAVFs can involve either the radiculomedullary vein or the 
bridging vein [2, 3, 5]. The dura mater at the level of the spinal 
cord are derived from the neural crest cell and consist of the 
single layer of dura propria, while the intracranial dura mater 
consists of dura propria and periosteal dura [9–12]. Thus, the 
characteristics of the dura mater of spinal cord are similar to 
the dura mater of crista galli (olfactory groove), falx cerebri, 
tentorium cerebelli, and falx cerebelli, because these dura 
maters consist only of the dura propria [13–16]. Additionally, 
those dura maters (dura propria) have the same origin of neu-
ral crest cell, while the convexity area of intracranial dura 
mater might derive from paraxial mesoderm, according to 
recent studies based on the immunostaining analysis of experi-
mental model [10, 14, 17–19].
 Conclusions
Three-dimensional angiography, particularly multiplanar 
reconstruction images with CBCT, is quite useful for evalu-
ating the microangioarchitecture of SDAVFs. This modality 
showed the exact localization of the shunt point. There are 
certain susceptibilities to the formation of the shunt on the 
lateral surface of the spinal canal, which is frequently inde-
pendent from the nerve sleeves. The vulnerability of the dura 
mater might be associated with the fact that dura mater in the 
spinal canal consists only of the dura propria and derives 
from neural crest. SDAVFs and intracranial DAVFs located 
on the dura mater of the falco-tentorial, olfactory groove, 
falx cerebri, and tentorium cerebelli might belong to the 
same anatomical entity and they are composed only of the 
dura propria derived from neural crest.
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 Introduction
Cerebrovascular reactivity (CVR) is the physiological capac-
ity of the brain vessels to modulate cerebral blood flow 
(CBF) by changing their caliber in response to a vasoactive 
stimulus: this allows an adequate supply of oxygenated 
blood to the brain despite wide variations of perfusion pres-
sure [1, 2].
Diverse neurological diseases can strain this physiologi-
cal capacity beyond a limit that the brain vessels cannot fur-
ther compensate, leading to exhaustion of the cerebrovascular 
reserve and, therefore, to CVR impairment [3]. Impaired 
CVR can be used as a measure of the hemodynamic stress 
the brain is undergoing in a particular anatomical area. Many 
studies have confirmed the validity of CVR as a marker of 
the hemodynamic state in vascular diseases [4–9]. The clini-
cal relevance of CVR in predicting stroke risk has been con-
firmed, and CVR is widely investigated with different 
techniques, allowing risk stratification and providing valu-
able information for therapeutic decision-making [9, 10]. We 
have recently proposed and tested an intraoperative CVR 
assessment to obtain early information that could potentially 
help during the surgical procedure [11, 12].
CVR can be studied by applying a vasoactive stimulus to a 
patient and measuring the resulting changes at the brain level, 
either by CBF modifications or by surrogate of blood flow. As 
vasoactive stimulus, drugs or endogenous substances like 
CO2 can be used [1]. Variations in the arterial CO2 concentra-
tions are obtainable by induced or voluntary apnea [1, 13]. To 
measure hemodynamic changes after administration of a 
vasoactive stimulus, many methods are granted, like Doppler 
sonography [9], arterial spin labeling (ASL) [14], or blood 
oxygenation-level dependent functional magnetic resonance 
imaging (BOLD-CVR) [3]. Detecting changes in the BOLD 
signal has proved a valid method with high imaging resolu-
tion, allowing a good depiction of the hemodynamic state at 
brain tissue level. This exploits deoxyhemoglobin paramag-
netic properties, which make the BOLD signal get lower with 
higher blood deoxyhemoglobin concentrations [1, 15]. Areas 
with a higher blood flow achieve a higher deoxyhemoglobin 
clearance, thereby displaying a higher oxyhemoglobin/
deoxyhemoglobin ratio, which ultimately results in higher 
BOLD signal [1].
 Materials and Methods
This study has been approved by the cantonal ethics board of 
the Canton of Zurich, Switzerland (KEK-ZH-Nr. 2012–0427) 
and all participants signed informed consent prior to the study. 
An attempt to measure BOLD-CVR intraoperatively was first 
accomplished in oncological patients [11, 12]. Considering the 
technical issues associated with obtaining controlled iso-oxic 
hypercapnic stimuli and the need of a cooperative patient for 
this purpose [1], only breath-holding tasks were feasible so far 
to obtain CO2 raises in unconscious patients. In the operating 
setting, a sedated and intubated patient is transferred from the 
operating theater to the adjacent MR suite, following a previ-
ously described protocol used at our institution [11, 16] and 
scanned on a 3-tesla device, obtaining BOLD, T1-weighted 
without contrast enhancement, plus other sequences according 
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to the specific patient’s case (i.e., T1-weighted with contrast, 
T2-weighted, fluid attenuation inversion recovery [FLAIR] and 
susceptibility weighted [SWI] sequences for tumor patients, 
TOF- MRA or diffusion weighted imaging [DWI] in vascular 
diseases). The technical details about acquisition parameters 
can be found in our previous publications [11, 12, 17]. During 
acquisition of the BOLD sequences, hypercapnia is induced by 
three 44-s apnea cycles obtained by halting the ventilator, fol-
lowed by hyperventilation to return to the subject’s baseline 
CO2. Between each hypercapnic challenge, an 88-s baseline 
CO2 period is maintained. This allows obtaining satisfactory 
CO2 oscillations and therefore adequate vasoactive stimuli 
resulting in coherent BOLD-signal fluctuations [11].
Pre-processing and data analysis are performed following 
a method described previously [11, 18, 19]. CVR can be thus 
calculated on a voxel-by-voxel basis and measured as the 
mean percentage BOLD signal change between baseline and 
hypercapnia. For optimal depiction, the percentage changes 
values are color-coded and overlaid on the T1-wighted ana-
tomical scan acquired during the same session (see Fig. 1).
 Results
The intraoperative BOLD-CVR assessment was performed 
at our institution on both oncological and vascular diseases 
[11, 12, 17, 20] (Table 1). In a first attempt to assess its fea-
+3%
-3%
Fig. 1 Example of intraoperative BOLD-CVR color-coded map. 
Intraoperative BOLD-CVR assessment in a patient with occlusion of 
the right internal carotid artery after STA-MCA bypass for flow- 
augmentation. Areas with impaired hemodynamic status are depicted in 
blue. The color scale refers to the mean percentage change in BOLD 
signal per voxel between baseline and hypercapnic state
Table 1 Patient sex, age, diagnosis and intraoperative CVR values of all the patients undergoing intraoperative BOLD-CVR assessment included 
in previous studies
Sex/age Diagnosis






Difference affected vs. 
unaffected
1. M 43 Anaplastic astrocytoma (grade III 
WHO)
0.9 1.18 0.94 125.5%
2. M 31 Oligoastrocytoma (grade III WHO) 0.13 0.83 0.18 461.1%
3. M 18 Inconclusive 1.12 1.24 1.05 118.1%
4. M 51 Glioblastoma (grade IV WHO) 1.01 1.02 0.8 127.5%
5. F 41 Anaplastic astrocytoma (grade III 
WHO)
0.95 1.01 0.89 113.5%
6. M 38 Anaplastic oligoastrocytoma (grade III 
WHO)
0.85 0.1 0.69 14.5%
7. M 18 Medulloblastoma 0.14 1.37 0.19 721.1%
8. M 46 Morbus Biswanger 1.35 0.48 1.33 36.1%
9. M 76 3-vessel atherosclerosis 0.43 0.42 0.38 110.5%
10. F 42 Intravasal and mural myxomas 0.4 0.72 0.37 194.6%
11. F 68 ICA occlusion 1.4 1 1.95 51.3%
12. F 66 ICA occlusion 2.08 1.54 2.61 59.0%
13. F 49 Moyamoya disease 1.44 1.64 1.22 134.4%
14. F 62 ICA, MCA ans ACA occlusion 0.16 0.03 0.28 10.7%
15. M 50 ICA occlusion 0.76 0.71 0.81 87.7%
16. F 46 Anaplastic astrocytoma (grade III 
WHO)
1.77 1.62 1.83 88.5%
CVR values are calculated as mean % BOLD signal change between baseline and the hypercapnic (breath-hold) challenge
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sibility, ten patients (two with vascular diseases and eight 
with oncological diseases) who were scheduled to undergo 
an intraoperative MR assessment to assess extent of resec-
tion in tumor cases or bypass anastomosis in STA-MCA 
revascularization surgery for flow augmentation were also 
scanned as described above with a BOLD scan.
As a preliminary finding, none of the patients displayed 
intra- or postoperative complications due to the prolonged 
time for anesthesia or for the breath-hold task. Analyzing 
CVR data showed impaired values for oncologic patients 
within the lesion and on both hemispheres [17]. We then 
scanned more patients and obtained a small cohort of five 
patients with high-grade gliomas. Interestingly, they showed 
a lower CVR in brain areas that showed tumor recurrence on 
follow-up [12].
In patients undergoing STA-MCA flow augmentation 
bypass surgery, intraoperative CVR values were on average 
higher after revascularization [20] and again, none of them 
had peri- or postoperative complications.
 Discussion
The aim of introducing and developing BOLD-CVR assess-
ment is to offer a new tool, which could help surgery and 
influence decision-making by offering an early feedback on 
the hemodynamic state of the brain. To this aim, further stud-
ies with larger cohorts and long follow-up are still needed. 
BOLD-CVR could be useful in discriminating normal brain 
from tumor tissue beyond the limits of current standards, like 
T1-weighted imaging with contrast enhancement [21] and, if 
future studies confirmed our preliminary results, offer a bet-
ter depiction of areas of tumor infiltration. This information, 
if gained intraoperatively, could be helpful to achieve a better 
extent of resection. It is important to stress, however, that 
BOLD signal is not a measure of CBF alone, being that it is 
dependent on other physiological parameters such as cere-
bral blood volume (CBV), hematocrit, and cerebral meta-
bolic rate of oxygen (CMRO2) consumption [15, 22]. More 
precisely, CVR is a measure of the vessels’ ability to modu-
late blood flow [2]. As mentioned previously, cerebrovascu-
lar reserve can be exhausted in some areas undergoing 
relevant hemodynamic stress. In these areas, a vasoactive 
stimulus produces a “steal” blood flow to areas with con-
sumed reserve capacity to others with preserved CVR [23]. 
This is depicted by a lower BOLD-signal in areas with 
exhausted capacity [3].
In patients undergoing STA-MCA bypass revasculariza-
tion for flow augmentation (for example in Moymoya dis-
ease), an immediate intraoperative feedback on the brain 
hemodynamic state after the microanastomosis could prove 
its efficacy in actually revascularizing the hypoperfused 
areas of the brain by depicting early CVR improvements, if 
present [20]. This information could also help in the opera-
tive decision-making process and to estimate the success of 
the bypass.
Despite these promising possibilities, this type of infor-
mation is currently not available. First, the technique associ-
ated with the vasoactive stimulus (i.e., breath-holding) has 
inherent limitations that impede a precise comparison 
between data. Specifically, breath-holding allows for a raise 
in CO2 arterial concentration, but since it also causes con-
comitant hypoxia, it can alter the cellular metabolism and 
therefore also the CO2 production [1]. Moreover, breath- 
holding allows for a raise in the CO2 arterial concentration, 
which varies between subjects according to each subject’s 
features and physiologic parameters (age, sex, weight, meta-
bolic status, and physical fitness) and in the same subject 
over time [1]. The entity of this change is therefore unpre-
dictable, and the vasoactive stimulus cannot be controlled or 
modulated [1], thereby providing different entities of vasoac-
tive stimulus in different investigations. This hinders inter- 
and intrasubject comparisons. These limitations are avoided 
by using a custom gas blender (Respiract™, Thornhill 
Medical, Toronto, Canada), which allows acquisition of tar-
geted hysoxic pseudo-square waved changes of arterial CO2 
concentration: a controlled and consistent stimulus can be 
provided by letting the subject inhale and rebreathe a gas 
mixture to obtain 10 mmHg raises of the CO2 arterial con-
centration from the previously registered subject’s baseline 
[1, 3] (Fig. 2). Nevertheless, this has technical nuisances that 
hinder its intraoperative employment. With the future 
improvements of currently used technologies [10, 24] to 
obtain controlled changes of the inhaled CO2 concentration, 
we expect to be able to perform BOLD-CVR investigations 
with controlled vasoactive stimuli also intraoperatively in the 
near future. In our experience, this also impeded a direct 
quantitative comparison between intra- and pre- or postop-
erative scans, since these were acquired with different tech-
niques (see also van Niftrik and Piccirelli [18, 19] for further 
technical details on the techniques and data analysis).
Secondly, we dealt with cohorts with limited numbers, 
which therefore does not allow us to extend our conclusions 
to other patients.
Nevertheless, intraoperative BOLD-CVR assessment 
offered interesting results, which we think deserve further 
investigation: first, we observed an early intraoperative 
change after revascularization in patients undergoing bypass 
revascularization surgery for flow augmentation with BOLD- 
CVR. Second, we identified an association with intraopera-
tive findings and the evolution of the disease. Third, we 
confirmed that this assessment is not associated with higher 
complication rates. All these findings offer, in our opinion, a 
reasonable basis for further investigations.
Further developments of this application will include 
patients with aneurysmal subarachnoid hemorrhage. 
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Specifically, impaired CVR has been found after aneurysmal 
subarachnoid hemorrhage (SAH) in patients with lower clin-
ical grade, and progressive impairment of CVR was associ-
ated with a higher risk of delayed cerebral ischemia (DCI) 
[25]. The purpose of obtaining an intraoperative or ultra- 
early BOLD-CVR assessment would be to identify areas 
with impaired CVR at risk for DCI or to assess a CVR value 
for future comparison for follow-up, in order to predict DCI.
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 Introduction
In Japan, hybrid neurosurgeons who perform both open sur-
gical clipping as well as endovascular embolization for the 
treatment of intracranial aneurysms are common. Over 90% 
of Japanese board-certified neuroendovascular therapists are 
board-certified neurosurgeons. Reasons for this situation 
include the fact that cerebral angiography and management 
of stroke patients are primarily performed by neurosurgeons. 
Although many Japanese neurosurgeons can perform surgi-
cal clipping of middle cerebral artery (MCA) or internal 
carotid-posterior communicating artery aneurysms and coil 
embolization of cerebral aneurysms using simple techniques, 
only a limited number of neurosurgeons are able to perform 
surgical clipping and endovascular procedures for anterior 
communicating artery (A-com), paraclinoid internal carotid 
artery (ICA), or posterior circulation aneurysms using both 
treatment modalities equally and safely.
 Materials and Methods
The senior author’s personal experience of more than 500 
cases each of surgical clipping and endovascular emboliza-
tion over the past 25 years included 110 cases of basilar tip 
aneurysms and 104 cases of paraclinoid ICA aneurysms.
 Results
The safety and efficacy of both treatments appears to be the 
same, while the durability of surgical clipping is superior to 
that of endovascular embolization. Among the 110 basilar tip 
aneurysms, 18 patients were treated by surgical clipping and 
94 were treated by endovascular embolization. The initial 
results of endovascular therapy seemed to be better than 
those of surgical clipping, although the rate of retreatment 
was higher (Table 1). Among the 104 cases of paraclinoid 
ICA aneurysm, 23 patients were treated by surgical clipping 
and 81 were treated by endovascular embolization. The 
results of both treatments seemed to be same, while surgical 
clipping had apparently good long-term durability (Table 2).
 Illustrative Cases
Case 1 A 67-year-old woman had a non-ruptured large basi-
lar tip aneurysm associated with Moyamoya disease. The 
bilateral posterior cerebral arteries (PCA) were incorporated 
in the aneurysm (Fig. 1a). As surgical clipping for such an 
aneurysm was thought to be extremely difficult, horizontal 
stent-assisted coil embolization via the right posterior com-
municating artery was performed. A micro-catheter was 
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Table 1 Treatment of basilar tip aneurysms
Clipping (16 cases;  
1 large)
Coil embolization (94 cases; 
9 large)
Morbidity 1/16 (6.3%) 2/94 (2.1%)




Retreatment 0 10/94 (10.6%)
Table 2 Treatment of paraclinoid IC aneurysms
Clipping (23 cases; 8 
large)
Coil embolization (81 cases; 
11 large)
Morbidity 2/23 (8.7%); minor 4/81 (4.9%)
Mortality 0 0
Regrowth 0 3/81 (3.7%)
Retreatment 0 10/81 (12. 3%)
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advanced to the right P-com and turned medial to the right 
P1 of PCA, across the aneurysmal orifice, ultimately reach-
ing the left P2 of the PCA. A Neuroform Atlas stent (Target 
Therapeutics, CA, USA) was deployed across the entire ori-
fice (Fig. 1b). Coil embolization was then completed without 
significant difficulty. Complete obliteration of the aneurysm 
with preservation of the bilateral PCA was achieved (Fig. 1c). 
The patient had a good clinical course without any neuro-
logical deficits.
Case 2 An 80-year-old woman had a left IC-ophthalmic 
large aneurysm (Fig.  2a) that demonstrated remarkable 
recanalization and regrowth following incomplete coil 
embolization (Fig. 2b). Three years later, she became blind 
due to severe compression of the bilateral optic nerves.
Case 3 A 41-year-old woman had a large left IC-ophthalmic 
aneurysm with mass effect (Fig. 3a). She had bilateral visual 
a
cb
Fig. 1 (a) 3D CTA demonstrating a non-ruptured large basilar tip 
aneurysm associated with Moyamoya disease. The bilateral posterior 
cerebral arteries (PCAs) are incorporated in the aneurysm. (b) A 
Neuroform Atlas stent was deployed across the entire orifice. (c) A 
post-embolization angiogram demonstrating complete obliteration of 
the aneurysm with preservation of the bilateral PCAs
a b
Fig. 2 (a) MRI demonstrating a left IC-ophthalmic large aneurysm. (b) MRI obtained 3  years later showing remarkable recanalization and 
regrowth of the aneurysm following incomplete coil embolization





Fig. 3 (a) 3D CTA demonstrating a large left IC-ophthalmic aneu-
rysm. (b) An intraoperative photograph demonstrating an aneurysm and 
the left optic nerve through standard left pterional craniotomy. (c) The 
aneurysm was punctured, and suction decompression was performed. 
(d) Reconstructive clipping was performed using three fenestrated 
clips, sparing all branches. (e) Postoperative 3D CTA demonstrating 
complete obliteration of the aneurysm with preservation of the ICA 
flow
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field defects. Through standard left pterional craniotomy, the 
aneurysm and left optic nerve were exposed (Fig. 3b). After 
extradural one-block anterior clinoidectomy, the proximal IC 
and ophthalmic arteries were secured. Temporary clips were 
applied to the proximal IC, distal IC, and ophthalmic artery. 
The aneurysm was punctured, and suction decompression 
was performed. After decompression, the superior hypophy-
seal artery was dissected (Fig. 3c). Reconstructive clipping 
was performed using three fenestrated clips while sparing all 
of the branches (Fig. 3d). The patency of the branches was 
confirmed by indocyanine green video-angiography. 
Postoperative three-dimensional computed tomography 
angiography (3D CTA) revealed complete obliteration of the 
aneurysm with preservation of the ICA flow (Fig. 3e). Her 
right-side visual field defect improved after the clipping.
 Discussion
In training programs in Japan for hybrid neurosurgeons, 
trainees start their training program as a resident in the 
department of neurosurgery, where they learn about general 
neurosurgical practices and perform cerebral angiography as 
well. The trainees finish the programs for both neurosurgery 
and neuro-endovascular treatment simultaneously, after 
which they take examinations and are finally certified for 
both programs at the fifth year of the senior resident pro-
gram. Thereafter, they gain further experience in both treat-
ments. While Japanese hybrid neurosurgeons who perform 
both open surgical clipping and endovascular embolization 
for the treatment of intracranial aneurysms are common, 
relatively few neurosurgeons are able to perform surgical 
clipping and endovascular procedures for difficult cerebral 
aneurysms, such as those of the A-com, paraclinoid ICA, or 
posterior circulation. Ideally, hybrid neurosurgeons need to 
have skills to treat such difficult aneurysms using both treat-
ment modalities equally and safely.
The senior author has performed more than 500 cases 
each of surgical clipping and endovascular embolization 
over the past 25 years. The safety and efficacy of both treat-
ments appears to be the same, while the durability of surgical 
clipping is superior to that of endovascular embolization 
[1–7]. Technical advances in coils and intracranial stents has 
meant that the treatment choice for cerebral aneurysms has 
changed over the years, especially that for basilar tip aneu-
rysms. Over the past 15 years, the frequency of surgical clip-
ping for basilar tip aneurysms has decreased, and the 
procedure may eventually be abandoned for this type of 
aneurysm. However, surgical clipping still offers several 
advantages in the treatment of paraclinoid ICA aneurysms. 
In the senior author’s personal experience of treating paracli-
noid IC aneurysms both surgically and endovascularly, the 
results of surgical clipping seemed to be the same as endo-
vascular treatment with good long-term durability. Even 
when using a flow-diverting stent, endovascular treatment is 
still associated with some morbidity or the recanalization/
regrowth of aneurysms.
According to the senior author’s personal impression, 
neurosurgeons tend to overestimate the efficacy and safety of 
endovascular treatment instead of long-term durability, while 
endovascular interventionists tend to exaggerate the inva-
siveness of modern surgical clippings. Endovascular inter-
ventionists are overconfident regarding the feasibility of the 
treatment, as this approach can be easily performed with the 
aid of satisfactory initial morphological results, although the 
long-term durability of the endovascular treatment seems 
less satisfactory than that of clipping. Hybrid neurosurgeons 
can make reasonable decisions concerning the choice of 
treatment for cerebral aneurysms, as they perform both treat-
ments and understand the benefits and drawbacks of each 
modality [8].
 Conclusions
Although many Japanese neurosurgeons can perform surgi-
cal clipping of MCA or IC-P-com aneurysms and coil embo-
lization of cerebral aneurysms using simple techniques, only 
a limited number of neurosurgeons are able to perform surgi-
cal clipping and endovascular procedures for A-com, para-
clinoid ICA, or posterior circulation aneurysms. Ideally, 
hybrid neurosurgeons should be able to treat such difficult 
aneurysms using both treatment modalities equally and 
safely, allowing them to make reasonable decisions on the 
choice of treatment for cerebral aneurysms.
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